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ABBREVIATION LIST 
°C degrees centigrade 
µg microgram 
µl microliter 
µm micrometer 
µTi titanium microbeads 
AD anno Domini 
ANOVA analysis of variance 
APMA 4-aminophenylmercuric acetate 
BC before Christ 
BCC body-centered cubic 
BGD Brilliant Green dye 
BGD1, BGD2, BGD3 PLA films embedded with BGD for 1, 2 and 3 hours respectively 
BSA bovine serum albumin 
CAT catestatin 
CCL chemokine (C-C motif) ligand 
CCR C-C chemokine receptor 
CD cluster of differentiation 
CD14 CD14 positive macrophages 
cDNA complementary deoxyribonucleic acid 
CHI3L1 chitinase-3-like protein 1 
CHIT1 chitotriosidase 
COX cytochrome c oxidase 
Cp Ti commercially pure titanium 
CR complement receptor 
Ct threshold cycle 
CXCL C-X-C motif chemokine ligand 
DAMP damage-associated molecular pattern 
ddH2O double distilled water 
DEPC diethyl pyrocarbonate 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
dNTPs deoxyribonucleotides 
EDTA ethylene diamine tetra acetic acid 
EGF epidermal growth factor 
ELISA enzyme-linked immunosorbent assay 
EM emission 
EMEM Eagle's minimal essential medium 
EU European Union 
EX excitation 
FACS fluorescent activated cell sorting 
Fc fragment crystallisable 
FCS fetal calf serum 
FcγR Fc gamma receptor 
FDR false discovery rate 
FPR N-formyl peptide receptor 
g gram / relative centrifugal force 
GAPDH glyceraldehyde 3-phosphate dehydrogenase 
GM-CSF granulocyte-macrophage colony-stimulating factor 
GPa gigapascal 
h hour(s) 
HA hydroxyapatite 
HA hyaluronic acid 
HCP hexagonal close-packed 
HMGB1 high mobility group box 1 protein 
HRP horseradish peroxidase 
HSP heat shock protein 
IFNγ interferon gamma 
Abbreviation list 
6 
IgG immunoglobulin G 
IL interleukin 
IL-1Ra Interleukin 1 receptor antagonist 
iNOS inducible nitric oxide synthase 
JMFI juxtacrine macrophage-fibroblast interaction 
L liter 
LIF leukemia inhibitory factor 
LPS lipopolysaccharide 
LTA lymphotoxin-alpha 
M molar concentration 
M(Control) non-stimulated macrophages 
M(IFNγ) macrophages activated with IFNγ 
M(IL-4) macrophages activated with IL-4 
M1 classically activated macrophages 
M2 alternatively activated macrophages 
MACS magnetic-activated cell sorting 
MARCO macrophage receptor with collagenous structure 
M-CSF macrophage colony-stimulating factor 
MIF macrophage migration inhibitory factor 
min minute(s) 
ml milliliter 
mM millimolar concentration 
mm millimeter 
MMP matrix metalloproteinase 
MPa megapascal 
MRI magnetic resonance imaging 
mRNA messenger RNA 
N equivalent concentration 
NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells 
ng nanogram  
NLRP3 NLR family pyrin domain containing 3 
nm nanometer 
nTi titanium nanoparticles 
OPG osteoprotegerin 
PAR polyarginine 
PAR/HA polyarginine-hyaluronic acid based coating 
PBMC peripheral blood mononuclear cell 
PBMC-CD14 PMBC depleted of the CD14 positive monocytes 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PDGF platelet-derived growth factor 
PEG poly(ethylene-glycol) 
PELA ethylene oxide/lactic acid copolymer 
PET polyethylene terephthalate 
PFA paraformaldehyde 
pg picogram 
PGE prostaglandin E 
PITPNM3 phosphatidylinositol transfer protein family member-associated 3 
PLA polylactic acid 
PLGA poly(lactide-co-glycolide) 
PMFI paracrine macrophage-fibroblast interaction 
PMMA polymethylmethacrylate 
pmol picomolar 
PRR pattern-recognition receptor 
psi pound per square inch 
PVA poly(vinyl-alcohol) 
RANK receptor activator of nuclear factor kappa B 
RANKL receptor activator of nuclear factor kappa-B ligand 
RBC red blood cells 
RMA Robust Multi-Array Average 
RNA ribonucleic acid 
RNS reactive nitrogen species 
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ROS reactive oxygen species 
rpm revolutions per minute 
RT room temperature 
RT-qPCR reverse transcription real-time polymerase chain reaction 
s second(s) 
SA heat killed Staphylococcus aureus 
SR scavenger receptor 
Std standard 
TAE tris/Acetate/EDTA-buffer 
TGF transforming growth factor  
TGFβR1 transforming growth factor, beta receptor I 
TLR toll-like receptor 
TNFRSF tumor necrosis factor receptor superfamily, member 
TNFSF tumor necrosis factor (ligand) superfamily, member 
TNFα tumor necrosis factor alpha 
TRADD tumor necrosis factor receptor type 1-associated DEATH domain protein 
TRAP tartrate-resistant acid phosphatase 
U conventional units 
UHMWPE ultra-high-molecular-weight polyethylene 
UV ultraviolet 
V volt(s) 
VBA Visual Basic for Applications 
vs versus 
wt% percentage by mass 
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1 INTRODUCTION 
1.1 Implants and medical devices 
Medical devices, prosthesis and implants were used in medicine since the dawn 
of civilization. The earliest records of medical tools describe the usage of flint scrapers 
and borers for trepanation as early as during the Neolithic age. Starting from the bronze 
age and during the Classical age the use of knives, needles, toothed forceps, bone 
elevators, dilators and other surgical instruments made of bronze and iron are 
described1. Early mentions of prosthesis can be found in the Vedas (between 3500 
and 1800 BC) where a prosthetic iron leg was made for the Warrior-Queen Vishpla. 
There is also evidence of prosthetic use in ancient Egypt. A toe from an Egyptian 
mummy displayed in Cairo museum was replaced by a prosthesis made of wood and 
leather (circa 1500 BC)2. Ancient Egyptians are also known to employ gold wires for 
the stabilization of periodontally involved teeth (circa 2500 BC). Later, Etruscans 
developed teeth replacements from oxen bones, while Phoenicians carved teeth out 
of ivory and utilized gold wires to stabilize them and create a fixed bridge. Mayans are 
credited with the use of first dental implants which were made from shells to replace 
mandibular teeth (circa 600 AD)3.  
It is only natural that throughout the ages, in line with advances in technology, 
medical devices greatly evolved. From simple metal scalpels to µm precise laser 
scalpels, medical devices have seen great progress during the ages and therefore the 
definition of medical device also changed. Modern definitions of medical devices and 
implants are presented below. 
Directive 2007/47/EC of the European Union defines a medical device as any 
instrument, apparatus, appliance, software, material or other article used for the 
purpose of:  
- diagnosis, prevention, monitoring, treatment or alleviation of disease;  
- diagnosis, monitoring, treatment, alleviation of or compensation for an 
injury or handicap; 
- investigation, replacement or modification of the anatomy or of a 
physiological process; 
- control of conception; 
and which does not achieve its principal intended action in or on the human body by 
pharmacological, immunological or metabolic means, but which may be assisted in its 
function by such means4.  
Implants (implantable devices) are medical devices intended: 
- to be partially or totally introduced in the human body by surgical 
intervention; 
- to replace an epithelial surface or the surface of the eye; 
and are intended (expected) to remain in place for at least 30 days after the procedure 
(Annex 9 directive 93/42/EEC)5.  
Nowadays millions of patients around the world improve their quality of life with the 
help of implants. In 2011, in the European Union alone, there were more than 44 million 
people with disabilities registered6. Some of them are able to restore the function of 
the disabled organs with implants. Surgeries for hip or knee replacement are very 
effective in relieving pain and restoring walking function, while cochlear implants 
greatly improve the hearing ability. For 2014, there were more than 1.5 million such 
procedures reported by European Union member states. Table 1 provides an overview 
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of surgeries related to hip or knee replacement and cochlear implantation performed 
by each member of the European Union7.  
 
Table 1. Number of surgeries performed for hip or knee replacement and cochlear 
implantation by the members of the European Union in 2014. (Data for Belgium, Bulgaria, 
Greece, Latvia and Netherlands are missing) 
European Union 
member 
Cochlear 
Implantation 
Hip 
Replacement 
Secondary Hip 
Replacement 
Total Knee 
Replacement 
Austria 336 23822 1781 18881 
Croatia 85 6291 662 2355 
Cyprus 10 412 5 380 
Czech Republic  18425  12698 
Denmark 304 13214 1431 9709 
Estonia  1450   
Finland 151 13360 1921 10436 
France 1461 158134 17310 103302 
Germany  3805 237067 24682 159686 
Hungary 175 12581 1089 7015 
Ireland 143 5781 565 2107 
Italy  101510 33446 65279 
Lithuania 21 4718 364 2193 
Luxembourg  1053 106 895 
Malta 11 326 12 636 
Poland 563 37152 1133 11780 
Portugal  9101 4256 6111 
Romania 110 12853 953 4604 
Slovakia  6737 507 5456 
Slovenia 30 3407 320 2178 
Spain 895 51849 5572 56364 
Sweden 353 22725 1886 12685 
United Kingdom 1294 119802 9395 95909 
Total 9747 861770 107396 590659 
 
Implants are used to restore many other functions as well. From dental implants 
that help with mastication to cardiac pacemakers that preserve life, implants can be 
used in virtually all body organs to improve or restore their function. As implants come 
in direct contact with body tissues the study of implant-tissue interaction from an 
immunological point of view is of great importance and will constitute the main focus of 
this study. 
1.1.1 Classification of medical devices and implants 
The European Union recommends a classification of medical devices according to 
their safety and purpose. The medical devices are divided in 4 classes (I, IIa, IIb and 
III) with the low risk devices being included in class I and high risk devices in class III. 
Classification is done according to the rules listed in Directive 93/42/EEC (Annex IX) 
which take into account the degree of invasiveness, duration of contact with the body, 
the ability to biologically or chemically modify body liquids, etc5. Table 2 presents the 
classification of medical devices according to the EU directive with some examples8. 
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Table 2. Classification of medical devices according to The Directive 93/42/EEC. Adapted 
from Journal of the Royal Society of Medicine, volume 105, Suppl 1:S22-8, Elaine French-
Mowat, Joanne Burnett, How are medical devices regulated in the European Union?, Copyright 
(2012), with permission from SAGE publishing.  
Class Associated 
risk 
Description Examples 
I  
Is (sterile) 
Im (measuring) 
low Most non-invasive devices hospital beds, 
sterile plasters,  
bandaging,  
thermometers, 
IIa medium Exchange energy with a patient 
in a non-hazardous way. 
Invasive but limited to natural 
orifices 
hearing aids,  
ultrasonic diagnostic devices,  
tooth crowns, 
contact lenses, 
IIb medium Exchange energy with a patient 
in a potential hazardous way. 
Invasive devices partially or 
totally implanted in the body. 
infusion pumps, 
surgical lasers, 
defibrillators, 
dialysis devices, 
dental implants 
III high Support and sustain human life. 
Connects directly to the central 
nervous system or to the 
central circulatory system 
heart catheters, 
heart valves, 
endoprosthesis, 
breast implants, 
implanted cerebella stimulators 
 
According to this classification implants fall under the classes IIb and III, because 
they present a medium to high risk for the health of patients. Implants can be further 
classified according to the medical field in which they are used: orthopedic, 
cardiovascular, neurological and sensory, respiratory, gastrointestinal, urogenital and 
cosmetic implants. Table 3 gives an overview of this classification and provides some 
examples9-14.  
 
Table 3. Classification of Implants according to the field of use. 
Medical Field Examples  
Orthopedic  Knee replacements 
Hip replacements 
Elbow implants 
Shoulder implants 
Ankle implants 
Thoracolumbar implants 
Intervertebral spacers 
Implantable spinal 
stimulators 
Internal fixation devices 
Craniomaxillofacial implants 
Cardiovascular Implantable cardioverter-defibrillators 
Cardiac pacemakers 
Coronary stents 
Tissue heart valves 
Ventricular assist devices 
Implantable heart monitors 
Neurological and sensory 
 
Neurostimulators 
Intraocular lenses 
Glaucoma and other lenses 
Tympanostomy tube 
Cochlear implants 
Respiratory  Artificial larynx 
Artificial trachea 
Diaphragm implants 
Gastrointestinal  LINX Reflux Management System 
Gastric bands 
Gastric electrical stimulators 
Biliary stents 
Urogenital  Soft tissue repair 
Intrauterine devices 
Penile implants 
Artificial urinary sphincter 
Cosmetic  Dental implants 
Breast implants 
Nose prosthesis 
Soft tissue fillers 
Gluteal implants 
Other  Hormonal implants 
Implantable drug pumps 
Brachytherapy products 
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1.1.2 Types of implant materials 
One of the most important decisions made during the design of an implant is the 
choice of its material. First of all, it has to be biocompatible, meaning that it performs 
with an appropriate host response in a specific application15. Since materials have 
different properties, the same material cannot be used for all applications. Mechanical 
properties (hardness, elasticity, brittleness, malleability, etc.) are one of the most 
important factors taken into account when selecting the implant material. Strong 
mechanical properties of metals make them ideal for the use in orthopedics where 
strength and stiffness are needed for the replacement of hard tissue, while the flexibility 
of polyesters make them ideal for artificial vascular graft, sutures and meshes11. Other 
properties that influence the selection of the implant material are biodegradability, ease 
of fabrication, conductibility (electrical, light, sound), thermal properties, surface 
properties and adhesion, resistance to corrosion, shelf life and price11, 14, 16. 
Currently there are numerous types of different materials used for fabrication of 
implants. They can all be grouped in 5 classes: metals, ceramics, polymers, composite 
and biologic materials11, 17. Each class has its advantages and disadvantages which 
also play a role in their selection for a specific application. For example, metals are 
strong, tough, possess electrical conductivity and are ductile, making them suitable for 
joint replacement, bone screws and plates, pacers and wires. Their drawback is that 
they are dense, may corrode and are difficult to make. Ceramics are very 
biocompatible, but also brittle, weak in tension and not resilient. They are mostly used 
in dental and orthopedic implants. Polymers are resilient and easy to fabricate and are 
used for sutures, blood vessels, ear and nose implants. Their disadvantage is that they 
deform with time, are not strong and may degrade. Composites are strong and can be 
tailor-made, but are difficult to produce. They are used in bone cement and dental 
resins14. Table 4 illustrates the 5 classes of materials along with some examples from 
each class9, 11, 14, 16, 17. 
 
Table 4. Types of implant materials. (PMMA, polymethylmethacrylate; HA, hydroxyapatite; 
UHMWPE, ultra-high-molecular-weight polyethylene; PELA, ethylene oxide/lactic acid 
copolymer). 
Class Subclass Examples 
Metals  Stainless Steel 
Co-Cr alloys 
Ti and Ti alloys 
Commercially pure Ta 
Gold 
Dental amalgam 
Platinum group (Pt, Pd, Rh, Ir, Ru, 
and Os) 
Ceramics Non-absorbable 
 
Alumina (Al2O3) 
Zirconia (ZrO2) 
Carbons 
Biodegradable Calcium Phosphate 
Coralline 
Tricalcium Phosphate 
Aluminium-Calcium-Phosphate  
Ferric–Calcium–Phosphorous-
Oxide Ceramics 
Bioactive Bioactive glasses Ceravital 
Polymers Non-absorbable Polyethylene 
Polypropylene 
Polyamides 
Polyurethanes 
Polymethylmethacrylate 
Polyesters 
Silicone  
Cyanoacrylates 
Biodegradable Polyglycolic acid (PGA) 
Polydioxanone 
Polylactic acid (PLA) 
Poly(Lactide-co-Glycolide)(PLGA) 
Composite 
materials 
Particulate Dental composite resins 
Polyethylene/HA 
PMMA/HA  
Starch/HA 
Fibrous  Graphite-epoxy 
PELA /Polyurethane 
Carbon fiber reinforced UHMWPE 
PMMA/UHMWPE 
Biologic 
materials 
 Collagen 
Silk 
AlloDerm 
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1.2 Titanium as an implantable material 
Titanium (Ti) is a widely used material in implantation, either in pure form or in the 
form of alloys. It is a member of transition metals and is located in the 4th period and 
the 4th group of the periodic table of elements. Titanium is the ninth most abundant 
element in the earth’s crust and can be found in nature within a number of minerals, 
the most common being ilmenite (FeTi03), which has black or brownish-black opaque 
crystals, and rutile (TiO2), which can be reddish-brown, red, yellow, or black in color. 
Titanium has an atomic number of 22 and its electron configuration is [Ar]3d24s2. There 
are 5 naturally occurring isotopes of titanium, 46Ti (8.25%), 47Ti (7.44%), 48Ti (73.72%), 
49Ti (5.41%) and 50Ti (5,18%) and it exists in 2 allotropic states (α and β)18, 19. 
Titanium exists mostly in the “+4” oxidation state and exhibits limited reactivity in 
“+2” and “+3” oxidation states. It has high affinity for oxygen and depending on the 
oxidation state forms the following oxides TiO, Ti2O3 and TiO2. Additionally, in the “+2” 
oxidation state titanium forms titanium dichloride (TiCl2), while in the “+3” oxidation 
state it forms titanous trichloride (TiCl3), titanous hydroxide (Ti[OH]3) and can also exist 
as the titanous ion (Ti3+) 19, 20. 
TiO2 is the most common oxide of titanium. In nature it is usually found in the form 
of rutile, but can also exist in 2 other polymorphs: anatase and brookite19, 21. Although 
both anatase and rutile have tetragonal structures, formed by chains of distorted TiO6 
octahedra, their structure is slightly different. In anatase each octahedron is in contact 
with 8 neighbor octahedrons, while in rutile each octahedron is in contact with 10 
neighbors22. TiO2 is white and has been extensively used in cosmetic and painting 
industries23, 24. Due to its excellent photocatalytic properties, it has also been used for 
hydrogen production under UV and water clean-up procedures where halogens and 
hydrocarbon contamination is found25-27.  
Titanium’s low density (4.506 g/cm3) together with low thermal conductivity and 
structural stability at high temperatures has made it ideal for aerospace industry. 
Combined with steel it is used to make strong alloys, which are lighter and also 
corrosion resistant28. At high temperatures, exceeding 883°C, titanium undergoes an 
allotropic transformation from α state to β. In α state its structure is hexagonal close-
packed (HCP), whereas in β state it is transformed into a body-centered cubic (BCC) 
crystal structure (Figure 1)19, 29.  
 
Figure 1. Allotropic states of titanium. Crystal structure of α state (left) and β state (right) of 
titanium. Adapted with permission from (Encyclopedia Britannica, 2011), Copyright 
Encyclopedia Britannica Inc. 
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Each state has its advantages and disadvantages and alloys are made taking into 
account their physical properties. To preserve the good weldability of α state, elements 
that raise the α to β transition temperature (α stabilizers), are added during alloy 
fabrication. These are aluminum, oxygen, gallium, germanium, calcium, and nitrogen. 
On the other hand, β stabilizers, like vanadium and molybdenum, lower the α to β 
transition temperature, in this way preserving its superior strength. Some alloys are 
fabricated with a combination of α and β stabilizers, thus obtaining a material with 
mixed properties. In this context titanium alloys are divided into 4 classes: α, near α, 
α–β and β alloys9, 11, 14, 19.  
1.2.1 Mechanical properties of titanium and titanium alloys  
Currently there are a number of titanium alloys specifically made for biomedical 
applications. For dental implants 5 grades of titanium and titanium alloys are being 
used. Grades 1-4 are unalloyed and are made of commercially pure titanium (Cp Ti) 
with traces of nitrogen (0.03-0.05%), carbon (0.1%), hydrogen (0.015%), iron (0.2-
0.5%) and oxygen (0.18-0.4%). Variation in these elemental compositions confers 
different properties to the titanium implant. The strength of the material increases with 
its grade, whereas elongation (change in physical shape without breaking) decreases14, 
30.  
Grade 5 (Ti-6Al-4V) is an α–β alloy with 6% aluminum (α stabilizer) and 4% 
vanadium (β stabilizer) and is one of the most used titanium alloys in biomedical 
applications. Higher strength compared to Cp Ti has made Ti-6Al-4V the material of 
choice for applications such as total joint replacement, where superior mechanical 
properties are needed31. When compared to other materials like 316 stainless steel or 
Co-based alloys, Ti-6Al-4V possesses higher specific strength (tensile strength per 
density). However, due to poor shear strength it is not suitable for bone screws or 
plates11, 14.  
Although Ti-6Al-4V is the most used biomedical titanium alloy, its mechanical 
properties for long-term orthopedic implants are still not ideal. The elastic modulus of 
human cortical bones and cancellous bones are 4-30GPa and 0.2-2GPa respectively. 
In comparison to bones, metallic implants have a much higher elastic modulus which 
can result in bone resorption in the connection part32. The big difference between 
elastic modulus of bones and implants has been shown to result in stress shielding of 
human bones33. This phenomenon is characterized by reabsorption of bone tissue, 
due to the distribution of the load stress to the implant34. When elastic modulus is 
considered, Ti-6Al-4V (110GPa) is superior to its metallic counterparts, like 316 
stainless steel (210GPa) or Co-Cr (240GPa) alloys, however it is still higher than that 
of human bones35. For this reason, other titanium alloys with lower elastic modulus are 
being developed. In this aspect, of particular interest are β alloys, since BCC crystal 
structure has a lower elastic modulus than HCP crystal structure. Titanium alloys 
containing niobium (Nb), zirconium (Zr), molybdenum (Mo) and tantalum (Ta) have 
been extensively studied in recent years. Additionally, low cost elements such as iron 
(Fe), chromium (Cr), manganese (Mn) and tin (Sn) are also used to reduce the cost of 
alloy making. Table 5 gives an overview of mechanical properties of titanium and its 
alloys designed for biomedical applications32. 
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Table 5. Mechanical properties of titanium and its alloys designed for biomedical 
applications. Adapted from Materials, volume 7, Li et al., New Developments of Ti-Based 
Alloys for Biomedical Applications, distributed under the Creative Commons Attribution 
License (CC BY 3.0). 
 
In clinical settings, surgeons have been raising concerns regarding springback 
(capacity of an elastic material to return to its original form) from materials with a low 
elastic modulus. On the other hand, patients need materials with low elastic modulus 
in order to avoid stress shielding. For this reason, titanium alloys with self-adjusting 
elastic modulus are being developed36. Although there is a tendency to make the 
implant as close as possible to its natural counterpart, it should be taken into account 
that natural tissue has the advantage of adaptability to new conditions, a quality that 
no artificial implant possesses14.  
1.2.2 Biomedical applications of titanium 
One of the reasons for choosing titanium over other metals for implants is its 
biocompatibility. Titanium has the ability to form, spontaneously in contact with air, an 
ultrathin (10nm) film of TiO2 on its surface in a process called passivation. Therefore, 
at the implant-tissue interface the material which comes into contact with cells is 
usually TiO2. The TiO2 layer is self-adherent and very stable providing titanium with 
corrosion resistance11. Additionally, it is biopassive, meaning it does not readily react 
with body fluids and their components. However, when titanium alloys are used for 
implantation, other oxides also form. In the most used titanium alloy, Ti-6Al-4V, the 
Alloy Designation (wt%) Tensile 
Strength 
(MPa) 
Yield 
Strength 
(MPa) 
Elongation 
(%) 
Elastic 
Modulus 
(GPa) 
 α-type 
CP Ti grade 1 (annealed) 240 170 24 102.7 
CP Ti grade 2 (annealed) 345 275 20 102.7 
CP Ti grade 3 (annealed) 450 380 18 103.4 
CP Ti grade 4 (annealed) 550 485 15 104.1 
 α+β-type 
Ti-6Al-4V ELI (annealed) 860–965 795–875 10–15 101–110 
Ti-6Al-4V (annealed) 895–930 825–869 6–10 110–114 
Ti-6Al-7Nb (wrought) 900–1050 880–950 8.1–15 114 
Ti-5Al-2.5Fe (cast) 1020 895 15 112 
 β-type 
Ti-13Nb-13Zr (aged) 973–1037 836–908 10–16 79–84 
Ti-12Mo-6Zr-2Fe (annealed) 1060–1100 1000–1060 18–22 74–85 
Ti-15Mo (annealed) 874 544 21 78 
Ti-15Mo-5Zr-3Al (solution 
treated/aged) 
852–1100 838–1060 18–25 80 
Ti-35Nb-7Zr-5Ta (annealed) 597 547 19 55 
Ti-16Nb-10Hf (aged) 851 736 10 81 
Ti-29Nb-13Ta-4.6Zr (aged) 911 864 13.2 80 
Ti-15Mo-2.8Nb-0.2Si 
(annealed) 
979–999 945–987 16–18 83 
Ti-24Nb-4Zr-7.9Sn (hot-rolled) 830 700 15 46 
Ti-24Nb-4Zr-7.9Sn (hot-forged) 755 570 13 55 
Ti-24Nb-4Zr-7.9Sn (selective 
laser melting) 
665 563 14 53 
Ti-35Nb-7Zr-5Ta-0.4O 
(annealed) 
1010 976 19 66 
Ti65.5Nb22.3Zr4.6Ta1.6Fe6 
(sintering/960 °C/0 min) 
– 2425 6.91 52 
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stable oxides formed are TiO2, Al2O3, V2O5 and V2O4. While TiO2 exhibits inertness, 
Al2O3, V2O5 and V2O4 display toxicity and can lead to necrosis around the implant37. 
For this reason, there is a need to design new titanium alloys and the biocompatibility 
of the introduced elements has to be considered. It has been shown that elements 
such as Nb, Ta, Zr, Si, Mo, Sn, Pd, In, Sr, B, Ca, and Mg do not exhibit cytotoxicity, 
while elements such as Be, Al, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, and Ag possess cytotoxic 
effects and therefore should not be used in titanium alloy fabrication for biomedical 
applications38.  
Although nickel displays some cytotoxic effects it has been alloyed with titanium 
and successfully used for biomedical applications for a long time. TiNi alloys possess 
unusual properties: if the material is plastically deformed, it can revert to its initial shape 
upon increase in temperature. This effect is called the shape memory effect. The TiNi 
alloy used in biomedical applications is commercially known as Nitinol and displays the 
shape memory effect near room temperature. Such properties are useful in 
applications like orthodontic archwires, aneurism clips, vascular stents and vena cava 
filters11. 
Titanium’s low magnetic susceptibility is another rationale for using it in biomedical 
applications. Since magnetic resonance imaging (MRI) has become an indispensable 
diagnostic tool in recent years, it is necessary to choose an implant material that 
produces smaller artifacts on MRI images. In this regard, titanium is superior to 
stainless steel, having a smaller magnetic susceptibility by an order of magnitude 
(2.3x10-4 and 3.0x10-3 respectively). In spinal surgery, where the position of the implant 
has to be adjusted in relation to the bones and adjacent soft tissues, and where MRI 
images are used for follow up, titanium is the material of choice37.  
The first records of the use of titanium in implantation came in the late 1930s, 
describing good tolerability of titanium in animal models14. Nowadays titanium is used 
in a variety of biomedical applications, ranging from cosmetic applications like dental 
implants to life-saving applications like cardiovascular stents. Commercially pure 
titanium, due to its corrosion resistance and biocompatibility, has been used in dental 
implants, maxillofacial and craniofacial implants, screws and staples for spinal injury, 
pacemaker cases, housings for ventricular assist devices and implantable infusion 
drug pumps. In applications where higher strength is needed, titanium alloys are used. 
These include femoral hip stems, fracture fixation plates, spinal components, fasteners 
and intramedullary nails. An overview of titanium and its alloys use in biomedical 
application is presented in Table 6 9, 13, 30, 31, 37, 39-41. 
 
Table 6. Uses of titanium and its alloys in biomedical application. 
Medical Field Examples  
Orthopedic implants Femoral hip stems 
Metal backed acetabular shell 
Fracture fixation screws and plates 
Spinal components 
Intramedullary nails 
Maxillofacial implants 
Cardiovascular implants Prosthetic heart valves 
Pacemakers and defibrillators 
Vascular access port 
Vena cava filters 
Annuloplasty ring 
Left Ventricular Assist Devices 
Vascular stents  
Vessel clips 
Dental applications Dental implants 
Zygomatic implants 
Brackets 
Dental cast metal framework 
Titanium copings 
Orthodontic archwires  
Neurological and sensory 
implants 
Bone-anchored hearing device  
Neurostimulators 
 
Respiratory implants Artificial larynx 
Nasal septal reparation 
 
 
Gastrointestinal implants LINX Reflux Management System  
Other implants Implantable infusion drug pumps  
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1.3 Foreign body reaction 
Nowadays many medical conditions can be solved with the help of implants and 
biomedical devices. Although the materials for implant manufacturing are chosen to be 
highly biocompatible, still, occasionally adverse immune reactions to implant materials 
occur. These can result in excessive inflammation at the implant-tissue interface, 
generate pain and sometimes even implant rejection. Consequently, this leads to an 
additional surgery procedure, higher costs and deteriorated quality of life42. The 
recognition of the implanted materials by immune cells is part of the foreign body 
reaction mechanism. 
Mosby’s medical dictionary defines foreign bodies as any object or substance that 
is introduced from outside in any organ or tissue in which it does not belong under 
normal circumstances43. There are two ways through which foreign bodies can be 
introduced in the organism, either through body’s natural orifices (mouth, nostrils, ear 
canals, etc.) or by penetrating the skin. By far the most common way of introduction of 
foreign bodies in the organism is through ingestion. They do not always have negative 
effects, as food can also be considered to be a foreign body. In 80% of cases of foreign 
body ingestion children up to the age of 6 are involved. The most common ingested 
objects are coins and batteries. In older children and adults, food boluses are the most 
frequent foreign bodies retained in the gastrointestinal tract. In adults this usually 
happens in context of underlying pathologies such as strictures, malignancy, 
esophageal rings or achalasia. However, up to 80% of cases of foreign body ingestion 
do not require any medical intervention44, 45. 
Implants and biomedical devices are inserted into the body through medical 
procedures, and usually need to pass through the skin. In this case the body’s first 
barrier of defense against foreign bodies is penetrated. There are also other defense 
mechanisms against foreign bodies such as cilia in the respiratory epithelium, 
peristalsis in the gastrointestinal tract, tears or cerumen. When these defense barriers 
are breached the body’s immune system is involved and inflammation is initiated45. 
From this point, there are three scenarios that can develop: i) failure to resolve the 
acute phase of inflammation can lead to chronic inflammation and peri-implantitis; ii) if 
the healing process successfully resolves the inflammation, homeostasis is achieved; 
iii) a pathological healing process can lead to encapsulation and fibrosis. Therefore, in 
order to obtain homeostasis, a balance needs to be reached between inflammatory 
and healing processes42, 46.  
1.3.1 Macrophages as main regulators of the foreign body reaction 
The primary role in initiating and regulating the foreign body reaction is attributed 
to macrophages. They are the cells responsible for the recognition and phagocytosis 
of the foreign body as well as for the initiation of the inflammatory reaction associated 
with it45. Moreover, due to their high level of plasticity, macrophages are able to also 
start the repair and healing process which can lead to the reinstatement of 
homeostasis46. For these reasons, in recent years a lot of attention has been paid to 
macrophages in terms of their interaction with biomaterials and numerous studies have 
used macrophages as models for assessing the biocompatibility of biomaterials47.  
Macrophages are cells of the immune system present in virtually all tissues. They 
originate from three sources: embryonic yolk sac, fetal liver monocytes, and adult bone 
marrow-derived monocytes. In different tissues they originate from different main 
sources: in brain from yolk sac, in liver and lung from fetal liver monocytes, while in the 
skin, heart and gut from adult bone marrow-derived monocytes. Macrophage origin 
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and localization plays an important role in their response to stress signals. Tissue-
specific environmental cues as well as ontogeny related signals influence macrophage 
activation. Thus the same activation signal can result in different outcomes in 
macrophages from distinct tissues and ontogeny48. 
An important aspect of macrophage physiology is their plasticity. Depending on 
the environmental cues macrophage can adopt different phenotypes and consequently 
secrete a distinct set of cytokines. For a long time, macrophage activation model 
depicted two groups of macrophages: classically activated macrophages and 
alternatively activated macrophages. Classically activated macrophages, also called 
M1, are known to be activated by IFNγ or TLR ligands and exert a pro-inflammatory 
function by secreting pro-inflammatory cytokines such as TNFα, IL-1β, IL-6, and IL-12. 
Alternatively activated macrophages, or M2 macrophages, are induced by IL-4, IL-13, 
immune complexes in combination with IL-1β or LPS, IL-10, TGFβ or glucocorticoids. 
They play a role in resolution of the inflammation and wound healing and secrete anti-
inflammatory cytokines such as IL-1Ra, IL-10 and TGFβ. Alternatively activated 
macrophages were further subdivided into 3 subsets: M2a (activated by IL-4 or IL-13), 
M2b (by ligation of Fc receptors in combination with IL-1β or LPS) and M2c (induced 
by IL-10, TGFβ or glucocorticoids)49. Additionally, studies have shown that activated 
macrophages, upon a change in environmental signals, can undergo a transformation 
into the opposite phenotype from M1→M2 and vice versa, hence the term plasticity50. 
However, recent studies, based on transcriptional profiling, suggest that macrophage 
physiology is much more complex, with experts in the field distancing themselves from 
the M1/M2 dichotomy as the new macrophage activation model is presented as a 
spectrum of activation states51, 52. 
Studies regarding implants show macrophages skewed towards a pro-
inflammatory state. As implantation is associated with a local injury caused by surgery, 
the release of damage-associated molecular patterns (DAMPs) will activate 
macrophages along with the activation of blood coagulation cascades and complement 
system. When a foreign body enters the organism macrophages are able to directly 
recognize it or to recognize the adsorbed protein layer on its surface. The protein layer 
is usually composed of extracellular matrix proteins, albumins, immunoglobulins and 
components of the complement system. Macrophages are able to recognize them via 
pattern-recognition receptors (PRRs) and opsonic receptors initiating an inflammatory 
reaction45, 53. A list of receptors and their ligands involved in recognition of biomaterials 
and the adsorbed protein layer is presented in Table 7. 
 
Table 7. Macrophage receptors involved in foreign body recognition. Adapted from Vrana 
et al., Cell and Material Interface: Advances in Tissue Engineering, Biosensor, Implant, and 
Imaging Technologies, Copyright (2015), with permission from CRC Press. 
Receptor Ligand 
FcγRI (CD64) IgG1, IgG3, IgG4 
FcγRIIa (CD32a) IgG3, IgG1, IgG2 
FcγRIIc (CD32c) IgG 
FcγRIIIa (CD16a) IgG 
CR1 (CD35) Mannan-binding lectin, C1q, C4b, C3b 
CR3 (αMβ2, CD11b/CD18, Mac-1) iC3b 
CR4 (αXβ2, CD11c/CD18) iC3b 
α5β1 Fibronectin, Vitronectin 
αvβ3 Vitronectin 
αvβ5 Vitronectin 
TLR1/2 Gram-positive bacteria, HSP60, HSP70, HMGB1 
TLR4 LPS, HSP60, HSP70, HMGB1, fibronectin EDA, fibrinogen 
SR-AI/II TiO2 particles 
MARCO TiO2 particles, silica 
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If the initial inflammation is resolved, implantation is considered successful and the 
implant can stay in place for years. However, with time, due to long-term mechanical 
stress (material fatigue), wear particles (microscopic wear debris) are released at the 
implant-tissue interface. These particles induce activation of macrophages either via 
recognition through the aforementioned receptors or via phagocytosis42. This is 
characterized by activation of several signaling pathways in macrophages, most 
notably NF-κB54. As a result, macrophages release a range of pro-inflammatory 
cytokines and growth factors such as TNFα, IL-1α, IL-1β, IL-6, IL-8, IL-11, IL-15, TGFα, 
GM-CSF, M-CSF, PDGF and EGF55. The pro-inflammatory environment promotes 
osteoclast formation via RANKL/RANK/OPG pathway, thus inducing osteolysis56.  
The size of the wear particles also plays a role in macrophage response to them. 
If the particle size is bigger than 10µm, macrophages are unable to engulf them. 
However, in certain conditions, in the presence of soluble factors such as IL-4, CCL2, 
fibronectin and osteopontin macrophages can fuse together to form foreign body giant 
cells. These cells are able to engulf particles bigger than 10µm and also take part in 
the phenomenon of frustrated phagocytosis, which is characterized by a release of a 
wide array of mediators of degradation that can ultimately lead to device failure. 
Furthermore, macrophages recruit additional immune cells to the periprosthetic tissue 
by secreting pro-inflammatory chemokines such as CCL2, CCL4, CCL8, CCL13 and 
CCL22. Accumulation of immune cells at the implant-tissue interface enhances the 
acute inflammatory phase. Failure to resolve the acute phase of inflammation leads to 
chronic inflammation, generation of foreign body giant cells and fibrous encapsulation 
of the implant57. 
1.3.2 Other cells involved in foreign body reaction 
It is well established that the foreign body reaction is initiated and coordinated by 
macrophages; however osteoclasts, osteoblasts, lymphocytes, fibroblasts and 
thrombocytes are also involved42. One of the first cell types able to reach and interact 
with implanted biomaterials are thrombocytes. As part of their involvement in the 
wound healing process they can deposit more than 300 proteins in the periprosthetic 
tissue. These proteins take part in the provisional matrix formation around the implant 
and are also recognized by macrophages. In response, macrophages up-regulate the 
expression of pro-inflammatory genes such as TNF, IL1A, IL1B, and CCL1 and down-
regulate the expression of anti-inflammatory genes like IL10, CXCL12 and CXCL1358. 
The main cells responsible for bone resorption and osteolysis are osteoclasts. 
Osteoclasts are multinucleated cells of monocyte-macrophage lineage that increase in 
number in the periprosthetic tissue as levels of CCL2 and CCL4 rise42. The release of 
pro-inflammatory cytokines in response to wear particles, activates osteoclasts through 
RANKL/RANK/OPG pathway. This is potentiated by inhibition of anti-osteoclastogenic 
signaling through IL-6 and IFNγ59. As a result, there is an increase in number of 
activated osteoclasts at the implant-bone interface which promote osteolysis and 
consequently lead to aseptic loosening60.  
Bone homeostasis is achieved only when there is a balance between bone 
resorption mediated by osteoclasts and bone formation mediated by osteoblasts. In 
inflammatory settings, such as those achieved during a foreign body reaction, the 
balance is tilted towards bone resorption61. Osteoblasts, when stimulated by wear 
particles, secrete osteoclastogenesis factors RANKL and M-CSF, thus promoting 
osteolysis62. Additionally, their ability to secrete osteoid and collagen I is impaired. 
Moreover, osteoblasts release an array of pro-inflammatory mediators like IL-1, IL-6, 
IL-8, TNFα, CCL2 and MMP-1 that enhance the inflammatory reaction and recruit 
immune cells to the periprosthetic tissue63, 64.  
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The current model of the interaction of macrophages with osteoblasts and 
osteoclasts in implantation settings is illustrated in Figure 2. Macrophages initiate the 
foreign body reaction either as a result of direct recognition of titanium, by contact with 
the adsorbed protein layer, bacteria, damage-associated molecular patterns (DAMP), 
or by phagocytosis of wear particles. These events activate macrophages and trigger 
the secretion of pro-inflammatory cytokines and chemokines, which in turn activate 
osteoblasts. Activated osteoblasts initiate the production of inflammatory cytokines and 
chemokines, thus enhancing the inflammation. Additionally, wear particles induce 
apoptosis in osteoblast and consequently the bone deposition decreases. Chemokines 
released by osteoblasts and macrophages recruit additional immune cells to the site 
of inflammation. Synergistic effect of wear particle-induced anti-osteoclastogenic 
signaling and osteoblast expression of RANKL, M-CSF and CCL2 increases the 
number of osteoclasts at the implant-tissue interface. Finally, macrophage 
inflammatory cytokines activate osteoclasts leading to increased osteolysis.  
 
 
Figure 2. Interaction between macrophages, osteoblasts and osteoclasts at the tissue-
implant interface. DAMP - damage-associated molecular pattern molecules, TLRs – toll-like 
receptors, SR – scavenger receptors, ROS – reactive oxygen species, RNS – reactive nitrogen 
species. Adapted from Kzhyshkowska et al., Macrophage responses to implants: prospects for 
personalized medicine, Copyright (2015), with permission from Society for Leukocyte Biology. 
Lymphocytes and fibroblasts are also involved in foreign body reaction. Upon wear 
particle stimulation, fibroblasts promote osteoclastogenesis by secreting pro-
inflammatory cytokines and growth factors such as IL-1β, IL-6, IL-8, CCL2, MMP1, 
COX-1, COX-2, LIF, TGFβ1 and TGFβR165. Lymphocytes, on the other hand, do not 
take part in osteolysis. Their role in foreign body reaction is to mediate the type IV 
delayed hypersensitivity response by interacting with macrophages through IL-15, IL-
15Rα and IL-2Rβ. Type IV delayed hypersensitivity response is sometimes found in 
patients with hypersensitivity to metal ions. When wear particles activate fibroblasts 
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they are able to attract and activate macrophages via secretion of IL-3, GM-CSF, IFNγ, 
LTA and MIF. In response, macrophages secrete IL-2 and activate more T helper cells, 
thus enhancing the reaction55, 56.  
1.3.3 Macrophage-driven immune response to titanium 
Titanium has been used in biomedical applications mainly due to its high 
biocompatibility, good mechanical properties, excellent corrosion resistance and low 
magnetic susceptibility. However, micromotion and friction between articulating 
surfaces under high mechanical stress may result in release of microscopic wear 
debris11. Immune cells recognize the released wear particles as foreign bodies and 
consequently will initiate an inflammatory reaction42. Numerous studies have tried to 
determine immune response to titanium by analyzing macrophage responses. The 
most common cellular models for in vitro testing are RAW264.7 cells (mouse leukemic 
monocyte-macrophage cell line), THP-1 cells (human monocytic leukaemia cell line) 
and mouse bone-marrow derived macrophages. When culturing macrophages with 
titanium nano- and microparticles, increased gene expression and secretion of TNFα, 
IL-1β and IL-6 was observed66-68. Furthermore, titanium up-regulates the expression 
of inflammatory chemokines like CCL2 and CCL3, which can recruit additional 
macrophages and neutrophils to the periprosthetic tissue69. Inflammasome protein, 
NLRP3, responsible for IL-1β and IL-18 activation, is also up-regulated in 
macrophages by titanium70, 71. Additionally, it was shown that titanium particles induce 
oxidative stress in macrophages, characterized by an increase in production of reactive 
oxygen species (ROS), NO and iNOS, factors known to be involved in osteolysis69, 72, 
73.  
In vivo studies corroborate the findings from cell culture experiments. Insertion of 
titanium particles, pins, rods and screws in tibia, femur, maxilla and calvaria are 
frequently used to model implantation settings. In these models, titanium was able to 
induce up-regulation of cytokines such as TNFα, IL-1β and IL-6 and chemokines like 
CCL2 and CCL374-76. Moreover, inflammasome protein NLRP3 as well as ROS and 
reactive nitrogen species (RNS) are also up-regulated in the areas adjacent to 
titanium77, 78. In vivo models also provide valuable information regarding titanium 
influence on osteolysis. Thus, it was found that in the proximity of the titanium implant 
there is an up-regulation of RANKL and TRAP (tartrate-resistant acid phosphatase) 
expression, which are common markers for osteoclasts74, 79. Previously it was shown 
that osteoclastogenesis in response to wear particles is highly reliant on RANKL80. In 
cellular models, RANKL expression was up-regulated by titanium particles in human 
osteoblasts62, 81. Therefore, titanium promotes osteolysis by employing macrophages 
and osteoblasts into secreting a range of pro-inflammatory cytokines and factors of 
osteoclastogenesis.  
The size and surface pattern of titanium also influences the inflammatory reactions 
towards it. In a comparative study between titanium particles and titanium discs, THP-
1 cells exhibited increased expression of cytokines such as TNFα, CCL2, CCL3 and 
IL-1Ra when cultured on discs82. When altering the surface of titanium, it was found 
that hydrophilic surfaces reduce the expression of pro-inflammatory cytokines like 
TNFα, IL-1α, IL-1β, IL-6 and CCL2 as well as increase the expression of anti-
inflammatory cytokines like IL-4 and IL-10, suggesting better biocompatibility 
properties. These effects were true for both macrophages and osteoblasts83-85.  
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1.4 Advanced solutions to overcome foreign body reaction in 
implantation  
Advances in medicine and technology have led to the use of implants as solutions 
for a variety of medical conditions. While implants can be lifesaving devices, they still 
carry a certain amount of risk, thus are classified as class II and III medical devices. 
The surgical procedure needed for the insertion of implants carries the usual 
perioperative risks like infection, excessive pain, hemorrhage, wound dehiscence, etc. 
However, the majority of implants fail long after the surgery was performed. This is due 
to long-term mechanical stress, release of wear particles and development of chronic 
inflammation. Some examples of implant failures associated with inflammation are 
presented in Table 842. 
 
Table 8. Examples of implant failures associated with inflammation. Reproduced from 
Kzhyshkowska et al., Macrophage responses to implants: prospects for personalized medicine, 
Copyright (2015), with permission from Society for Leukocyte Biology. 
Type of implant Commonly used 
material 
Cause for 
implantation 
Reasons for failure 
Teeth   Titanium 
 Zirconium 
 Ti-Ni alloy 
Tooth loss Periimplantitis, 
Osteolysis,  
Fibrosis at the implant-
bone interface 
Knee   Co-Cr alloy 
 Polyethylene 
 Titanium alloys 
 Stainless steel 
Osteoarthritis, 
Rheumatoid arthritis 
Aseptic loosening, 
Infection, 
Periprosthetic fracture, 
Arthrofibrosis 
Hip   Co-Cr alloy 
 Polyethylene 
 Titanium alloy 
 Ceramic 
 Stainless steel 
Osteoarthritis, 
Osteonecrosis, 
Inflammatory arthritis 
Aseptic loosening, 
Infection, 
Periprosthetic fracture 
Spine   Titanium 
 Stainless steel 
 Plastic 
Spinal deformity, 
Scoliosis, 
Osteoporosis 
Pseudoarthrosis, 
Infection, 
Pain 
Left ventricular assist 
device  
 Titanium End-stage heart failure Coagulation disorders,  
Wound infections,  
Stroke 
 
To reduce the rate of implant failure there is a need for a more biocompatible 
implant material. The ideal implant material should produce no foreign body reaction, 
should not support the growth of microorganisms and should be nontoxic, nonallergic 
and noncarcinogenic. Additionally, it should possess adequate mechanical properties 
(strength, stiffness, fatigue, etc.), adequate optical properties and density and should 
be sterilizable, easy to manufacture and have a long shelf-life11, 16. Unfortunately, 
together, all these properties are not found in any implant material. Titanium possesses 
most of these properties; however, to overcome some of the deficiencies, different 
techniques to modify titanium implants are being developed. 
1.4.1 Porous materials 
Today, even the best β-type titanium alloys possess an elastic modulus higher 
than that of bones (Table 5). This may result in bone resorption through stress shielding. 
To reduce the elastic modulus to values close to those of cortical and cancellous bones, 
porous alloys were introduced. Porous alloys reduce the amount of material supporting 
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a cross section, when compared to bulk alloys, ensuring that under mechanical stress, 
the deformation is larger, while stiffness is smaller32. Additionally it was shown that 
porous materials allow for greater osseointegration, by providing cells with the 
necessary space to grow inside the implant86.  
When designing a porous implant, several features such as porosity, pore size and 
the interconnectivity network need to be taken into account. Porosity (void fraction) 
needs to be higher than 50% in order to promote adequate osseointegration, while the 
minimum pore size has to be 100µm. The optimal pore size however, has to be higher 
than 300µm in order to promote not only attachment, differentiation and growth of 
osteoblasts but also to promote capillary formation to supply the new bone tissue with 
blood87. An open interconnectivity network provides space for bone tissue ingrowth 
and capillary formation. While porosity increases osseointegration, it also reduces 
mechanical properties of the material. Therefore, porosity and pore size have to be 
designed in such a way that the mechanical requirements for a specific application are 
met32.  
1.4.2 Surface modifications 
The biocompatibility of an implant material is mainly determined by its surface. 
Some materials have better mechanical properties than others, however suffer from 
biocompatibility issues. To preserve the mechanical properties and at the same time 
increase a material’s biocompatibility, surface modification techniques are used. For 
titanium, there are a number of methods used to modify the surface, which can be 
broadly grouped into mechanical, physical and chemical methods. Mechanical 
methods such as machining, grinding, polishing or blasting are used to remove surface 
contamination, improve adhesion in subsequent bonding steps and to produce specific 
nano or micro patterns on the surface of the implant, which consequently alters the 
roughness of the surface88. Surface roughness has a significant influence on cell 
behavior, as it was demonstrated that an increase in surface roughness can boost cell 
attachment and proliferation89. Additionally, surface topography is known to influence 
macrophage activation state, which, as previously explained, play a pivotal role in the 
initiation and coordination of the foreign body reaction90.  
Physical methods such as thermal spray (flame spray, plasma spray), physical 
vapor deposition and ion implantation and deposition can be used to improve corrosion 
and wear resistance as well as increase biocompatibility. Glow discharge plasma 
treatment is applied to remove the native oxide layer or to sterilize, oxide or nitride the 
surface. With chemical methods like alkaline treatment, hydrogen peroxide treatment 
and sol-gel method titanium implant biocompatibility, bioactivity and bone conductivity 
can be improved. Acidic treatment can be used to remove contamination or oxide 
scales. Chemical vapor deposition and anodic oxidation are applied to improve wear 
and corrosion resistance and increase biocompatibility37, 88.  
In general surface modification methods are used to achieve the following 
outcomes37: 
 cleaning or removal of the native surface layers 
 modification of the surface structure and topography 
 modification of the composition and structure of oxide layer 
 controlled formation of a new surface layer 
Controlled formation of a new surface layer is primarily used to generate a thin 
biomaterial coating on the surface of the implant. It is a promising approach to preserve 
the bulk properties of the implant and at the same time achieve higher 
biocompatibility42. By immobilizing certain peptides, proteins or growth factors on the 
surface of the implant specific cell and tissue responses can be obtained88. Coatings 
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can also change the hydrophilicity of the surface, as it is known that hydrophilic 
surfaces closely interact with biological fluid, promoting protein adsorption and, 
consequently, cell receptor activation91. Additionally, surface hydrophilicity can alter 
macrophage phenotype, and thus their inflammatory response to the implant material92. 
Moreover, implants with special surface coatings can decrease the inflammatory 
response, thus reducing the chance of complications. For coating purposes, various 
natural polymers such as alginate, chitosan, collagen, dextran and hyaluronic acid are 
used. The advantage of natural polymers is that they offer better integration chances, 
however they can be immunogenic and are thermolabile, which makes the 
manufacturing process more complicated. An alternative approach is to use synthetic 
polymers such as polylactic-acid (PLA), poly(lactide-co-glycolide) (PLGA), 
poly(ethylene-glycol) (PEG) and poly(vinyl-alcohol) (PVA)93. Synthetic polymers used 
for coatings besides being highly hydrophilic, can also provide resistance to biofilm (a 
thin layer of microorganisms) formation94. 
Common implant coating structures are hydrogels and polyelectrolyte multilayers. 
Hydrogels are three-dimensional networks of polymers, which absorb high amounts of 
water (can consist up to 90% of water) and are permeable to small bioactive molecules. 
Their advantages are that their mechanical properties are similar to those of soft 
tissues and they can be pre-loaded with drugs, growth factors or other bioactive 
substances that are gradually released in the adjacent tissue. The release rate can be 
adjusted by controlling the degree of crosslinking42, 93. Some proof of concept 
experiments show promising results in vivo, with extracellular matrix-based hydrogel 
coatings promoting an anti-inflammatory phenotype of macrophages95. The 
disadvantages of hydrogels are that they have a poor adhesion to the substrate, the 
mechanical strength can be inadequate for some applications and sometimes they 
have biocompatibility issues93. 
Polyelectrolyte multilayers are implant coatings obtained using layer by layer (LbL) 
alternated deposition of polyanions and polycations. These structures can also be 
loaded with bioactive molecules that are slowly released into the tissue. Polyelectrolyte 
multilayers can be fabricated with nanoscale precision, varying thickness, porosity, 
charge density and viscoelasticity96. Moreover they can be designed to possess anti-
microbial and immunomodulatory properties, a very attractive feature in implantation97. 
However, some drawbacks such as degradation under physiological conditions and 
difficulties in controlling the release rate of the bioactive molecule still need to be 
addressed42. 
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1.5 Aim and objectives 
Despite broad application of titanium as an implant material, the molecular and 
cellular mechanisms of detrimental inflammatory responses and implant failure still 
have to be elucidated. Macrophages are key innate immune cells that mediate 
recognition of foreign body and orchestrate local tissue inflammatory reactions. 
However, the knowledge about the molecular profile of the responses of different 
subtypes of macrophages to titanium surface as well as to implant coatings is limited. 
 
The aim of the thesis project was to study the reactions of human primary 
macrophage subtypes to titanium and biodegradable implant coating materials.  
 
 
The specific objectives were: 
 
1. To identify cytokine and transcriptional profile of human primary 
macrophages to titanium surfaces by ELISA, Affymetrix microarray analysis 
and RT-qPCR. 
 
2. To compare reactions of macrophages to titanium of different size. (titanium 
discs, microbeads and nanoparticles) using ELISA and RT-qPCR. 
 
3. To analyze the combined effects of bacteria (Staphylococcus aureus) and 
titanium on macrophage cytokine secretion.  
 
4. To analyze how fibroblasts or PBMC may alter inflammatory reactions of 
macrophages to titanium.  
 
5. To identify inflammatory reactions of macrophages to biodegradable implant 
coating materials.  
Materials and Methods 
25 
2 MATERIALS AND METHODS 
This work was written under the operating system Windows 10 with the text 
processing program Microsoft Office Word 2016. The presented pictures, as well as 
numerous reports, have been processed using the programs Microsoft Office Excel 
2016, GraphPad Prism 6, Corel Draw Graphics Suite X6 and Adobe Photoshop CS6. 
2.1 Chemicals, reagents and kits 
Table 9. Chemicals and reagents. 
Product Company 
0.05% Trypsin/EDTA solution Biochrom 
10× Earle's Balanced Salt Solution (EBSS) Sigma Aldrich 
10x Incomplete PCR buffer BIORON 
Acetic Acid Merck 
Agarose Roth 
AlamarBlue® Invitrogen 
Biocoll solution Biochrom 
Bovine Serum Albumin (BSA)  Sigma Aldrich 
CD14 MicroBeads Miltenyi Biotec 
D-(+)-Glucose solution 10% Sigma Aldrich 
Deoxyribonucleotides (dNTPs) 10M Fermentas 
DEPC Water Thermo Fisher Scientific 
Dexamethasone Sigma Aldrich 
Dimethylsulfoxide (DMSO) Sigma Aldrich 
DNase Buffer(10x) Thermo Fisher Scientific 
DNase I RNase free 1U/µl solution Fermentas 
EMEM medium ATCC 
Ethanol Roth 
FcR Blocking Reagent, human Miltenyi Biotec 
Fetal calf serum (FCS) Biochrom  
GelRed Nucleic Acid Gel Stain, 10,000x Biotium 
GeneRuler DNA ladder Fermentas 
Glycerol Sigma Aldrich 
Heat Killed Staphyloccocus aureus Invivogen 
Loading dye 6x Fermentas 
Macrophage-SFM (serum-free medium) Life Technologies 
MEM Spinner modification Sigma Aldrich 
MgCl2 Sigma Aldrich 
Oligo(dT) primer Thermo Fisher Scientific 
PBS Dulbecco, w/o Ca 2+, Mg 2+ Biochrom 
PCR primers (designed in the lab) Eurofins MWG Operon 
PCR probes (designed in the lab) Eurofins MWG Operon 
PCR ready-made mixes Life Technologies 
Penicillin / Streptomycin Biochrom 
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Product Company 
Percoll GE Healthcare Life Sciences 
Phosphate buffered saline (D-PBS), sterile 1x Invitrogen 
Recombinant Human IFN-γ Peprotech 
Recombinant Human IL-4 Peprotech 
Recombinant Human M-CSF Peprotech 
Sensimix II Probe kit Bioline 
Sodium Azide Alfa Aesar 
SytoxRed  Invitrogen 
Triton X-100 Sigma Aldrich 
Trypan blue solution Sigma Aldrich 
Tween 20 Sigma Aldrich 
UltraPure™ 0.5M EDTA Invitrogen 
β-Mercaptoethanol Sigma Aldrich 
 
Table 10. Kits. 
Product Company 
Chitotriosidase (Human) Custom ELISA Kit RayBiotech 
E.Z.N.A. total RNA kit I Omega bio-tek 
Human CCL18 DuoSet ELISA kit R&D systems 
Human Chitinase 3-like 1 DuoSet ELISA kit R&D systems 
Human IL-1beta DuoSet ELISA kit R&D systems 
Human IL-1ra DuoSet ELISA kit R&D systems 
Human IL-6 DuoSet ELISA kit R&D systems 
Human IL-8 DuoSet ELISA kit R&D systems 
Human LIGHT/TNFSF14 DuoSet ELISA kit R&D systems 
Human MMP-7 activity assay Quickzyme Biosciences 
Human MMP-9 activity assay Quickzyme Biosciences 
Human TNF-alpha DuoSet ELISA kit R&D systems 
Human Total MMP-7 DuoSet ELISA kit R&D systems 
Human Total MMP-9 DuoSet ELISA kit R&D systems 
RevertAid H Minus First Strand Synthesis Kit Fermentas 
RNeasy mini kit Qiagen 
 
2.2 Consumables 
Table 11. Consumables. 
Product Company 
22µm filters Fisherbrand 
22x22mm coverslips Marienfeld 
CASYcups Omni Life Sciences 
Cell culture plates Greiner 
Cryovials Nunc 
Elisa plate sealers R&D systems 
Elisa Plates R&D systems 
GeneChip® Human Gene 1.0 ST Array Affymetrix 
LS columns Miltenyi Biotec 
Parafilm American National Can 
PCR tubes Star Labs 
Petri dishes Nunc 
Pipette tips Eppendorf 
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Product Company 
Pipettes Gilson, Eppendorf 
Plastic wrap Toppits 
qPCR plate sealers Axon Labortechnik 
qPCR plates Axon Labortechnik 
Safe-Lock Eppendorf Tubes, 1.5ml Eppendorf 
Scalpel Feather 
Sterile pipette tips Avantguard, Star Labs, Nerbeplus 
TiO2 15nm nanoparticles  NanoAmor Europe 
Transwell inserts (0.4µm pore size) Sigma 
Tubes Falcon 
 
2.3 Equipment 
Table 12. Equipment. 
Product Company 
Autoclave VX-95 Systec 
BD FACSCanto II BD Biosciences 
CASY Cell counter Schärfe System 
Centrifugal vacuum concentrator 5301 Eppendorf 
Centrifuge 5415 D Eppendorf 
Centrifuge 5804R Eppendorf 
Centrifuge Rotina 420 Hettich 
Centrifuge Rotina 420R Hettich 
Centrifuge Universal 320 Hettich 
Cryo freezing container Nalgene 
Deep freezer (-80°C) Sanyo 
ENDURO Electrophoresis comb Labnet 
ENDURO Electrophoresis power supply Labnet 
Freezer (-20°C) Liebherr 
HydroFlex ELISA microplate washer Tecan 
Ice machine Scotsman AF100 
Incubator 37°C Edmund Bühler GmbH 
Inverted microscope Leica 
Laminar flow hood Thermo 
LightCycler 480 Roche 
Magnetic stirrer MR3000 Heidolph 
Microwave oven Sharp 
MultiDoc-It™ Imaging System UVP 
Neubauer haemocytometer Assistent 
Pipette Controller  Accu Jet Pro, Brand 
Roller Ortho Diagnostic Systems 
Rotator Neolab 
Shaker KS 260 basic IKA 
Tecan Infinite 200 PRO Tecan 
Thermocycler DNA Engine  Bio-Rad 
Thermomixer 5436 Eppendorf 
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Product Company 
Thermomixer comfort Eppendorf 
Tweezers Neolab 
Vortex Genie 2 Scientific Industries 
Water bath Memmert 
 
 
2.4 Buffers and solutions 
2.4.1 Running buffer for electrophoresis 
50xTAE buffer  
242g of Tris free base and 18.61g of Disodium EDTA were added to 700ml 
ddH2O and stirred until they dissolved. 57.1ml Glacial Acetic Acid was added 
and the volume was adjusted to 1L. 
1xTAE buffer 
20ml of 50xTAE buffer was added to 980ml of ddH2O. 
2.4.2 Solutions for immunological methods 
Wash buffer for ELISA (0.05% Tween 20 in PBS) 
500µl of Tween 20 was pipetted into 1L of PBS. The beaker was stirred on a 
magnetic stirrer for 30min and the solution was stored at RT. 
  
FACS buffer (0.4% BSA, 0.02% Sodium Azide): 
4g of BSA and 2ml of 10% Sodium Azide solution were dissolved in 1L of PBS. 
The solution was adjusted to pH 7.4 and sterile filtered with a 0.22μm filter. 
 
Red blood cell lysis buffer (RBC-lysis buffer): 
For a 10xRBC-lysis buffer 82,91g of NH4Cl (1.55M), 7.91g of NH4HCO3 (0.1M) 
and 0.29g of EDTA (1mM) were dissolved in 1L of ddH2O.  
1x RBC-lysis buffer was prepared by adding 100ml of 10xRBC-lysis buffer to 
900ml of ddH2O. 
2.4.3 Solutions for monocyte isolation 
Percoll gradient: 
Every 30ml of Percoll gradient solution was prepared in a 50ml Falcon tube with 
13.5ml Percoll, 15ml Minimal Essential Medium Eagle Spinner modification and 
1.5ml of 10xEarle’s Balanced Salt Solution.  
 
MACS buffer (0.5% BSA, 2mM EDTA): 
2.5g of BSA was dissolved in 500ml PBS. 2ml of 0,5M EDTA was added and 
the mixture was filtered to a sterile flask. 
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2.5 Molecular biology techniques 
2.5.1 Primers 
Table 13: List of primers designed in the lab. F: forward, R: reverse, Pr: probe. All primers 
and probes were ordered from Eurofins MWG Operon. 
Primer name Target gene Sequence (5'-3' direction) 
F848 GAPDH CATCCATGACAACTTTGGTATCGT 
R848 GAPDH CAGTCTTCTGGGTGGCAGTGA 
Pr849 GAPDH AAGGACTCATGACCACAGTCCATGCC 
F2229 MMP7  CTTCCTGTATGCTGCAACTCA 
R2229 MMP7  GGGATCTCCATTTCCATAGG 
Pr2229 MMP7 TCCCATACCCAAAGAATGGCCAA 
F2020 CCL18 ATACCTCCTGGCAGATTCCAC 
R2020 CCL18 GCTGATGTATTTCTGGACCCAC 
Pr2020 CCL18 CAAGCCAGGTGTCATCCTCCTAACCAAGAGAG 
F896 TNF TCTTCTCGAACCCCGAGTGA 
F896 TNF AGCTGCCCCTCAGCTTGA 
Pr896 TNF AAGCCTGTAGCCCATGTTGTAGCAAACC 
 
Table 14: List of ready-made mixes. All ready-made mixes were ordered from Life 
Technologies. 
Assay code Target Gene 
Hs00234646_m1 CCL13 
Hs00270756_m1 CCL23 
Hs04187715_m1 CCL8 
Hs00609691_m1 CHI3L1 
Hs00185753_m1 CHIT1 
Hs00174164_m1 CSF1 
Hs00218889_m1 IL17RB 
Hs01029060_m1 MMP8 
Hs00234579_m1 MMP9 
Hs01560899_m1 TNFRSF21 
Hs00542477_m1 TNFSF14 
2.5.2 Isolation of total RNA 
E.Z.N.A. total RNA kit I from Omega was used for RNA isolation. The lysis buffer was 
prepared by adding 20µl of -mercaptoethanol to each 1ml of the TRK buffer.  
1. For cells: 350µl of lysis buffer was added to 3-5x106 cells, which were 
completely disrupted by passing through a needle fitted to a syringe for 10-15 
times.  
2. 350µl of 70% ethanol were added to the lysate and vortexed briefly. The 
sample was added to a HiBind RNA spin column placed into a 2ml collection 
tube.  
3. After centrifuging for 1min at 10000g the flow-through was discarded. The 
column was washed once with 500µl wash buffer I. 
4. The column was centrifuged at 10000g followed by washing twice in 500µl 
wash buffer II (each wash was followed by a centrifugation step at 10000g).  
5. The final flow-through was discarded and a new 2ml collection tube was 
placed under the column which was centrifuged for 2min at maximum speed. 
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6. The column was placed in a fresh 1.5ml RNase free Eppendorf tube and RNA 
was eluted with 40µl of DEPC-treated water and incubated for 5min. Samples 
were centrifuged at maximum speed for 1min. 
7. The elution step was repeated with the eluate to increase RNA concentration 
as recommended by the manufacturer. 
8. The RNA concentration was determined by measuring the absorption peak at 
260nm wavelength with Tecan Infinite 200 PRO.  
9. The quality of RNA samples was determined by running the RNA on 1% 
agarose gel. RNA samples were stored at –80°C for later application. 
2.5.3 First strand cDNA synthesis 
For cDNA synthesis RevertAid H Minus First Strand Synthesis Kit from Fermentas was 
used. 
1. RNA samples were digested with DNase I to remove possible contamination 
of isolated RNA with fragments of genomic DNA. For this the following 
components were used: 
 
Total RNA 5µl (up to 1µg) 
10x DNase I buffer with MgCl2 (Fermentas) 1µl 
RNase free DNase I (Fermentas) 1µl 
Distilled water (RNase free) 3µl 
 
2. The samples were incubated at 37°C for 40min (DNA digestion step) in a 
Thermomixer followed by enzyme inactivation at 70°C for 10min. 
3. For primer annealing 1µl of Oligo (dT) primer and 1µl of water was added to 
each sample and incubated at 70°C for 5min. The samples were placed on 
ice. 
4. For cDNA synthesis the following components were added and mixed well: 
 
5x Reaction Buffer 4µl 
Ribolock RNase inhibitor 1µl 
10M dNTP mix 2µl 
RevertAid H minus reverse transcriptase 1µl 
           
5. The samples were incubated at 42°C for 1h in a Thermomixer. Afterwards, 
the enzymatic activity was stopped by incubation at 70°C for 10min.  
6. The cDNA samples were diluted 10 times with ddH2O and stored at -20°C for 
later use.  
2.5.4 RNA preparation for Affymetrix microarray analysis 
Total RNA was prepared using E.Z.N.A. total RNA kit I as described above.  
1. The volume of RNA sample was adjusted with DEPC-treated water to 100µl. 
12µl of 10x DNase I buffer with MgCl2 (Fermentas) and 10µl of RNase free 
DNase I (Fermentas) were added to sample and mixed well by pipetting.  
2. DNA digestion was done at 37°C for 40min in a Thermomixer. 
3. For RNA cleanup procedure RNeasy kit from Qiagen was used. 350µl of RLT 
buffer were added to the samples and the samples were vortexed.  
4. 250µl of 100% ethanol were added to the samples and mixed by pipetting.  
5. The samples were added to RNeasy mini column, placed in a 2ml collection 
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tube and centrifuged at 10000g for 1min.  
6. The flow through was discarded and columns were washed two times with 
500µl of RPE buffer (each wash was followed by a centrifugation step at 
10000g).  
7. The collection tubes were changed and the samples were centrifuged at 
maximum speed for 2min. 
8. The columns were placed in fresh 1.5ml RNase free Eppendorf tube and RNA 
was eluted with 40µl of DEPC-treated water and incubated for 5min. Samples 
were centrifuged at maximum speed for 1min. 
9. The elution step was repeated with the eluate to increase RNA concentration 
as recommended by the manufacturer. 
10. The RNA concentration was determined by measuring the absorption peak 
at 260nm wavelength with Tecan Infinite 200 PRO 
11. If the concentration of RNA was lower than 30ng/µl, the samples were 
concentrated using Eppendorf centrifugal vacuum concentrator 5301.  
2.5.5 Hybridization of gene chip microarray data 
RNA was tested by capillary electrophoresis on an Agilent 2100 bioanalyzer (Agilent) 
and high quality was confirmed. Hybridization of probes was done using arrays of 
human HuGene-1_0-st-type from Affymetrix. Biotinylated antisense cRNA was then 
prepared according to the Affymetrix standard labelling protocol with the GeneChip® 
WT Plus Reagent Kit and the GeneChip® Hybridization, Wash and Stain Kit (both from 
Affymetrix, Santa Clara, USA). Afterwards, the hybridization on the chip was performed 
on a GeneChip Hybridization oven 640, then dyed in the GeneChip Fluidics Station 
450 and thereafter scanned with a GeneChip Scanner 3000. All of the equipment used 
was from the Affymetrix-Company (Affymetrix, High Wycombe, UK). All the necessary 
procedures needed for hybridization and scanning of chips were performed by 
technical assistants Ms. Maria Muciek and Ms. Carolina De La Torre in the Affymetrix 
Core Facility of Medical Research Center, Medical Faculty Mannheim.  
2.5.6 Polymerase chain reaction (PCR) 
Genes were amplified from cDNA templates using primers specific to the gene of 
interest. 
1. The following reagents were added to a 1.5ml Eppendorf tube to make a 
master mix for the number of samples: 
 
Reagent Amount/sample (µl) 
ddH2O 18.3 
Buffer (w/o +Mg2+) 10x 2.5 
dNTPs (10 mM) 0.5  
MgCl2 (100 mM) 0.4  
Taq polymerase (5 U/µl) 0.3  
Forward primer (10 pmol/µl) 1  
Reverse primer (10 pmol/µl) 1  
 
2. The master mix was divided amongst PCR tubes and 1µl of cDNA template 
was added to each tube and mixed by pipetting. 
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3. Amplification was performed using Thermocycler DNA Engine from Biorad 
and the following program was used: 
 
95°C 3min 
95°C 30s 
60°C 30s 
72°C 1min 
72°C 10min 
12°C forever 
 
*PCR products were visualized using agarose gel electrophoresis. 
2.5.7 Real-time PCR with Taqman probe 
Genes were amplified from cDNA templates using primers specific to the gene of 
interest.  
1. A master mix for all the samples was prepared in a 1.5ml Eppendorf tube 
containing:  
 
Reagent Amount (µl) / sample 
Sensimix II 5 
Reference Primer 0.5 
Target Primer 0.5 
ddH2O 3 
 
2. The master mix was divided amongst 1.5ml Eppendorf tubes. As each 
sample was run in triplicates, 3µl of cDNA template was added to each tube 
and mixed by pipetting 
3. Amplification was performed using LightCycler 480 from Roche and the 
following program was used: 
 
95°C 10min 
95°C 15s 
60°C 1min 
37°C 2min 
 
Dual-labeled probes for target genes contained FAM on 5’ end and BHQ1 quencher at 
3’ end of sequence. In all experiments GAPDH was used as the reference gene. The 
probe for GAPDH contained JOE on 5’ end and BHQ1 quencher at 3’ end of sequence.  
2.5.8 Agarose gel electrophoresis 
1. 2g of agarose was mixed with 100ml of 1xTAE electrophoresis buffer to 
obtain a 2% agarose gel mixture (used for detecting DNA fragments less 
than 200bp). The mixture was heated in a microwave until completely 
dissolved.  
2. The solution was allowed to cool down to 50-60°C and 10µl of GelRed 
Nucleic Acid Gel Stain (10000x) was added to the solution. 
3. The solution was poured into a gel tray equipped with a comb and allowed 
to solidify (approximately 30min).  
35 cycles 
50 cycles 
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4. The comb was removed and the gel was placed into the electrophoresis unit 
filled with 1xTAE buffer.  
5. To verify the size of the target fragments 3μl of GeneRuler DNA Ladder was 
added to the first lane. 
6. The samples were prepared as follows: 2μl of sample + 8µl of ddH2O + 2μl 
of loading dye. 
7. Electrophoresis was carried out at 130 V for 45 min. The results were 
visualized by UV illumination and captured using MultiDoc-It™ Imaging 
System. 
2.6 Cell culture techniques 
2.6.1 Cultivation of cell lines and primary cells 
Table 15. Cultivation conditions of cell lines and primary cells. 
Cell line / primary 
cell 
Growth medium  Growth 
conditions 
Morphology  Cell type 
BJ EMEM  
+ 10% FCS  
+ 100µg/ml penicillin/ 
streptomycin 
5% CO2 adherent Human fibroblasts 
from skin, foreskin 
Primary human 
monocytes 
Macrophage-SFM 
+ 10-8M Dexamethasone 
+ 1ng/ml M-CSF 
Optional: cytokines as 
indicated in Section 2.6.8 
7.5% CO2 suspension Human peripheral 
blood monocytes 
PBMC Macrophage-SFM 
+ 10-8M Dexamethasone 
+ 1ng/ml M-CSF 
Optional: cytokines as 
indicated in Section 2.6.8 
7.5% CO2 suspension Human peripheral 
blood mononuclear 
cells 
2.6.2 Thawing of fibroblasts 
1. A T25 flask was prepared with 5ml medium. 
2. The vial with the frozen cells was thawed at 37°C in a water bath. 
3. The cell suspension was added to 9ml of PBS in a 15ml Falcon tube and 
centrifuged for 8min at 1200rpm. 
4. The supernatant was discarded and the pellet was resuspended in 1ml of 
medium. 
5. The cells were added to the flask. 
6. The flask was put into the 37°C incubator with 5% CO2 and 95% humidity. 
7. At 80-90% confluence the cells were split and cultivated further in T75 flasks. 
2.6.3 Splitting of fibroblasts 
Cells were cultivated in T75 flasks and were split when their confluence reached 80-
90%. 
1. A 15ml Falcon tube was prepared for each flask. 
2. The medium was aspirated from the flasks and the cells were washed with 
10ml of PBS. PBS was added carefully on the side and then aspirated. 
3. 3ml of warm (37°C) Trypsin/EDTA solution was added to each flask and the 
flasks were incubated at 37°C for 3min. 
4. To stop the enzymatic reaction 2ml of medium was added to each flask. 
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5. 10ml of PBS was vigorously added to each flask to wash and detach the 
cells. 
6. The cell suspension of each flask was added to its corresponding Falcon 
tube and the tubes were centrifuged for 8min at 1200rpm. 
7. The supernatant was aspirated and the pellets were resuspended in 1ml of 
medium. 
8. New T75 flasks were prepared with 10ml medium. 0.5ml of the cell 
suspension was added to each new T75 flask.  
9. The plates were incubated at 37°C with 5% CO2 and 95% humidity. 
2.6.4 Cryopreservation of fibroblasts 
1. A 15ml Falcon tube was prepared for each flask. 
2. The medium was aspirated and the cells were washed with 10ml of PBS. 
PBS was added carefully on the side and then aspirated. 
3. 3ml of warm (37°C) Trypsin/EDTA solution was added to each flask and the 
flasks were incubated at 37°C for 3min. 
4. To stop the enzymatic reaction 2ml of medium was added to each flask. 
5. 10ml of PBS was vigorously added to each flask to wash and detach the 
cells. 
6. The cell suspension of each flask was added to its corresponding Falcon 
tube and the tubes were centrifuged for 8min at 1200rpm. 
7. The supernatant was aspirated and the pellets were resuspended in 1ml of 
freezing medium (EMEM + 20% FCS + 10% DMSO). 
8. The suspension was put into cryovials and transferred into a cryo freezing 
container with 250ml of isopropanol. The container was placed into a -80°C 
freezer. 
9. The next day, the samples were transferred to liquid nitrogen tanks. 
2.6.5 Isolation of CD14+ monocytes from human peripheral blood (buffy coats) 
1. Buffy coats with 20-50ml of blood were received from the German Red 
Cross blood bank. A unique donor number was given to each Buffy Coat.  
2. Blood was transferred from the plastic bag to a T75 flask, diluted 1:1 with 
PBS (without Ca2+ and Mg2+) and mixed by pipetting up and down. 
3. For each 30ml of diluted blood a 50ml Falcon tube with 15ml Biocoll 
separating solution was prepared. 
4. 30ml of diluted blood was carefully layered (against the tube wall) on top of 
Biocoll solution. The tubes were centrifuged at 420g, for 30min without 
break. 
5. PBMC (the second layer) were collected with a sterile Pasteur pipet and 
transferred into a new 50ml Falcon tube (cells from each tube were 
transferred into a new one). 
6. The mixture was added up to 50ml with PBS and the tubes were centrifuged 
at 420g for 10min with break.  
7. The supernatant was discarded and the cell pellets from each donor were 
resuspended with 5ml PBS and collected in one 50ml Falcon tube for each 
donor (tubes from the same donor were combined in this step). 
8. The cells were washed with 50ml PBS and centrifuged at 420g for 10min 
with break. The supernatant was discarded.  
9. Percoll gradient (30ml) was prepared with 13.5ml Percoll, 15ml of MEM 
Spinner modification and 1.5ml 10x Earle's Balanced Salt Solution. 
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10. The cells were resuspended with 3ml PBS and carefully layered (against 
the tube wall) on top of the Percoll gradient.  
11. The old tube was washed with 4ml of PBS and the content was added to 
the Percoll gradient tube. Cells were centrifuged at 420g, for 30min without 
break. 
12. The upper phase (PBS) and second phase (cells enriched for monocytes) 
were collected into a 50ml Falcon tube. 
13. The solution was mixed well, filled up to 50ml with PBS and centrifuged at 
420g, for 10 min with break. The supernatant was discarded. 
14. The cell pellets were resuspended with 3ml PBS and transferred into a 15ml 
Falcon tube. The 50ml tube was washed with 4ml of PBS. The solution was 
added into the 15ml tube and filled up to 10ml. 
15. Cells were counted and the rest of them were centrifuged at 420g, for 10 
min with break. Cell counting was performed on CASY Cell counter. 
16. The cell pellet was resuspended in CD14+ microbeads and MACS buffer 
according to the formula: 5µl CD14 beads and 95µl MACS buffer per 1x107 
cells. 
17. The cells were incubated for 20 minutes on a rotator at 4°C. 
18. The tubes were filled up to 10ml with MACS buffer and centrifuged at 420g, 
for 10min. 
19. During this time, LS columns were attached to the magnetic stand (One 
column is maximal for 1x108 cells) and 15ml Falcon tubes were placed 
under columns. The columns were washed with 3ml of MACS buffer. 
20. The cell pellet was resuspended in 1ml MACS buffer and then added to 
each column. The column was washed 3 times with MACS buffer, each time 
3ml. 
21. The column was removed from the magnetic separation unit and placed on 
top of a fresh 15ml Falcon tube. CD14+ monocytes were eluted from the 
column with 10ml MACS buffer. 
22. Cells were counted and centrifuged at 420g, for 10min. The cell pellet was 
resuspended in 1ml of Macrophage-SFM medium and cultured according to 
the experimental plan. 
2.6.6 Isolation of PBMC and generation of CD14+ and PBMC-CD14 fractions 
from human peripheral blood (buffy coats) 
Steps 1-7 are identical to those from the protocol for isolation of CD14+ monocytes 
from human peripheral blood (section 2.6.5). 
8. The 50ml Falcon tubes were filled up to 50ml with PBS and a sample of cell 
suspension was taken for counting. The rest were centrifuged at 420g for 
10min with break. Counting was done on a CASY cell counter. 
9. Cell pellets were resuspended in 5ml of PBS and 20x106 PBMC were taken 
out and placed on ice until cultured. 
10. The remaining cells were washed with 50ml PBS and centrifuged at 420g 
for 10min. 
11. The cell pellet was resuspended in CD14+ microbeads and MACS buffer 
according to the formula: 10µl CD14 beads and 90µl MACS buffer per 1x107 
cells. 
12. The cells were incubated for 20min on a rotator at 4°C. 
13. The tubes were filled up to 10ml with MACS buffer and centrifuged at 420g, 
for 10min. 
Materials and Methods 
36 
14. During this time, LS columns were attached to the magnetic stand (One 
column is maximal for 1x108 cells) and 15ml Falcon tubes were placed 
under columns. The columns were washed with 3ml of MACS buffer. 
15. The cell pellet was resuspended in 1ml MACS buffer and then added to 
each column. The column was washed 3 times with MACS buffer, each time 
3ml. 
16. The column was removed from the magnetic separation unit and placed on 
top of a fresh 15ml Falcon tube. CD14+ monocytes were eluted from the 
column with 10ml MACS buffer. 
17. Cells from both the tubes containing CD14+ monocytes and those 
containing PBMC-CD14+ monocytes (flow-through) were counted and 
centrifuged at 420g, for 10min. The cell pellet was resuspended in 1ml of 
Macrophage-SFM medium and cultured according to the experimental plan. 
2.6.7 Cell counting 
Monocyte and PBMC cell counting was performed on a CASY cell counter from 
Schärfe System. 
1. 10µl of sample was added to 10ml of CASYton solution in a CASYcup.  
2. The CASYcup was placed under the CASY capillary and the appropriate 
program for PBMC was chosen. 
3. After each measurement 3 cycles of cleaning procedure were performed. 
4. Only the viable cell number was used for further calculations. 
 
Fibroblasts were counted using a Neubauer hemocytometer.  
1. 20μl of cells were mixed with 20μl of Trypan blue solution in a 1.5ml 
Eppendorf tube. 
2. 10μl of the mixture was pipetted into the hemocytometer chamber via 
capillary action. 
3. The number of cells in the four marked squares which did not take up Trypan 
blue were counted using a microscope.  
4. Cells overlapping the top and left boundaries were counted while cells 
overlapping the bottom and right boundaries were not. 
5. The number of cells per ml was calculated using the following formula: 
number of cells in the 4 corners/4 x 104 x dilution factor 
2.6.8 Specific conditions used for primary human monocytes and PBMC 
Isolated primary human monocytes and PBMC were cultured in Macrophage-SFM 
medium supplemented with 10-8M Dexamethasone and 1ng/ml M-CSF. The 
concentration of cells was 1x106/ml for coating materials and 2x106/ml for titanium 
experiments. For coating experiments the medium was additionally supplemented with 
5mM Glucose. Cells were seeded in 24-well plates, 1.5ml/well. Three subtypes of 
monocytes were obtained by stimulation: M(Control) - no additional stimulation; 
M(IFNγ) - stimulated with 100ng/ml IFNγ; M(IL-4) - stimulated with 10ng/ml IL-4. The 
same stimulations were used for PBMC and PMBC depleted of CD14+ monocytes 
(PBMC-CD14). Cells were cultured for 6 days. 
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2.6.9 Co-culturing of primary human monocytes and BJ Fibroblasts 
To preserve the same conditions in all experiments, isolated primary human 
monocytes and BJ Fibroblasts were co-cultured in Macrophage-SFM medium 
supplemented with 10-8M Dexamethasone and 1ng/ml M-CSF. The concentration of 
cells was 1x106/ml for monocytes and 1x105/ml for fibroblasts. Cells were seeded in 
24-well plates, 1ml/well. Monocytes were co-cultured with BJ Fibroblasts either directly 
in the same well (cell-cell contact) or in a transwell system (0.4µm pores). When co-
cultured in transwell system, 1ml of monocyte suspension was added outside the 
transwell insert (0.4µm pore size with PET track-etched membrane), while 105 
fibroblasts were seeded inside the transwell supplemented with 200µl of culture 
medium. As controls, both monocytes and fibroblasts alone were cultured. Additional 
stimulation with IFNγ and IL-4 was done as described in section 2.6.8. Cells were 
cultured for 6 days.  
2.6.10 Activation of macrophages with heat killed Staphylococcus aureus.  
Isolated primary human monocytes were cultured in Macrophage-SFM medium 
supplemented with 10-8M Dexamethasone and 1ng/ml M-CSF. Cells were seeded 24-
well plates, 1.5ml/well (2x106 cells/ml). Three subtypes of monocytes were obtained by 
stimulation: M(Control) - no additional stimulation; M(IFNγ) - stimulated with 100ng/ml 
IFNγ; M(IL-4) - stimulated with 10ng/ml IL-4. Cells were cultured in total for 7 days. 107 
heat killed Staphylococcus aureus cells per ml was used to additionally activate 
monocytes either immediately on day 0 or on the 6th day.  
2.6.11 Analysis of macrophage cell viability with Alamar Blue 
1. 0.5ml of supernatants from each well was removed, leaving 1ml of 
supernatant inside. 
2. 100µl of Alamar Blue was added to each well, and the plate was incubated 
at 37°C for 3h.  
3. Three times 100µl of supernatant from each well (triplicates) was collected 
and transferred into a 96-well plate for measuring. 
4. Measurement was done on with Tecan Infinite 200 PRO using 560EX 
nm/590EM nm filter settings. 
2.6.12 Preparation of biomaterials for cell culture 
Titanium discs 
Medical grade titanium discs of 13.7x2mm size (both polished and porous) were 
provided by our collaborators from Protip Medical in the frames of EU FP7 IMMODGEL 
project. The discs were autoclaved at 121°C for 20 min at 18psi. 
 
Titanium microbeads 
Medical grade titanium microbeads (125-200µm in size) were provided by our 
collaborators from Protip Medical in the frames of EU FP7 IMMODGEL project.  
1. 45mg of microbeads were weighted in 1.5 Eppendorf tubes. This amount of 
beads was sufficient to cover up to ¾ of the area of a well (24-well plate). 
2. 200µl of 70% Ethanol was added to each tube and incubated for 1h. 
3. The beads were carefully washed twice with 400µl sterile PBS. 
4. The beads were placed in the appropriate wells and the plate was further 
sterilized under UV light for 1h. 
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TiO2 nanoparticles 
TiO2 nanoparticles of 15nm size were purchased from NanoAmor Europe. Prior to use, 
they were sterilized under UV light for 1h. nTi particles were added in 0.0025wt% per 
well. 
 
PLA films 
PLA films were sterilized with ethylene oxide. PLA films were provided by Dr. Sergei I. 
Tverdokhlebov from Tomsk Polytechnic University.  
 
PAR/HA and PAR/HA+CAT coatings 
PAR/HA and PAR/HA+CAT coatings were provided as coatings on coverslips by Dr. 
Philippe Lavalle from Strasbourg University. The coverslips were sterilized under UV 
light for 1h. 
 
2.7 Immunological methods 
2.7.1 Antibodies 
Table 16. List of primary antibodies. 
Antibody Company Catalog 
number 
Species Application Working 
concentration; 
dilution 
Anti-Human CD14 FITC eBioscience 11-0149-42 Mouse FACS 
10µg/ml 
1:20 
IgG1 K Isotype Control eBioscience 11-4714-42 Mouse FACS 
10µg/ml 
1:20 
 
2.7.2 Flow cytometry 
Flow cytometry was used to verify the purity of CD14+ monocytes after isolation. 
Additionally, it was used to determine the depletion of CD14+ monocytes in the PBMC-
CD14 fraction of PBMC. All procedures were performed in FACS tubes. 
1. After monocyte or PBMC isolation 1x106 cells were taken for FACS staining.  
2. The cells were divided into two fractions (0.5x106 cells) and possible 
contamination with erythrocytes was removed with addition of 2ml of RBC-
lysis buffer. Cells were incubated for 10min at RT. 
3. Cells were centrifuged for 4min at 400g with break, at RT. 
4. Cells were resuspended in 100µl FACS buffer.  
5. 10µl of FcR Blocking Reagent was added and incubated with cells for 5min 
at 4°C. 
6. Antibodies (conjugated with fluorochrome) were added (0,2-1µg per tube 
according to manufacturer instructions) to each sample. The cells were 
briefly vortexed and incubated for 30min at 4°C. 
7. Cells were washed 2 times with 500µl FACS buffer. Each wash was 
followed by a centrifugation step (4min at 400g with break, at RT) 
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8. Cells were resuspended in 200µl FACS buffer before measurement. 
Staining was analyzed using BD FACS Canto II. 
 
2.8 Protein-related techniques 
2.8.1 Enzyme-linked Immunosorbent Assay (ELISA) 
Protocol for ELISA kits from R&D systems. 
All procedures were performed at RT unless stated otherwise. ELISA was performed 
according to the manufacturer’s instructions. 
1. The Capture Antibody was diluted to working concentration according to 
manufacturer instruction in PBS without carrier protein. 
2. A 96-well micro plate was immediately coated with 100µl per well of Capture 
Antibody. The plate was sealed and incubated overnight. 
3. The plate was washed with HydroFlex ELISA microplate washer (350µl 
wash buffer 4 times). 
4. Each well was filled with 100µl of Reagent Diluent (1% BSA in PBS) to block 
unspecific binding sites. Incubate 1 hour. 
5. The Reagent Diluent was aspirated from the wells and 100µl of fresh 
Reagent Diluent was added to the wells designated for standards and 50µl 
of Reagent Diluent was added to the wells designated for samples. 
6. 50µl of sample or 100µl of standards diluted in Reagent Diluent was added 
per well. The plate was covered with an adhesive strip and incubated for 2 
hours. 
7. The plate was washed with HydroFlex ELISA microplate washer (350µl 
wash buffer 4 times). 
8. The Detection Antibody was diluted to working concentration according to 
manufacturer instruction in Reagent Diluent. 100µl of Detection Antibodies 
were pipetted into each well and the plate was incubated for 2 hours. 
9. The plate was washed with HydroFlex ELISA microplate washer (350µl 
wash buffer 4 times). 
10. Streptavidin-HRP was diluted to working concentration according to 
manufacturer instruction in Reagent Diluent. 100µl of Streptavidin-HRP was 
added to each well and the plate was incubated for 20 minutes in the dark. 
11. The plate was washed with HydroFlex ELISA microplate washer (350µl 
wash buffer 4 times). 
12. Substrate Solution was prepared by mixing 5ml of Reagent A with 5ml of 
Reagent B. 100µl of Substrate Solution was added to each well and the 
plate was incubated for 20 minutes in the dark. 
13. 50µl of Stop Solution (2N H2SO4) was added to each well. The absorbance 
at 450nm was read on a Tecan Infinite 200 PRO reader. 
14. To determine each sample’s concentration a standard curve was drawn by 
plotting the mean absorbance for each standard on the y-axis against the 
concentration on the x-axis. Individual sample absorbance values were then 
compared to the standards values and the concentration was calculated 
according to the polynomial equation that describes the curve. In diluted 
samples, the concentration read from the standard curve was multiplied by 
the dilution factor. The sample’s concentration was extrapolated if the 
absorbance values were below the lowest standard and above blank. 
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Protocol for ELISA kits from RayBiotech 
All procedures were performed at RT unless stated otherwise. ELISA was performed 
according to the manufacturer’s instructions. 
1. Assay Diluent (Item E2), Wash buffer (Item B), TMB One-step Substrate 
Reagent (Item H) and Stop solution (Item I) were thawed approximately 1h. 
2. 1xAssay Diluent (Item E2) was prepared to a working concentration by 
dilution 1:5 in ddH2O. 
3. The samples and standard was prepared by dilution with 1xAssay Diluent 
(Item E2). 
Standard (std) preparation: 400µl of 1xAssay Diluent (Item E2) was added 
to the standard vial (Item C) to get stock concentration of 10ng/ml. 
Standards were prepared in seven 1.5ml Eppendorf tubes. For highest 
standard concentration 100µl of stock standard solution was added to 400µl 
of 1xAssay Diluent (Item E2). In the other 6 tubes 300µl of 1xAssay Diluent 
(Item E2) was added. 200µl of concentrated standard solution was used for 
preparing serial dilutions.  
 
 Std1 Std2 Std3 Std4 Std5 Std6 Std7 Blank 
Diluent volume 
+ 
higher standard 
400µl 
+ 
100µl 
std 
300µl 
+ 
200µl 
std1 
300µl 
+ 
200µl 
std2 
300µl 
+ 
200µl 
std3 
300µl 
+ 
200µl 
std4 
300µl 
+ 
200µl 
std5 
300µl 
+ 
200µl 
std6 
400µl 
Concentration 
(pg/ml) 
2000 800 320 128 51.20 20.48 8.19 0 
 
4. Samples and standards were incubated for 2.5h. 
5. Detection Antibody (Item F) was prepared by adding 100µl of 1xAssay 
Diluent (Item E2). Detection Antibody (Item F) was adjusted to a working 
concentration by 1:80 dilution in 1xAssay Diluent (Item E2). 
6. Wash buffer (Item B) was diluted 1:20 to a working concentration in ddH2O. 
The plate was washed 4 times with 300µl of 1xWash buffer (Item B). 
7. 100µl of 1xDetection Antibody (Item F) was added to each well and 
incubated for 1h. 
8. The plate was washed 4 times with 300µl of 1xWash buffer (Item B). 
9. Working concentration of Streptavidin-HRP was prepared by dilution 1:400 
in 1xAssay Diluent (Item E2). 100µl of Streptavidin-HRP was added to each 
well and incubated for 45min. 
10. The plate was washed 4 times with 300µl of 1xWash buffer (Item B). 
11. 100µl of TMB One-step Substrate Reagent (Item H) was added to each well 
and incubated for 30min in the dark with gentle shaking. 
12. 50µl of Stop solution (Item I) was added to each well. The absorbance at 
450nm was read on a Tecan Infinite 200 PRO reader. 
13. To determine each sample’s concentration a standard curve was drawn by 
plotting the mean absorbance for each standard on the y-axis against the 
concentration on the x-axis. Individual sample absorbance values were then 
compared to the standards values and the concentration was calculated 
according to the polynomial equation that describes the curve. In diluted 
samples, the concentration read from the standard curve was multiplied by 
the dilution factor. The sample’s concentration was extrapolated if the 
absorbance values were below the lowest standard and above blank. 
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2.8.2 MMP-7 and MMP-9 activity assays 
The concentration of active MMP-7 and MMP-9 was measured using MMP activity 
assays from Quickzyme Biosciences. MMP activity assays were performed according 
to the manufacturer’s instructions. All procedures were performed at RT unless stated 
otherwise. 
1. Assay Buffer and Wash Buffer were thawed for 2h. 
2. Wash Buffer was prepared by repeated washing with distilled water and 
collected in a 500ml bottle. 
 
Steps 3 to 5 were done only for MMP-7 activity assay 
 
3. MMP-7 antibody dilution was thawed and prepared as follows: 100µl in 10ml 
Assay Buffer. 
4. The plate was covered with 100µl of MMP-7 antibody and incubated at 37oC 
for 2h. 
5. The plate was washed 4 times. 
6. The standard was prepared by adding 950µl Assay Buffer to the standard 
vial (C = 32ng/ml).  
7. Standards were prepared in twelve 1.5ml Eppendorf tubes. First 250 µl of 
Assay Buffer was added to each tube and then 250µl of concentrated 
standard was added to the first tube. After this 250µl of solution from the 
first tube was transferred to the next one and so on (serial dilution). 
8. 100µl of standards and samples were added to the appropriate wells. Plate 
was incubated overnight at 4oC. 
9. APMA stock solution was prepared by adding 50µl DMSO to the APMA vial.  
10. 10µl of stock APMA was added to 10ml of Assay buffer to prepare ready-
to-use APMA solution. 
11. The plate was washed 4 times. 
12. 50µl of ready-to-use APMA solution was added to the standards and Blank 
and 50µl of Assay Buffer to the wells in which endogenous MMP activity is 
analyzed. 
 
Step 13 was done only for MMP-9 activity assay 
13. The plate was incubated for 1.5h at 37oC. 
14. The Detection Reagent was prepared by adding 550µl of Detection Enzyme 
and 880µl of Substrate Solution to 4070µl of Assay Buffer. 
15. 50µl of Detection Reagent was added to each well. 
16. The plate was incubated at 37oC and MMP activity was read at 405nm with 
20s shaking on Tecan Infinite 200 PRO at the following time points: 0h, 3h, 
6h, 24h.  
17. To determine the active concentration in each sample, a standard curve was 
drawn by plotting the mean absorbance for each standard on the y-axis 
against the concentration on the x-axis. Individual sample absorbance 
values were then compared to the standards values and the concentration 
was calculated according to the polynomial equation that describes the 
curve. In diluted samples, the concentration read from the standard curve 
was multiplied by the dilution factor. The sample’s concentration was 
extrapolated if the absorbance values were below the lowest standard and 
above blank. 
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2.9 Statistical analysis 
2.9.1 Statistical analysis of ELISA and RT-qPCR data 
The significance of difference between groups of experimental data in ELISA and RT-
qPCR analysis was determined using Wilcoxon matched-pairs rank test or Student’s 
paired t-test. A P-value less than 0.05 was considered statistically significant. All 
statistical analysis was performed in GraphPad Prism 6. 
 
2.9.2 Statistical analysis of Affymetrix microarrays 
Statistical analysis of microarray data was done by Dr. Carsten Sticht from the 
Affymetrix Core Facility of Medical Research Center, Medical Faculty Mannheim. A 
Custom CDF Version 19 with ENTREZ based gene definitions was used to annotate 
the arrays98.  The Raw fluorescence intensity values were normalized applying quantile 
normalization and RMA background correction. One-way-ANOVA was performed to 
identify differential expressed genes using a commercial software package SAS 
JMP10 Genomics, version 6, from SAS (SAS Institute, Cary, NC, USA). A false positive 
rate of a=0.05 with FDR correction was taken as the level of significance. Plots (3D 
Scatterplots and Venn diagrams) are made with JMP. 
 
Further analysis of gene expression data was done in Microsoft Excel with self-made 
VBA scripts. Heat maps were generated in Morpheus application from Broad Institute. 
Gene families were selected from the Molecular Signatures Database from Broad 
Institute. 
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3 RESULTS 
3.1 Experimental design 
Titanium is a widely used material for implant fabrication. This is due to its superior 
mechanical properties and excellent biocompatibility. However, the development of 
chronic inflammation at the implant-tissue interface often leads to implant failure. High 
mechanical stress and friction between articulating surfaces causes the release of 
wear particles, which are recognized by the immune system as foreign bodies. Since 
macrophages are the key initiators of the foreign body reaction and orchestrators of 
inflammation, their reaction to titanium was tested.  
To determine the reaction of macrophages to titanium an in vitro test system based 
on human peripheral blood-derived monocytes was developed. Monocytes were 
isolated from buffy coats and were cultured on titanium discs with a polished surface 
or on cell culture plastic for control. The size of titanium discs was optimized 
(13.7x2mm) to cover maximum surface in a well of a 24-well plate. To maximize the 
contact with titanium and increase RNA yield, 3x106 cells (2x106 cells/ml) were seeded 
in each well. In order to mimic physiological conditions Macrophage-SFM medium was 
supplemented with 10-8M Dexamethasone and 1ng/ml M-CSF. To simulate distinct 
activation states of macrophages, the cells were stimulated either with IFNγ or with IL-
4. The experimental design is illustrated in Figure 3. In order to isolate high quality RNA 
for further microarray analysis cells were seeded in triplicates per stimulation. 
Supernatants and RNA were collected after 6 days of culture. 
 
 
Figure 3. Schematic representation of the experimental design. Human peripheral blood 
monocytes were isolated from buffy coats by magnetic cell sorting using CD14 beads. M(IFNγ) 
and M(IL-4) macrophages have been generated by stimulating human monocytes with IFNγ 
and IL-4, correspondingly, for 6 days in serum-free medium. In this study the new 
nomenclature for designating macrophage activation and polarization will be used52. 
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3.2 Analysis of macrophage reaction to polished titanium discs 
3.2.1 Analysis of macrophage cytokine secretion induced by polished titanium 
Macrophages control both acute inflammatory reactions and healing processes. 
IFNγ induces a pro-inflammatory cytokine profile in macrophages, while IL-4 is 
responsible for the activation of healing activities of macrophages. To determine if 
titanium is able to induce secretion of pro-inflammatory or anti-inflammatory cytokines, 
supernatants from macrophages cultured on polished titanium discs were analyzed by 
ELISA. As members of pro-inflammatory cytokines TNFα, IL-1β and IL-6 were chosen, 
while CCL18 was selected as a cytokine that displays anti-inflammatory properties. 
 
 
 
Figure 4. Macrophage cytokine secretion in response to polished titanium determined 
by ELISA. A. TNFα secretion; B. IL-1β secretion; C. IL-6 secretion; D. CCL18 secretion. All 
graphs represent mean values from 8 individual donors with standard deviations. For statistical 
analysis Wilcoxon matched-pairs rank test was used (* p < 0.05; ** p < 0.01). 
Figure 4A illustrates the secretion of TNFα by macrophages in response to titanium. 
TNFα was significantly up-regulated by titanium in macrophages activated by IFNγ 
(98.2 ± 64.6pg/ml vs 51.9 ± 25.7pg/ml), while no difference was found in other 
activation states. Similar results were obtained when analyzing IL-1β secretion (Figure 
4B), with up-regulated secretion in response to titanium in IFNγ stimulated 
macrophages (24.3 ± 8.6pg/ml vs 14.3 ± 12.4pg/ml). IL-6 (Figure 4C) was up-regulated 
by titanium regardless of the activation state, with the highest values in M(Control) 
(23.2 ± 16.3pg/ml vs 6.7 ± 3.2pg/ml) and M(IFNγ) (21.6 ± 18.7pg/ml vs 6.25 ± 2.4pg/ml). 
As expected, CCL18 was highest in M(IL-4). It was slightly down-regulated by titanium 
(146.6 ± 53.3ng/ml vs 173.9 ± 52.3ng/ml), however not statistically significant (Figure 
4D). In M(IFNγ) titanium induces down-regulation of CCL18 (23.7 ± 7.3pg/ml vs 42.9 
± 34.8pg/ml), while in M(Control) up-regulation of CCL18 was detected (220 ± 
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236.2pg/ml vs 105.8 ± 139.8pg/ml). In summary, these data suggest that titanium 
induces the secretion of pro-inflammatory cytokines and, at the same time, inhibits the 
secretion of anti-inflammatory cytokines, thus promoting a pro-inflammatory state of 
macrophages. 
3.2.2 Microarray gene expression analysis of macrophages stimulated by 
polished titanium 
In order to analyze the effect of polished titanium on the gene expression in 
macrophages, peripheral blood CD14+ monocytes from 8 donors were cultured on 
polished titanium discs. On day 6 cells were harvested and used for RNA isolation. 
Based on RNA integrity number and concentration, RNA from 6 of them was chosen 
for microarray analysis. For each donor 6 different groups of macrophages were 
analyzed: M(Control), M(IFNγ), M(IL-4), M(Control) Ti, M(IFNγ) Ti and M(IL-4) Ti 
(Figure 3). The summary of microarray analysis of macrophage gene expression in 
response to polished titanium is presented in Figure 5.  
 
 
 
Figure 5: Summary of microarray analysis of gene expression in macrophages cultured 
on polished titanium discs. A. Venn’s diagramm of differentially expressed genes in 
macrophages cultured with polished titanium vs control. Each number represents the number 
of genes differentially expressed in response to titanium. Each circle represents a population 
of macrophages with a different stimulation (Red – Control, Green – IFNγ, Blue - IL-4). 
Intersecting points represent the number of genes differentially regulated by polished titanium 
in 2 or more stimulations. B. Clustering of the microarray data in a 3D scatterplot. Each sphere 
represents genes from one donor. α - clustering of data from M(Control) (pink – Control; orange 
- Titanium); β - clustering of data from M(IFNγ) (green – Control; brown - Titanium); γ - 
clustering of data from M(IL-4) (yellow – Control; cyan - Titanium). 
A total of 1690 genes were differentially regulated by polished titanium (Figure 5A). 
Whereof, 1452 genes were found statistically significant up- or down-regulated in M(IL-
4), 214 genes in M(Control) and 150 genes in M(IFNγ). The 3D scatterplot confirmed 
these findings and revealed that polished titanium has the most pronounced effect on 
M(IL-4), while M(Control) and M(IFNγ) have more homogeneous populations (Figure 
5B). The analysis also showed that titanium induces differential regulation of 14 
common genes for both M(Control) and M(IFNγ), 98 common genes for M(Control) 
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and M(IL-4), 21 common genes for M(IFNγ) and M(IL-4), and 7 common genes across 
all 3 macrophage activation states (Figure 5A).  
A number of gene families were found to be differentially regulated in macrophages 
cultured with polished titanium (Table 17). These included: metallothioneins (9 
members), matrix metalloproteinases (6 members), cytokine-cytokine receptors (44 
members), zinc fingers C2-H2 type (52 members), immunoglobulin-like domain 
containing (23 members) and endogenous ligands (25 members). 
 
Table 17. Gene families that are differentially expressed in macrophages cultured on 
polished titanium discs. 
Gene Family No. of genes 
up/down-regulated 
Biological function Prominent Member 
Metallothioneins 9 Metal binding and 
transport; control of 
oxidative stress 
MT2A  > 7 fold change  
Matrix 
metalloproteinase 
6 Breakdown of 
extracellular matrix 
MMP9 > 6 fold change 
Cytokine-cytokine 
receptor family 
44 Role in cell signaling, 
inflammation and 
immunomodulation, 
hematopoiesis 
TNFSF14 > 4 fold 
change 
Zinc Fingers, C2-H2 
type 
52 Interaction modules that 
bind DNA, RNA, 
proteins 
EGR1 > 5 fold change 
Immunoglobulin-like 
domain containing 
23 Receptors, co-receptors, 
co-stimulatory 
molecules, cell adhesion 
TIE1  > 6 fold change 
Endogenous ligands 25 Signal transduction SPP1 > 5 fold change 
 
To narrow down the number of genes, whose expression changed in response to 
polished titanium discs, a stimulation-specific gene profile based on Affymetrix 
microarray data was computed. For each stimulation, additionally to the statistical 
threshold (p<0.05), an arbitrary cut-off was introduced. Thus, only the genes in which 
the difference in signal intensity between control and titanium was higher than 1 were 
taken into profile. This cut-off corresponds to a 2-fold change in gene expression and 
is commonly used for microarray analysis99. Following this algorithm, the number of 
genes that are more biologically meaningful (in contrast to only statistically significant) 
up- or down-regulated in response to polished titanium stimulation was determined. 
Thus, in M(Control) titanium induced significant up-regulation of 36 genes, in M(IFNγ) 
up-regulation of 10 genes and down-regulation of 5 genes, while in M(IL-4) up-
regulation of 164 genes and down-regulation of 10 genes. A list of genes that are most 
up-regulated and down-regulated in macrophages cultured on polished titanium discs 
vs control is presented in Figure 6. To obtain a better overview of the most affected 
genes, the gene list was divided into 4 groups: genes affected by titanium regardless 
of activation state (4 genes); genes from the cytokine-cytokine receptor family (10 
genes); genes involved in extracellular matrix degradation (3 genes); other genes with 
at least a 3-fold change (51 genes). The analysis of microarray data using the algorithm 
for the identification of biologically meaningful differentially regulated genes in 
response to titanium, reinforced the previous findings and revealed that the highest 
number of affected genes were in M(IL-4) macrophages. Thus, macrophage activation 
state significantly influences the response to polished titanium. 
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Figure 6. List of the most differentially regulated genes in macrophages cultured on 
polished titanium discs. A. Common genes for all activation states; B. Genes from cytokine-
cytokine receptor family; C. Genes involved in extracellular matrix degradation; D. Genes with 
a 3-fold change. Colors indicate relative expression of each gene between different 
stimulations in the presence or absence of titanium. Genes are presented in alphabetical order. 
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3.2.3 Validation of microarray data obtained from macrophages cultured on 
polished titanium  
Members of cytokine-cytokine receptors family and mediators of extracellular 
matrix degradation are key factors that control local level of inflammation and tissue 
remodeling. These are essential processes that define implant related complications. 
Therefore, several prominent members of these gene families were primarily selected 
from the microarray data for RT-qPCR validation (Figure 6). The following genes from 
cytokine-cytokine receptor family were analyzed: CSF1, CCL8, CCL23, TNFRSF21 
and TNFSF14 (Figure 7). Additionally, the expression of three other members of the 
family (CCL13, CCL18 and IL17RB), for which titanium-induced differential expression 
was close to the selection criteria, were also analyzed due to their involvement in 
inflammation and implant related complications100-102.  
 
 
 
Figure 7. RT-qPCR analysis of expression of cytokine-cytokine receptor family genes in 
macrophages cultured on polished titanium discs. A. CSF1 expression; B. CCL8 
expression; C. CCL13 expression; D. CCL18 expression; E. CCL23 expression; F. IL17RB 
expression; G. TNFRSF21 expression; H. TNFSF14 expression. All graphs represent mean 
values from 8 individual donors with standard deviations. In E, F and H only data for M(IL-4) is 
shown due to very low expression in other activation states (Ct > 40). For statistical analysis 
Wilcoxon matched-pairs rank test was used (* p < 0.05; ** p < 0.01). 
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CSF1 expression was significantly up-regulated by polished titanium in M(Control) 
(3.5 times) and in M(IL-4) (8 times) (Figure 7A). Similar findings were observed in the 
expression of TNFRSF21 and TNFSF14, with titanium up-regulating TNFRSF21 in 
M(Control) (2.5 times) and TNFSF14 in M(IL-4) (2.3 times) (Figures 7G and 7H). A 
different pattern was noted in the expression of CCL8, CCL13, CCL18, CCL23 and 
IL17RB. Titanium induced down-regulation of CCL8 expression in M(Control) (3.2 
times) and in M(IL-4) (4.8 times) (Figure 7B). Likewise, titanium induced down-
regulation of CCL13, CCL18, CCL23 and IL17RB expression in M(IL-4) (CCL13 – 3.5 
times; CCL18 – 3.6 times; CCL23 – 3.1 times; IL17RB – 2.5 times) (Figures 7C, 7D, 
7E and 7F). 
Based on the stimulation-specific gene profile computed from the microarray data, 
two other genes (CHI3L1 and MMP9) were selected for RT-qPCR validation (Figure 
8). CHI3L1 and MMP9 are involved in inflammation and tissue remodeling and, thus, 
potentially play a role in implant related complications103, 104. Additionally, the 
expression of two related genes (CHIT1 and MMP8), for which titanium-induced 
differential expression was close to the selection criteria, was also analyzed due to 
their involvement in implant related complications105, 106. CHIT1 and MMP8 expression 
was not significantly influenced by polished titanium stimulation, regardless of the 
activation state (Figures 8A and 8C). In contrast, CHI3L1 expression was up-regulated 
by polished titanium in all activation states: in M(Control) (2 times) in M(IFNγ) (1.8 
times) and in M(IL-4) (3.3 times) (Figure 8B). While the highest expression levels for 
MMP9 were found in M(Control), MMP9 expression was stimulated by titanium only in 
M(IL-4) (5.1 times) (Figure 8D).  
 
 
 
Figure 8. RT-qPCR analysis of expression of CHIT1, CHI3L1, MMP8 and MMP9 in 
macrophages cultured on polished titanium discs. A. CHIT1 expression; B. CHI3L1 
expression; C. MMP8 expression; D. MMP9 expression. All graphs represent mean values 
from 8 individual donors with standard deviations. In C only data for M(Control) and M(IL-4) is 
shown due to very low expression in M(IFNγ) (Ct > 40). For statistical analysis Wilcoxon 
matched-pairs rank test was used (* p < 0.05; ** p < 0.01). 
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To determine if the same patterns of expression can be observed on the protein 
level, secretion of chitotriosidase, CHI3L1 (YKL-40), MMP-9 and TNFSF14 (LIGHT) 
was analyzed by ELISA. The secretion levels of chitotriosidase mirrors the results from 
RT-qPCR and was not statistically significantly changed under stimulation with 
polished titanium, although increased secretion in M(IL-4) was observed (32.3 ± 
64.4ng/ml vs 0.7 ± 1.4ng/ml) (Figure 9A). Secretion of CHI3L1 maintained the same 
tendency observed on RT-qPCR (up-regulation upon titanium stimulation), however 
the changes were not statistically significant (Figure 9B). The biggest difference was 
noted in M(IL-4) where titanium increased CHI3L1 secretion to 60.5 ± 59.9ng/ml vs 1.3 
± 1.7ng/ml. MMP-9 secretion was significantly increased under polished titanium 
stimulation in M(Control) (156.9 ± 61.5ng/ml vs 73.1 ± 38.6ng/ml) and in M(IL-4) (133.4 
± 138.4ng/ml vs 1.4 ± 0.9ng/ml), while in M(IFNγ) no significant change was observed 
(Figure 9C). For TNFSF14, in contrast with data from RT-qPCR, there was no 
significant change on protein level, however the tendency for higher secretion in M(IL-
4) under titanium stimulation (213.6 ± 210.9pg/ml vs 98.3 ± 13.5pg/ml) was maintained 
(Figure 9D). 
 
 
 
Figure 9. Secretion of chitotriosidase, CHI3L1, MMP-9 and TNFSF14 in macrophages 
cultured on polished titanium discs determined by ELISA. A. chitotriosidase secretion; B. 
CHI3L1 secretion; C. MMP-9 secretion; D. TNFSF14 secretion. All graphs represent mean 
values from 4 individual donors with standard deviations (except C – 8 donors). For statistical 
analysis Student’s paired T test was used (* p < 0.05; ** p < 0.01). 
In summary, RT-qPCR analysis provided a confirmation of microarray data. On 
protein level similar tendencies in expression patterns were observed. Altogether these 
results indicated that polished titanium is able to induce significant changes in the 
expression profile of genes involved in inflammation and extracellular matrix 
remodeling. 
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3.3 Analysis of macrophage reaction to porous titanium discs 
3.3.1 Analysis of macrophage cytokine secretion induced by porous titanium 
Since porous materials have been shown to promote osseointegration86, it is 
reasonable to assume that these materials also display higher biocompatibility, and 
thus do not elicit a strong inflammatory reaction. In order to test this hypothesis, primary 
human macrophages were cultivated on porous titanium discs and cytokine production 
was analyzed by ELISA. TNFα was chosen as a pro-inflammatory cytokine, while 
CCL18 was selected as a cytokine that displays anti-inflammatory properties. Previous 
results have demonstrated that polished titanium significantly up-regulates MMP-9 
secretion (section 3.2.3). To determine whether porous titanium also increases MMP-
9 secretion, it was analyzed by ELISA.  
 
 
 
Figure 10. Secretion of TNFα, CCL18 and MMP-9 in macrophages cultured on porous 
titanium discs determined by ELISA. A. TNFα secretion; B. CCL18 secretion; C. MMP-9 
secretion. A and B represent mean values with standard deviation from 11 individual donors, 
C from 4 donors. For statistical analysis Student’s paired T test was used (* p < 0.05; ** p < 
0.01; *** p < 0.001). 
Figure 10A illustrates the secretion of TNFα by macrophages in response to 
porous titanium stimulation. TNFα was significantly up-regulated by titanium in all 
activation states: in M(Control) (39.9 ± 34pg/ml vs 22.8 ± 27.2pg/ml), in M(IFNγ) (171.9 
± 127.3pg/ml vs 127.6 ± 124.6pg/ml) and in M(IL-4) (27.6 ± 23.2pg/ml vs 7.4 ± 
9.8pg/ml). In contrast porous titanium induced down-regulation of CCL18 only in M(IL-
4) (38.6 ± 37.7ng/ml vs 218.9 ± 142.4ng/ml), while no difference was found in other 
activation states (Figure 10B). Secretion of MMP-9 was significantly up-regulated by 
porous titanium in M(IFNγ) (157.9 ± 100.5ng/ml vs 59.6 ± 73.9ng/ml) and M(IL-4) (237 
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± 129ng/ml vs 5.1 ± 3.5ng/ml). A tendency for higher secretion of MMP-9 was noted 
also in M(Control) (272.1 ± 178.8ng/ml vs 65.2 ± 17.7ng/ml), however the difference 
was not statistically significant (Figure 10C). Contrary to our initial hypothesis, these 
data indicate that porous titanium is able to induce the secretion of pro-inflammatory 
cytokines and matrix metalloproteinases and, at the same time, to inhibit the secretion 
of cytokines with anti-inflammatory properties, thus promoting both inflammation and 
matrix remodeling. 
3.3.2 Microarray gene expression analysis of macrophages stimulated by 
porous titanium 
Analysis of the secretion of TNFα, CCL18 and MMP-9 suggested that porous 
titanium induces similar changes in activation of pro-inflammatory and matrix 
remodeling activities of macrophages as those observed under polished titanium 
stimulation. In order to analyze the effect of porous titanium on the gene expression in 
macrophages, an Affymetrix microarray analysis was performed. To this end, RNA 
from macrophages cultured on porous titanium discs was isolated and samples from 8 
donors out of 11 were chosen (based on RNA integrity number and concentration) for 
microarray analysis. For each donor 6 different groups of macrophages were analyzed: 
M(Control), M(IFNγ), M(IL-4), M(Control) Ti, M(IFNγ) Ti and M(IL-4) Ti (Figure 3). The 
summary of microarray analysis of macrophage gene expression in response to 
porous titanium is presented in Figure 11. 
 
 
 
Figure 11. Summary of microarray analysis of gene expression in macrophages 
cultured on porous titanium discs. A. Venn’s diagramm of differentially expressed genes in 
macrophages cultured with porous titanium vs control. Each number represents the number of 
genes differentially expressed in response to titanium. Each circle represents a population of 
macrophages with a different stimulation (Red – Control, Green – IFNγ, Blue - IL-4). 
Intersecting points represent the number of genes differentially regulated by porous titanium 
in 2 or more stimulations. B. Clustering of the microarray data in a 3D scatterplot. Each sphere 
represents genes from one donor. α - clustering of data from M(Control) (dark green – Control; 
violet - Titanium); β - clustering of data from M(IFNγ) (red – Control; green - Titanium); γ - 
clustering of data from M(IL-4) (blue – Control; orange - Titanium). 
A total of 4648 genes were differentially regulated by porous titanium. Whereof, 
1244 genes were found statistically significant up- or down-regulated in M(Control), 
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861 genes in M(IFNγ) and 3560 genes in M(IL-4). Microarray analysis also revealed 
that porous titanium induced differential regulation of 37 common genes for both 
M(Control) and M(IFNγ), 713 common genes for M(Control) and M(IL-4), 150 common 
genes for M(IFNγ) and M(IL-4), and 59 common genes across all 3 activation states of 
macrophages (Figure 11A). The 3D scatterplot confirmed these findings and showed 
that porous titanium has the most pronounced effect on M(IL-4) and M(Control), while 
M(IFNγ) have a more homogeneous population (Figure 11B).  
Under stimulation with porous titanium a number of gene families were found to be 
differentially regulated in macrophages (Table 18). These are: metallothioneins (15 
members), matrix metalloproteinases (6 members), cytokine-cytokine receptors (65 
members), solute carrier family (92 members), chitinase-like proteins (3 members), 
integrins (19 members) and purinergic receptors (7 members). 
 
Table 18. Gene families that are differentially expressed in macrophages cultured on 
porous titanium discs. 
Gene Family No. of genes diff. 
regulated 
Biological function Prominent Member 
Metallothioneins 15 Metal binding and 
transport; control of 
oxidative stress 
MT2A  >5 fold change  
Matrix 
metalloproteinase 
6 Breakdown of 
extracellular matrix 
MMP7 > 7 fold change 
Cytokine-cytokine 
receptor family 
65 Role in cell signaling, 
inflammation and 
immunomodulation, 
hematopoiesis 
CSF1 > 2 fold change 
Solute carrier family 92 Transmembrane 
transporters 
SLC28A3 > 5 fold 
change 
Chitinase-like proteins 3 Role in inflammation, 
angiogenesis 
CHIT1 > 5 fold change 
Integrins 19 Cell attachment, signal 
transduction 
ITGA3 > 3 fold change 
Purinergic receptors 7 Proliferation, migration, 
vascular reactivity, 
apoptosis, cytokine 
secretion 
P2RY14 > 12 fold 
change 
 
To narrow down the number of genes, whose expression changed in response to 
porous titanium discs, the algorithm described in section 3.2.2 was employed. Thus, a 
stimulation-specific gene profile based on Affymetrix microarray data, similar to the one 
used for polished titanium discs, was computed. Following this algorithm, the number 
of genes that are more biologically meaningful (in contrast to only statistically 
significant) up- or down-regulated in response to porous titanium stimulation was 
determined. In M(Control) porous titanium induced significant up-regulation of 74 
genes and down-regulation of 4 genes, in M(IFNγ) up-regulation of 7 genes and down-
regulation of 22 genes, while in M(IL-4) up-regulation of 121 genes and down-
regulation of 49 genes. A list of genes that are most up-regulated and down-regulated 
in macrophages cultured on porous titanium discs vs control is presented in Figure 12. 
To obtain a better overview of the most affected genes, the gene list was divided into 
4 groups: genes affected by porous titanium regardless of the activation state (9 genes); 
genes from the cytokine-cytokine receptor family (14 genes); genes involved in 
extracellular matrix degradation (6 genes); other genes with at least a 3-fold change 
(54 genes). The analysis of microarray data using the algorithm for the identification of 
biologically meaningful differentially regulated genes revealed that the highest number 
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of genes affected by porous titanium were in M(IL-4) macrophages. Thus, macrophage 
activation state significantly influences the response to porous titanium. 
 
 
 
Figure 12. List of the most differentially regulated genes in macrophages cultured on 
porous titanium discs. A. Common genes for all activation states; B. Genes from cytokine-
cytokine receptor family; C. Genes involved in extracellular matrix degradation; D. Genes with 
at least a 3-fold change. Colors indicate relative expression of each gene between different 
stimulations in the presence or absence of titanium. Genes are presented in alphabetical order. 
Results 
55 
3.3.3 Validation of microarray data obtained from macrophages cultured on 
porous titanium 
Mediators of inflammation and matrix remodeling play an important role in implant 
related complications107. To confirm the results obtained by microarray analysis, 
several genes from the cytokine-cytokine receptor family were selected for RT-qPCR 
validation, namely: CSF1, CCL8, CCL13, CCL18, CCL23, IL17RB, TNFRSF21 and 
TNFSF14 (Figure 13). 
 
 
 
Figure 13. RT-qPCR analysis of expression of genes from cytokine-cytokine receptor 
family in macrophages cultured on porous titanium discs. A. CSF1 expression; B. CCL8 
expression; C. CCL13 expression; D. CCL18 expression; E. CCL23 expression; F. IL17RB 
expression; G. TNFRSF21 expression; H. TNFSF14 expression. Graphs A, B, C, E, G, H 
represent mean values with standard deviations from 11 individual donors, D – from 9 donors, 
F – from 10 donors. In E, F and H only data for M(IL-4) is shown due to very low expression in 
other activation states (Ct > 40). For statistical analysis Wilcoxon matched-pairs rank test was 
used (* p < 0.05; ** p < 0.01; *** p < 0.001). 
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CSF1 expression was significantly up-regulated by porous titanium in M(Control) 
(4.2 times). A tendency for higher CSF1 expression upon titanium stimulation was 
noted in M(IL-4), however it was not statistically significant (Figure 13A). The 
expression pattern of CCL8 showed a clear down-regulation in macrophages cultured 
on porous titanium in M(Control) (2.6 times) and in M(IL-4) (9.7 times) (Figure 13B). 
Similar results were observed in the analysis of CCL13, CCL18, CCL23 and IL17RB 
expression, where porous titanium induced down-regulation of gene expression in 
M(IL-4) (CCL13 – 8.7 times; CCL18 – 5.8 times; CCL23 – 38.9 times; IL17RB – 32.6 
times) (Figures 13C, 13D, 13E and 13F). In contrast, TNFRSF21 and TNFSF14 
expression was not significantly influenced by porous titanium (Figures 13G and 13H). 
Although a tendency for higher TNFSF14 expression in titanium samples in M(IL-4) 
was observed, the difference was not statistically significant (Figure 13H).  
Additionally, several genes (CHIT1, CHI3L1, MMP8 and MMP9), with potential role 
in implant related complications, due to their involvement in inflammation and tissue 
remodeling, were selected for RT-qPCR validation (Figure 14). Thus, it was noted that 
porous titanium induces up-regulation in CHIT1 expression regardless of the activation 
state: in M(Control) (4 times), in M(IFNγ) (1.4 times) and in M(IL-4) (4.4 times) (Figure 
14A). Similarly, CHI3L1 expression was up-regulated by titanium in M(Control) (3.5 
times) and in M(IL-4) (2.5 times) (Figure 14B). Expression of MMP8 and MMP9 was 
also up-regulated by titanium in M(IL-4) (MMP8 – 4.7 times; MMP9 – 3 times), with 
tendencies of higher expression observed in M(Control) (Figures 14C and 14D). 
 
 
 
Figure 14. RT-qPCR analysis of expression of CHIT1, CHI3L1, MMP8 and MMP9 in 
macrophages cultured on porous titanium discs. A. CHIT1 expression; B. CHI3L1 
expression; C. MMP8 expression; D. MMP9 expression. All graphs represent mean values 
from 11 individual donors with standard deviations. In C only data for M(Control) and M(IL-4) 
is shown due to very low expression in M(IFNγ) (Ct > 40). For statistical analysis Wilcoxon 
matched-pairs rank test was used (* p < 0.05; ** p < 0.01). 
In summary these results indicate that porous titanium, similarly to polished 
titanium, is able to induce significant changes in the expression of genes involved in 
inflammation and extracellular matrix remodeling, especially in M(IL-4) activation state. 
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3.4 Comparison of macrophage reactions to Ti discs, Ti microbeads 
and Ti nanoparticles  
It was reported that THP-1 cells have a slightly different cytokine release pattern 
when exposed to titanium discs in comparison to titanium particles, suggesting that the 
size of titanium also influences the immune reaction82. To determine if human 
peripheral blood-derived monocytes exhibit similar properties, an experiment involving 
polished titanium discs, titanium microbeads (µTi) and titanium nanoparticles (nTi) was 
designed. The previously described experimental setup (Figure 3) was used with the 
addition of the new materials.  
In order to study if the size of titanium is able to alter the secretion of inflammatory 
or anti-inflammatory cytokines, supernatants from macrophages cultured on polished 
titanium discs, µTi and nTi were analyzed by ELISA. TNFα was chosen as a model of 
pro-inflammatory cytokines, while CCL18 was selected as a cytokine that displays anti-
inflammatory properties. 
In contrast to previous results, there was no significant change in secretion of 
TNFα induced by any type of titanium regardless of the activation state (Figure 15A). 
However, CCL18 secretion was down-regulated upon stimulation with any type of 
titanium in M(IL-4), with a significant difference in secretion between µTi and nTi (192.6 
± 113.7ng/ml vs 40.9 ± 36.5ng/ml) (Figure 15B). 
 
 
 
Figure 15. Effect of Ti discs, Ti microbeads and Ti nanoparticles on macrophage 
secretion of TNFα and CCL18. Cytokine secretion was determined by ELISA. A. TNFα 
secretion; B. CCL18 secretion. A. represents mean values with standard deviation from 4 
individual donors, B. from 5 individual donors. In B only data for M(IL-4) is shown due to very 
low secretion levels in other activation states. For statistical analysis Student’s paired T test 
was used. * denotes statistical significance between titanium and control of the respective 
activation state, while σ denotes statistical significance between different types of titanium (* p 
< 0.05; ** p < 0.01; σ p < 0.05). 
Previous results revealed that titanium is able to alter the expression of several 
genes from cytokine-cytokine receptor family. To analyze whether titanium µTi and nTi 
induce a different expression pattern of CSF1, CCL8, CCL13, CCL23, IL17RB and 
TNFSF14 in comparison to polished titanium discs, RT-qPCR was performed (Figure 
16). The expression of CSF1 correlated with previous data. In both M(Control) and 
M(IL-4) polished Ti discs and nTi up-regulated the expression of CSF1 compared to 
control, while no significant effect was observed in µTi samples. Additionally, nTi 
significantly up-regulated CSF1 expression compared to both Ti discs (3.9 times) and 
µTi (5.6 times). Similar results were observed in M(IFNγ) where nTi induced higher 
expression of CSF1 compared to Ti discs (6.9 times). In M(IL-4) both Ti discs and nTi 
up-regulated CSF1 expression compare to µTi (5.2 times and 3.3 times respectively) 
(Figure 16A). A different expression pattern was observed for CCL8. In M(Control) and 
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M(IL-4) all types of titanium down-regulated CCL8 expression, while no changes were 
noted in M(IFNγ). There was a significant difference in CCL8 expression between nTi 
and µTi (2.2 times) in M(Control). In M(IL-4) both Ti discs and µTi expressed higher 
levels of CCL8 compared to nTi (5.5 times and 7.1 respectively) (Figure 16B).  
 
 
 
Figure 16. Comparison of gene expression from cytokine-cytokine receptor family in 
macrophages cultured on Ti discs, Ti microbeads and Ti nanoparticles. Gene expression 
was measured by RT-qPCR. A. CSF1 expression; B. CCL8 expression; C. CCL13 expression; 
D. CCL23 expression; E. IL17RB expression; F. TNFSF14 expression. All graphs represent 
mean values from 5 individual donors with standard deviations. In C, D, E and F only data for 
M(IL-4) is shown due to very low expression in other activation states (Ct > 40). For statistical 
analysis Student’s paired T test was used. * denotes statistical significance between titanium 
and control of the respective activation state, while σ denotes statistical significance between 
different types of titanium (* p < 0.05; ** p < 0.01; *** p < 0.001; σ p < 0.05; σσ p < 0.01). 
Similar results were obtained in the analysis of CCL13, CCL23 and IL17RB 
expression in M(IL-4), where all types of titanium down-regulated their expression 
compared to control (Figures 16C, 16D and 16E). The lowest expression of CCL13 
and CCL23 was induced by nTi and was significantly lower than in Ti discs (CCL13 – 
5.6 times; CCL23 – 59 times) and in µTi (CCL13 – 7 times; CCL23 – 55.8 times) 
(Figures 16C and 16D). TNFSF14 expression in M(IL-4) was up-regulated by Ti discs 
compared to control, with a similar tendency observed in µTi samples. Additionally, 
TNFSF14 expression induced by Ti discs was significantly higher than in nTi (3.3 times) 
(Figure 16F). 
To verify if µTi and nTi in comparison to polished titanium discs differentially 
regulate the expression of other genes with potential implication in implant related 
complications, the expression of CHIT1, CHI3L1, MMP7 and MMP9 was analyzed by 
RT-qPCR (Figure 17). Expression of CHIT1 was significantly up-regulated compared 
to control only by nTi in both M(Control) and M(IFNγ), with no difference in expression 
in M(IL-4). In M(Control) nTi also induced higher levels of CHIT1 when compared with 
both Ti discs (12.4 times) and µTi (6.3 times), with similar findings in M(IFNγ) 
(compared to Ti discs – 8.3 times; to µTi – 5.4 times) (Figure 17A). Similar results were 
obtained in the analysis of CHI3L1 expression with nTi displaying highest levels of 
expression. In M(Control) both µTi and nTi induced up-regulation of CHI3L1 expression 
compared to Ti discs (µTi – 1.5 times; nTi – 4.6 times). In M(IL-4) only Ti discs and nTi 
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up-regulated CHI3L1 expression compared to control, with nTi displaying higher levels 
compared to both Ti discs (1.8 times) and µTi (3.1 times) (Figure 17B). 
 
 
 
 
Figure 17. Comparison of CHIT1, CHI3L1, MMP7 and MMP9 gene expression in 
macrophages cultured on Ti discs, Ti microbeads and Ti nanoparticles. Gene expression 
was measured by RT-qPCR. A. CHIT1 expression; B. CHI3L1 expression; C. MMP7 
expression; D. MMP9 expression. All graphs represent mean values from 5 individual donors 
with standard deviations. For statistical analysis Student’s paired T test was used. * denotes 
statistical significance between titanium and control of the respective activation state, while σ 
denotes statistical significance between different types of titanium (* p < 0.05; ** p < 0.01; σ p 
< 0.05; σσ p < 0.01). 
Previous results from the polished titanium experiment did not show significant 
changes in MMP8 expression (section 3.2.3). For this reason it was decided to focus 
on the analysis of MMP7 which showed up-regulation in polished titanium samples in 
the microarray data, although not statistically significant. MMP7 expression was 
significantly up-regulated in M(IL-4) by Ti discs and µTi, with nTi presenting the same 
tendency. However, no significant change in MMP7 between Ti types was observed 
regardless of the activation state (Figure 17C). In contrast, the size of titanium had an 
effect on the MMP9 expression. In M(Control) both Ti discs and nTi down-regulated 
MMP9 expression. Additionally, nTi displayed a significantly lower level of expression 
compared to Ti discs (1.6 times). In M(IL-4) a different scenario could be recognized, 
in which Ti discs and µTi up-regulated MMP9 expression, with nTi displaying the same 
tendency (Figure 17D).  
In order to identify whether patterns of MMP-7 and MMP-9 gene expression 
correspond to the patterns of protein production, their secretion levels were analyzed 
by ELISA. MMP-7 partially confirmed the results from RT-qPCR with tendencies of up-
regulation in M(IL-4) present in all Ti types. No significant difference was noted 
between the different types of Ti (Figure 18A). Secretion of MMP-9 was significantly 
up-regulated by Ti discs and nTi in M(IL-4) and the same tendency was noted for µTi 
as well, correlating with RT-qPCR data. However, no significant differences were 
observed between all Ti types in all activation states (Figure 18B). 
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Figure 18. Effect of Ti discs, Ti microbeads and Ti nanoparticles on macrophage 
secretion of MMP-7 and MMP-9. MMP secretion was determined by ELISA. A. MMP-7 
secretion; B. MMP-9 secretion. Both graphs represent mean values with standard deviation 
from 5 individual donors. For statistical analysis Student’s paired T test was used. * denotes 
statistical significance between titanium and control of the respective activation state, while σ 
denotes statistical significance between different types of titanium (* p < 0.05; ** p < 0.01; σ p 
< 0.05). 
The comparison of macrophage reactions to Ti discs, Ti microbeads and Ti 
nanoparticles revealed that all 3 types of titanium induce similar reactions in 
macrophages in terms of cytokine expression and production as well as in expression 
and secretion of matrix remodeling proteases. However, macrophages cultured with 
nTi generally displayed stronger reactions to the material, suggesting that nanoparticle 
phagocytosis enhances these reactions.   
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3.5 Analysis of the combined effects of bacteria and titanium on 
macrophage cytokine secretion  
It is well established that biofilm formation is one of the reasons for implant 
failures108. To determine if bacteria found in orthopedic infections of titanium implants 
can influence the secretion of inflammatory cytokines by macrophage an experiment 
with Staphylococcus aureus and polished titanium was designed. For this purpose, 
heat killed Staphylococcus aureus (SA) was added to mature macrophages on day 6, 
and cells were cultured for additional 24h. The secretion of cytokines in response to 
SA stimulation was measured by ELISA. As pro-inflammatory cytokines TNFα, IL-1β, 
IL-6 and IL-8 were chosen, while CCL18 was selected as a cytokine that displays anti-
inflammatory properties. 
 
 
 
Figure 19. Cytokine secretion of mature macrophages upon stimulation with 
Staphylococcus aureus in the presence of titanium. SA was added to mature 
macrophages on day 6, and cells were cultured for additional 24h. Protein concentrations were 
measured by ELISA on day 7 of culture. A. TNFα secretion; B. IL-1β secretion; C. IL-6 
secretion; D. IL-8 secretion; E. CCL18 secretion. All graphs represent mean values from 4 
individual donors with standard deviations. For statistical analysis Student’s paired T test was 
used (* p < 0.05; ** p < 0.01). SA – heat killed staphylococcus aureus; Control – macrophages 
without SA stimulation; SA Day 6 – macrophages stimulated with SA on day 6. 
Figure 19A illustrates the secretion of TNFα by macrophages in response to 
polished titanium alone or in combination with SA. The highest levels of TNFα were 
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secreted in M(IFNγ) challenged with SA alone and in combination with polished 
titanium, however no significant difference in response to SA was observed in the 
presence of titanium (60.1 ± 33.9pg/ml vs 64.8 ± 44.4pg/ml). Similar results were 
obtained in the analysis of IL-1β secretion (Figure 19B). The highest levels of IL-6 
secretion were in M(IFNγ) in SA alone, while in combination with titanium the levels of 
IL-6 were much lower (426.3 ± 441.1pg/ml vs 75 ± 38.3pg/ml). A different pattern was 
noted in M(IL-4) where the combination of SA and polished titanium induced higher 
levels of IL-6 when compared to SA alone (9.4 ± 4.9pg/ml vs 249.9 ± 229.3pg/ml) 
(Figure 19C). Secretion of IL-8 was significantly higher in M(IFNγ) in titanium samples 
when compared to control, as well as in SA alone and in SA in combination with 
titanium. A slight decrease was observed in SA in combination with titanium when 
compared to SA alone (31.2 ± 16.9ng/ml vs 24.5 ± 8.9ng/ml). In contrast, in M(Control) 
SA alone induced significantly lower production of IL-8 when compared to SA in 
combination with polished titanium discs (4.5 ± 4ng/ml vs 13.8 ± 6.3ng/ml) (Figure19D). 
The highest secretion levels for CCL18 were found in M(IL-4), while SA had no 
additional effect on CCL18 secretion in all types of macrophages. Titanium decreased 
CCL18 secretion in both control settings and when combined with SA (Figure 19E). 
Infection and inflammation induce recruitment of monocytes into the tissue109. In 
order to examine if Staphylococcus aureus induces stronger reaction in naive 
monocytes during differentiation to mature macrophages, an experiment was designed 
with SA added on day 0 to naive monocytes cultured on titanium. Monocytes were 
differentiated in 3 subtypes of macrophages (M(Control), M(IFNγ), M(IL-4)), and on 
day 7 of culture the supernatants were analyzed by ELISA. 
As expected, when SA was added to naive monocytes significantly higher cytokine 
levels were accumulated during the differentiation process. SA induced the highest 
levels of TNFα secretion in M(IFNγ). When combined with polished titanium, a 
tendency to inhibit TNFα secretion (34.6 ± 40ng/ml vs 27 ± 22.5ng/ml) was observed, 
however not statistically significant. In M(Control) and M(IL-4) no significant changes 
between SA alone and SA in combination with titanium were noted (Figure 20A). 
Similar results were obtained in the analysis of IL-1β secretion, where in all activation 
states SA alone induced the highest secretion levels. The most elevated levels were 
detected in M(IFNγ) in which SA alone induced a significantly higher secretion than 
when combined with polished titanium (1.3 ± 0.6ng/ml vs 0.9 ± 0.5ng/ml) (Figure 20B). 
IL-6 secretion was significantly up-regulated by SA in all activation states, with highest 
levels in M(Control) and M(IFNγ). Still, no significant difference was observed between 
SA alone and SA in combination with polished titanium (Figure 20C). 
 Similar results were noted in the analysis of IL-8 secretion. The highest levels 
were observed in M(IFNγ) and no significant difference was noted between SA alone 
and SA in combination with titanium (Figure 20D). In contrast to mature macrophages 
(Figure 19E), monocytes that underwent differentiation in the presence of SA alone in 
M(IL-4) secreted significantly higher levels of CCL18 (Figure 20E). When combined 
with polished titanium, CCL18 secretion was strongly inhibited, although not 
statistically significant (1253.4 ± 1040.3ng/ml vs 83.2 ± 64.9ng/ml) (Figure 20E). 
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Figure 20. Cytokine secretion upon stimulation with Staphylococcus aureus on day 0. 
SA was added to naive monocytes on day 0 and cells were differentiated and cultured for 7 
days. Protein concentrations were measured by ELISA on day 7 of culture. A. TNFα secretion; 
B. IL-1β secretion; C. IL-6 secretion; D. IL-8 secretion; E. CCL18 secretion. All graphs 
represent mean values from 4 individual donors with standard deviations. For statistical 
analysis Student’s paired T test was used (* p < 0.05; ** p < 0.01). SA – heat killed 
staphylococcus aureus; Control – macrophages without SA stimulation; SA Day 0 – 
macrophages stimulated with SA on day 0. 
 
To analyze if SA stimulation can support secretion of matrix remodeling molecules, 
the secretion of MMP-7 and MMP-9 was measured by ELISA. SA was added to naive 
monocytes and mature macrophages (day 6) in the presence or absence of titanium 
and the concentration of MMP-7 and MMP-9 was measured on day 7 of culture (Figure 
21). In mature macrophages SA stimulation alone did not influence the secretion of 
MMP-7 in any activation state. The highest levels of secretion were noted in M(IL-4). 
Although in SA stimulation in combination with polished titanium the levels of MMP-7 
were higher than in polished titanium alone (16.4 ± 12.7ng/ml vs 7.9 ± 9.9ng/ml), the 
difference was not statistically significant (Figure 21A). In contrast, during monocyte to 
macrophage differentiation, SA stimulation alone strongly up-regulated the secretion 
of MMP-7 in M(Control) and in M(IL-4) when compared to control settings. Additionally, 
in M(IL-4), SA in combination with titanium induced significantly higher levels of MMP-
7 than SA stimulation alone (69.5 ± 17.6ng/ml vs 28.9 ± 16.9ng/ml) (Figure 21B). 
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Figure 21. Secretion of MMP-7 and MMP-9 upon stimulation of naive monocytes and 
mature macrophages with Staphylococcus aureus. SA was added either on day 6 or on 
day 0 of cell culture and cells were further cultured for 24h or 7 days respectively. Protein 
concentrations were measured by ELISA on day 7 of culture. A. MMP-7 secretion with SA 
stimulation on day 6; B. MMP-7 secretion with SA stimulation on day 0; C. MMP-9 secretion 
with SA stimulation on day 6; D. MMP-9 secretion with SA stimulation on day 0. All graphs 
represent mean values from 4 individual donors with standard deviations. For statistical 
analysis Student’s paired T test was used (* p < 0.05; ** p < 0.01). SA – heat killed 
staphylococcus aureus; Control – macrophages without SA stimulation; SA Day 6 – 
macrophages stimulated with SA on day 6; SA Day 0 – macrophages stimulated with SA on 
day 0.  
The secretion pattern of MMP-9 in mature macrophages was similar to MMP-7, 
and SA stimulation alone did not induce additional changes in MMP-9 secretion. In 
M(Control) SA stimulation combined with titanium induced significantly higher levels of 
MMP-9 than SA alone (233 ± 164.8ng/ml vs 14.7 ± 16.6ng/ml). Similarly, in M(IL-4), 
SA stimulation in combination with polished titanium induced higher levels of MMP-9 
than polished titanium alone (576.8 ± 352.3ng/ml vs 272.9 ± 336.6ng/ml), however the 
difference was not statistically significant (Figure 21C). Different results were obtained 
by the analysis of MMP-9 secretion when SA was added to naive monocytes. 
Stimulation with SA alone was able to up-regulate the secretion of MMP-9 in all 
activation states. SA in combination with polished titanium displayed lower levels of 
MMP-9 when compared to SA alone (479.7 ± 172.5ng/ml vs 621.9 ± 131.8ng/ml) in 
M(IFNγ), with no significant differences noted in other activation states (Figure 21D). 
In summary these data demonstrate that the secretion of TNFα, IL-1β, IL-6, IL-8, 
CCL18, MMP-7 and MMP-9 is significantly altered only when SA is added to naive 
monocytes that undergo differentiation and not in case when SA is added to already 
maturated macrophages. Moreover, with the exception of MMP-7, titanium did not 
enhance the effects of SA both in mature macrophages and in naive monocytes. 
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3.6 Analysis of secretion of MMP-7 and MMP-9 by PBMC in response 
to polished titanium discs 
Previous results have shown that titanium, regardless of its size, porosity and SA 
contamination, when compared to control generally stimulates a higher level of 
secretion of MMP-9 in M(Control) and M(IL-4) (Figures 9C, 10C, 18B, 21C and 21D). 
Likewise, a tendency for higher MMP-7 secretion induced by titanium in (M-IL4) has 
also been observed (Figures 18A, 21A and 21D). Both of these molecules are involved 
in matrix remodeling and thus possess a potential role in implant related complications. 
In order to investigate whether other immune cells can enhance or inhibit macrophage 
secretion of MMP-7 and MMP-9 in reaction to polished titanium, an experiment 
involving the whole fraction of peripheral blood mononuclear cells (PBMC) was 
designed. For this purpose, the previously described experimental design was 
employed (section 3.1) with the addition of PBMC and PBMC depleted of CD14+ 
monocytes (PBMC-CD14). Since no significant differences in MMP-7 and MMP-9 
secretion patterns were previously observed in M(IFNγ), this stimulation was omitted. 
 
 
Figure 22. Secretion of MMP-7 and MMP-9 in macrophages, PBMC-CD14 and PBMC 
upon stimulation with polished titanium. Protein concentrations were measured by ELISA. 
A. MMP-7 secretion; B. MMP-9 secretion. Both graphs represent mean values from 5 
individual donors with standard deviations. For statistical analysis Student’s paired T test was 
used. * denotes statistical significance between titanium and control of the respective activation 
state, while σ denotes statistical significance between different types of cell populations (* p < 
0.05; ** p < 0.01; σ p < 0.05).CD14 – macrophages; PBMC – peripheral blood mononuclear 
cells; PBMC-CD14 – PBMC depleted of CD14+ monocytes. 
Figure 22A illustrates MMP-7 secretion in macrophages, PBMC-CD14 and PBMC 
upon stimulation with titanium. A tendency for higher levels of MMP-7 secretion in 
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macrophages stimulated with polished titanium was observed in both M(Control) and 
M(IL-4). However, the highest levels of secretion were observed in PBMC cultured on 
titanium in both Control and IL-4 stimulation. Without titanium in IL-4 stimulation, PBMC 
induced a minor increase in MMP-7 secretion compared to macrophages alone (0.11 
± 0.03ng/ml vs 0.07 ± 0.03ng/ml). Titanium induced higher levels of MMP-7 in PBMC 
when compared to macrophages (CD14) in both Control stimulation (6.3 ± 9.9ng/ml vs 
0.4 ± 0.7ng/ml) as well as in IL-4 stimulation (7.3 ± 4.8ng/ml vs 1.1 ± 1.5ng/ml) 
Interestingly, only in PBMC-CD14, titanium did not induce any increase in MMP-7 
secretion regardless of the stimulation (Control or IL-4) (Figure 22A). Similar results 
were obtained in the analysis of MMP-9 secretion. Titanium induced higher levels of 
MMP-9 in macrophages (CD14) and PBMC in both Control and IL-4 stimulations, while 
no reaction to titanium was observed in PBMC-CD14 population. Although without 
titanium PBMC secreted a low amount of MMP-9, when stimulated with titanium they 
produced the highest levels of MMP-9 in both Control and IL-4 stimulation. Additionally, 
titanium induced higher levels of MMP-9 in PBMC when compared to macrophages 
(CD14) in both Control (1519.3 ± 1350.6ng/ml vs 389.1 ± 118.3ng/ml) and IL-4 
stimulation (1088.9 ± 371.9ng/ml vs 188.7 ± 87.1ng/ml) (Figure 22B). 
Since MMPs are generally synthesized in their pro-form and require additional 
activation110, the concentration of active MMP-7 and MMP-9 was also measured 
(Figure 23).  
 
 
Figure 23. Analysis of the concentration of active MMP-7 and MMP-9 in supernatants 
from macrophages, PBMC-CD14 and PBMC stimulated with polished titanium. A. active 
MMP-7; B. active MMP-9. Graphs represent mean values with standard deviations from A – 3 
and B – 5 individual donors. For statistical analysis Student’s paired T test was used. CD14 – 
macrophages; PBMC – peripheral blood mononuclear cells; PBMC-CD14 – PBMC depleted 
of CD14+ monocytes. 
The concentration of active MMP-7 was measured only in IL-4 stimulated CD14+ 
macrophages and in whole PBMC fraction where statistically significant differences 
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were identified for the total secreted MMP-7 levels (Figure 22A). PBMC-CD14 fraction 
was omitted due to very low levels of MMP-7 and absence of reaction to titanium. 
Concentration of active MMP-9 was measured in both Control and IL-4 stimulations in 
CD14+ macrophages, PBMC-CD14 and PBMC. 
The concentration of active MMP-7 in macrophages (CD14) was not significantly 
changed by titanium. However, in PBMC stimulated with titanium a higher 
concentration of active MMP-7 was observed (0.5 ± 0.4ng/ml vs 0.03 ± 0.008ng/ml) 
although not statistically significant (Figure 23A). The concentration of active MMP-9 
was not significantly changed by titanium in any stimulation (Control and IL-4) 
regardless of the cell population. Surprisingly the highest levels of active MMP-9 were 
observed in PBMC-CD14 fraction in Control stimulation. However, they were not 
statistically significantly higher than in other cell populations (Figure 23B). 
Altogether these results show that PBMC greatly enhance macrophage reaction to 
titanium, increasing both MMP-7 and MMP-9 secretion. Furthermore, the results 
indicate that macrophages are essential for the recognition of titanium by PBMC, with 
no increase of MMP-7 and MMP-9 in response to titanium found in PBMC-CD14 
fraction. The concentration of active MMP-7, but not of MMP-9, is also increased in 
PBMC cultured on titanium. However, the concentration of active MMPs in comparison 
with the total amounts of MMPs secreted by PBMC cultured on titanium is still less than 
10%, suggesting that other cells in the periprosthetic tissue are responsible for their 
activation. 
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3.7 Analysis of the impact of macrophage–fibroblast interaction on 
the secretion of MMP-7 and MMP-9 on titanium surfaces 
A major role in the deposition of extracellular matrix is attributed to fibroblasts. To 
determine if fibroblasts can inhibit or enhance macrophage secretion of MMP-7 and 
MMP-9 in reaction to polished titanium a macrophage-fibroblast co-culture system was 
employed. Fibroblasts were co-cultured with macrophages either in direct co-cultures 
(juxtacrine macrophage-fibroblast interaction, JMFI) or indirectly in transwells 
(paracrine macrophage-fibroblast interaction, PMFI). As a fibroblast model BJ 
fibroblasts were used. 
MMP-7 secretion in M(Control) did not vary between direct and indirect fibroblast- 
macrophage culture conditions. In M(IFNγ) an increase in MMP-7 secretion was 
observed in PMFI when compared to JMFI (0.6 ± 0.8ng/ml vs 0.05 ± 0.02ng/ml), 
however it was not significantly higher than in macrophages in monoculture (0.5 ± 
0.6ng/ml). Titanium was able to induce higher levels of MMP-7 secretion only in M(IL-
4), although in all culture conditions. In M(IL-4), upon titanium stimulation, 
macrophages secreted higher levels of MMP-7 in comparison to control (0.5 ± 0.7ng/ml 
vs 0.06 ± 0.05ng/ml), however much lower than JMFI (2.9 ± 4.3ng/ml) and PFMI (2.2 
± 2.7ng/ml) with titanium stimulation (Figure 24A). Due to high variation between 
individual donors the differences between the culture conditions are not statistical 
significant. It is worth mentioning that in the presence of IL-4, fibroblasts alone secreted 
very low amounts of MMP-7 both without titanium (0.06 ± 0.009ng/ml) and with titanium 
(0.03 ± 0.007ng/ml) (data for fibroblasts alone are not shown).  
 
 
Figure 24. Secretion of MMP-7 and MMP-9 in macrophages co-cultured with fibroblasts 
upon stimulation with polished titanium. Protein concentrations were measured by ELISA.  
A. MMP-7 secretion; B. MMP-9 secretion. Both graphs represent mean values from 4 
individual donors with standard deviations. For statistical analysis Student’s paired T test was 
used. * denotes statistical significance between titanium and control of the respective activation 
state, while σ denotes statistical significance between different types of culture conditions (* p 
< 0.05; ** p < 0.01; σ p < 0.05). CD14 – macrophages alone; JFMI – juxtacrine macrophage-
fibroblast interaction; PMFI – paracrine macrophage-fibroblast interaction. 
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A different secretion patter was identified in the analysis of MMP-9 secretion. 
Titanium up-regulated the secretion of MMP-9 in M(Control) and M(IL-4) in all culture 
conditions. In M(Control) PMFI when stimulated by titanium displayed higher levels of 
MMP-9 when compared to control (110 ± 45.7ng/ml vs 16.9 ± 5.3ng/ml) and to JMFI 
on titanium (110 ± 45.7ng/ml vs 10.6 ± 5ng/ml) (Figure 24B). Likewise, macrophage 
stimulated with titanium also secreted higher levels of MMP-9 when compared to JMFI 
on titanium (64.3 ± 26.6ng/ml vs 10.6 ± 5ng/ml). Similar results were noted in M(IL-4), 
where titanium stimulation in macrophages and in PMFI induced higher MMP-9 levels 
compared to JMFI (macrophages: 93.4 ± 143.1ng/ml; PMFI: 161.7 ± 204.5ng/ml; JMFI: 
8.2 ± 11.7ng/ml). Interestingly, JMFI with and without titanium strongly inhibited the 
secretion of MMP-9 in all activation states. In M(IFNγ) titanium led to a reduction of 
MMP-9 in all culture conditions, however it was not statistically significant (Figure 24B). 
Fibroblasts alone did not secrete detectable levels of MMP-9 in any culture condition 
(data not shown). 
In order to investigate whether fibroblasts are able to activate MMP-7 and MMP-9, 
the concentration of their active form was measured. Concentration of active MMP-7 
was measured only in M(IL-4) where the differences between macrophage-fibroblast 
co-cultures and macrophages monocultures were the most evident (Figure 24A). 
Active MMP-9 concentration was measured only in M(Control) and M(IL-4) where 
titanium induced an increase in the secretion of MMP-9 (Figure 24B). 
 
 
Figure 25. Analysis of active MMP-7 and MMP-9 secretion in macrophages co-cultured 
with fibroblasts upon stimulation with polished titanium discs. A. active MMP-7; B. active 
MMP-9. Graphs represent mean values with standard deviations from A – 4 donors, B – 3 
donors. For statistical analysis Student’s paired T test was used. CD14 – macrophages alone; 
JFMI – juxtacrine macrophage-fibroblast interaction; PMFI – paracrine macrophage-fibroblast 
interaction. 
Figure 25A illustrates the concentration of active MMP-7 in macrophages co-
cultured with fibroblasts in M(IL-4). Titanium generally increased the level of active 
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MMP-7 in all culture conditions. Upon titanium stimulation higher levels of active MMP-
7 were observed in JMFI and PMFI in comparison to macrophages alone (JFMI: 0.25 
± 0.29ng/ml; PMFI: 0.2 ± 0.22ng/ml; macrophages: 0.07 ± 0.08ng/ml) (Figure 25A). A 
different pattern was observed in the analysis of active MMP-9 secretion. In M(IL-4), in 
all culture conditions no additional effect of titanium in up-regulation of active MMP-9 
secretion was noted. In contrast to total MMP-9 secretion (Figure 24A), in M(Control), 
in macrophages cultured on titanium when compared to control a decrease in the 
concentration of active MMP-9 was detected (0.05 ± 0.01ng/ml vs 0.17 ± 0.21ng/ml). 
No significant difference between titanium and control was observed in JMFI group 
(0.07 ± 0.002ng/ml vs 0.04 ± 0.001ng/ml). The highest levels of active MMP-9 were 
detected in PMFI culture conditions, where a tendency for higher active MMP-9 
secretion upon titanium stimulation in comparison to control was noted (1.3 ± 1.5ng/ml 
vs 0.4 ± 0.3ng/ml) (Figure 25B).  
In summary, the analysis of macrophage-fibroblast interaction demonstrated that 
fibroblasts up-regulate MMP-7 secretion by macrophages cultured on titanium in both 
juxtacrine and paracrine interaction models. MMP-9 secretion was significantly 
inhibited in the juxtacrine interaction model, but not in the paracrine model, indicating 
that direct cell-cell contact is needed for MMP-9 inhibition. Still, in the macrophage-
fibroblast interaction models the concentration of active molecules is less than 10% of 
the total amount, suggesting that fibroblasts do not significantly contribute to the 
activation of MMPs released by macrophages. 
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3.8 Analysis of individual responses to titanium 
Analysis of cytokine secretion and gene expression in macrophages cultured on 
titanium revealed a broad spectrum of responses in individual donors. While implant 
failures do not happen in all patients, it is reasonable to assume that in patients with 
an elevated immune reaction to titanium there is a higher chance of implant failure. In 
order to better visualize individual responses to titanium a donor-specific gene 
expression profile, based on RT-qPCR data, was computed (Figure 26). 
 
 
Figure 26. Donor profile of gene expression on polished titanium in M(IL-4). Each square 
represents the fold change of gene expression in M(IL-4) titanium versus M(IL-4) control. Red 
represents highest fold change while blue the smallest. 
Since gene expression changes induced in titanium were more evident in M(IL-4), 
for the generation of the donor-specific gene expression profile only this activation 
state was used. In Figure 26 relative expression differences between titanium and 
control settings in M(IL-4) were graphically presented as colors. Red color indicates a 
bigger difference between titanium and control. For genes that are down-regulated by 
titanium (CCL8, CCL13, CCL18, CCL23 and IL17RB), the modulus of values was taken, 
in order to consistently represent the highest differences between titanium and control 
as red color. Thus donors with more red blocks present a higher reaction to titanium, 
while donors with more blue blocks present a milder reaction to titanium. This analysis 
suggests that Donor 4 (4 red blocks + 1 intermediate), 5 (3 red blocks + 1 intermediate) 
and 1 (2 red blocks + 2 intermediate) manifest highest reaction to titanium, while Donor 
3 (0 red blocks) reacts mildly to titanium (Figure 26). These results indicate that a 
personalized approach for analysis of titanium-induced foreign body reactions is a 
promising tool for identification of patients for which titanium implants have to be 
avoided. 
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3.9 Analysis of inflammatory reactions of macrophages to 
biodegradable implant coating materials  
Great mechanical properties and biocompatibility of titanium has made it the 
material of choice for implant manufacturing. However, due to the development of 
chronic inflammation at the implant-tissue interface, a part of implants is projected to 
fail111. One possible practical solution to overcome undesired immune reactions is to 
apply a surface coating to the titanium implant to increase its biocompatibility. For this 
purpose, synthetic polymers such as PLA, PLGA, PEG and PVA can be applied93. In 
this study 2 types of coatings were used: Polyarginine/Hyaluronic acid-based coating 
(PAR/HA) and polylactic acid-based coating (PLA).  
3.9.1 Analysis of inflammatory reaction of macrophages to PAR/HA coating 
Bacterial infection of implants represents a common reason for early implant 
failure108. In order to avoid bacterial contamination of implants antimicrobial coatings 
can be used. In this study a polyelectrolyte multilayer coating was used with 
polyarginine as polycation and hyaluronic acid as polyanion (PAR/HA). Since arginine 
is a common amino acid in the structure of antimicrobial peptides, it can be 
hypothesized that polyarginine also displays antimicrobial properties112. 
Polyelectrolyte multilayers can be used as delivery systems for biologically active 
molecules113. To increase the antimicrobial properties of the coating, PAR/HA coating 
was loaded with catestatin (PAR/HA+CAT), an antimicrobial peptide which exhibits 
activity against bacteria, yeast and fungi114. PAR/HA and PAR/HA+CAT coatings were 
provided by Dr. Philippe Lavalle from Strasbourg University. To analyze if PAR/HA and 
PAR/HA+CAT coatings can induce in macrophages the secretion of cytokines with 
inflammatory or anti-inflammatory properties, the secretion of TNFα and CCL18 on day 
6 was measured by ELISA. Additionally, to identify individual reactions towards 
PAR/HA or PAR/HA+CAT coatings each donor was analyzed separately. 
 
 
 
Figure 27. Secretion of TNFα and CCL18 by macrophages cultured on PAR/HA and 
PAR/HA+CAT coatings. A. TNFα secretion; B. CCL18 secretion. Both graphs represent 
values for each of the 4 individual donors separately. Due to very low secretion levels in other 
activation states in A only data for M(IFNγ) are shown, while in B only data for M(IL-4) are 
shown. PAR/HA – polyarginine/hyaluronic acid coating; PAR/HA+CAT – polyarginine/ 
hyaluronic acid coating loaded with catestatin. 
The analysis of TNFα secretion by macrophages cultured on PAR/HA and 
PAR/HA+CAT coatings revealed that both coatings significantly inhibit its secretion in 
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M(IFNγ). For donor 1 the concentration of TNFα decreased from 217.2pg/ml in control 
to 16.2pg/ml on PAR/HA coating and 27.2pg/ml on PAR/HA+CAT coating. Similarly, 
for donor 2 the concentration of TNFα decreased from 113.5pg/ml in control to 
18.6pg/ml on PAR/HA coating and 14.8pg/ml on PAR/HA+CAT coating. Macrophages 
from donor 3 and 4 did not secrete any detectable levels of TNFα on any of the coatings 
(Figure 27A). Similar results were obtained in the analysis of CCL18 secretion. Both 
PAR/HA and PAR/HA+CAT significantly suppressed the secretion of CCL18 in all 
donors. Minimal amounts of CCL18 were detected on PAR/HA in samples from donor 
2 (0.23ng/ml) and 3 (0.16ng/ml), and on PAR/HA+CAT in samples from donor 2 
(0.51ng/ml) (Figure 27B). 
In summary, these data indicate that PAR/HA and PAR/HA+CAT coatings 
significantly inhibit the secretion of both TNFα and CCL18. Therefore, PAR/HA and 
PAR/HA+CAT are promising coating materials for titanium implants and can be used 
to avoid bacterial infection as well as local chronic inflammation. 
 
3.9.2 Analysis of inflammatory reaction of macrophages to PLA coating 
PLA as a material offers good mechanical properties, processability as well as high 
biocompatibility and is widely used in resorbable sutures, clips, screws and in drug 
delivery devices115, 116. Moreover, PLA can acquire additional properties by entrapment 
of biologically active molecules into its surface layer117. In the present study two types 
of PLA coatings were used: unmodified PLA films and PLA films embedded with 
Brilliant Green dye (BGD), which possesses antiseptic properties. PLA films were 
prepared and provided by Dr. Sergei I. Tverdokhlebov from Tomsk Polytechnic 
University. To analyze whether the PLA coatings alone (modified or unmodified) can 
induce inflammatory or anti-inflammatory reactions in macrophages, secretion of TNFα 
and CCL18 on day 6 of culture was measured by ELISA. The experimental design is 
depicted in Figure 28. In order to identify individual reactions to the coating material, 
both modified and unmodified PLA films were analyzed for each donor separately.  
 
 
 
Figure 28. Experimental design for PLA coatings. PLA films were dipped into a 
toluene/ethanol miscible mixture (3:7 v/v) for 10min then rapidly transferred into a 0.001 M 
solution of BGD in ethanol/water mixture (1:1 v/v) (stabilizing solution). Films were incubated 
for 1, 2 or 3 hours, to enable different amounts of BGD to be embedded into the film. CD14 
monocytes were seeded on top of the films and allowed to differentiate intro macrophages. 
M(IFNγ) and M(IL-4) macrophages have been generated by stimulating human monocytes 
with IFNγ and IL-4 respectively, for 6 days in serum-free medium. On day 6 TNFα and CCL18 
were measured by ELISA. Adapted from Stankevich et al., Surface modification of biomaterials 
based on high-molecular polylactic acid and their effect on inflammatory reactions of primary 
human monocyte-derived macrophages: Perspective for personalized therapy, Copyright 
(2015), with permission from Elsevier. 
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Figure 29A illustrates the secretion of TNFα by macrophages cultured on PLA films. 
In M(IFNγ) unmodified PLA films did not increase TNFα secretion for all donors. 
However, all modified PLA films increased the secretion of TNFα in donor 5 from 
105.4pg/ml in control to 163.3pg/ml on BGD1, 221.9pg/ml on BGD2 and 204.5pg/ml 
on BGD3. Similarly, macrophages from donor 7 secreted higher levels of TNFα on 
BGD1 (580.6pg/ml), BGD2 (694.2pg/ml) and BGD3 (661.2pg/ml) when compared to 
control (366.9pg/ml). For donor 9 BGD2 increased TNFα secretion (191.5pg/ml vs 
99.8pg/ml in control), while for donors 6 and 8 the modified PLA films did not induce 
increased secretion of TNFα (Figure 29A).  
 
 
 
Figure 29. Secretion of TNFα and CCL18 by macrophages cultured on PLA films. A. 
TNFα secretion; B. CCL18 secretion. Both graphs represent values for each of the 5 individual 
donors separately. Due to very low secretion levels in other activation states in A only 
data for M(IFNγ) are shown, while in B only data for M(IL-4) are shown. PLA – polylactic 
acid film; BGD1 – PLA film treated with Brilliant Green dye for 1h; BGD2 – PLA film treated 
with Brilliant Green dye for 2h; BGD3 – PLA film treated with Brilliant Green dye for 3h. 
 
A different secretion pattern was observed in the analysis of CCL18 in M(IL-4). 
Donor 5 showed a reduction of CCL18 secretion with both modified and unmodified 
PLA films in comparison to the control. The lowest values were observed on BGD2 
(65.2ng/ml). Modified PLA films decreased the secretion of CCL18 in donor 6 from 
47.6ng/ml in control to 21.1ng/ml on BGD1, 7.5ng/ml on BGD2 and 27.7ng/ml on BGD3 
films, while unmodified PLA films increased CCL18 levels to 65.8ng/ml. In contrast, 
modified PLA films increased the secretion of CCL18 for donor 8 from 13.5ng/ml in 
control to 161.1ng/ml in BGD1, 110.8ng/ml in BGD2 and 24.9ng/ml in BGD3. For donor 
7 a suppression of CCL18 secretion was observed on PLA (14.8ng/ml vs 76.3ng/ml), 
BGD1 (8.6ng/ml) and BGD2 (38.4ng/ml), while on BGD3 an increase of CCL18 was 
observed (106.7ng/ml). Compared to control all PLA films increased the secretion of 
CCL18 of donor 9, with highest levels observed in BGD1 (67.2ng/ml vs 9.6ng/ml) 
(Figure 29B). 
These results show that modification of PLA material surface can change the 
inflammatory responses of macrophages. Additionally, a monocyte-based in-vitro 
system for testing individual responses to the implanted material and variants of 
coating can be useful for selecting a personalized implant. 
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4 DISCUSSION 
4.1 Macrophage reaction to titanium 
As an implantable material titanium offers many advantages, demonstrating good 
mechanical properties, outstanding corrosion resistance and high biocompatibility. 
However, adverse immune reactions to titanium can lead to the development of chronic 
inflammation and to implant rejection. In order to obtain long-lasting, failure-free 
titanium implants it is important to understand the immune mechanisms involved in the 
recognition and initiation of inflammatory reaction towards titanium. It is well 
established in the biomaterial community that macrophages are essential cells 
involved in the recognition of the implant material and initiation of the foreign body 
reaction45, 53. Therefore, a number of studies have attempted to elucidate macrophage 
reaction towards titanium. In comparison to other research groups, which have used 
RAW264.7 cells67, THP-1 cells68 and mouse bone-marrow derived macrophages66, in 
this study human peripheral blood monocyte-derived macrophages were used. It was 
previously shown, that when mouse bone-marrow derived macrophages, THP-1 cells 
and human peripheral blood monocyte-derived macrophages are compared in parallel, 
a big difference in gene expression and cytokine production patterns among them can 
be observed47, 118. Thus, the model used in this study better reflects in vivo settings in 
human tissues.  
Additionally, macrophages are known to display high phenotypic plasticity, 
adopting different phenotypes depending on microenvironmental cues. It is widely 
accepted that macrophages activated by IFNγ secrete more pro-inflammatory 
cytokines (TNFα, IL-1β, IL-6), while those activated by IL-4 secrete anti-inflammatory 
molecules (IL-1Ra, IL-10 and TGFβ)46, 49. Moreover, studies have shown that 
macrophages with different activation states exhibit diverse reactions towards 
biomaterials119, 120. In the present study, in order to simulate diverse activation states 
of macrophages, but also discriminate among their reactions to titanium, human 
peripheral blood-derived monocytes were brought to 3 distinct activation states: 
M(Control) (no additional stimulation), M(IFNγ) (stimulation with IFNγ) and M(IL-4) 
(stimulation with IL-4).  
In order to simulate various interactions of macrophages with titanium implants, 
several types of titanium were used in this study. Polished titanium discs were used as 
a model of bulk titanium implants which are commonly employed in dental 
applications121. Furthermore, the smooth surface of polished titanium discs permitted 
to avoid interference from surface micro- or nanopatterns in the analysis of 
macrophage reactions to titanium as an implant material, with micro- and nanopatterns 
known to induce additional cell behaviors89, 90. Porous titanium discs were used to 
analyze whether porous titanium implants, which display promising results in terms of 
osseointegration86, also display higher biocompatibility and consequently may reduce 
the foreign body reaction. These types of implants are currently applied for femoral and 
tracheal prosthesis39, 122. Additionally, implant debris has been implicated in 
periprosthetic osteolysis and induction of the production of pro-inflammatory cytokines 
in macrophages123. To simulate macrophage interaction with titanium implant debris, 
micro titanium beads of 125-200µm in diameter (µTi beads) and titanium nanoparticles 
of 15nm in diameter (nTi particles) were used. 
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4.1.1 Macrophage cytokine release in response to titanium 
In this study, the first step was to analyze macrophage reaction on polished 
titanium discs. As foreign body reactions are characterized by a release of pro-
inflammatory mediators42, to determine if titanium is able to induce secretion of pro-
inflammatory cytokines, supernatants from macrophages cultured on polished titanium 
discs were analyzed by ELISA. Pro-inflammatory cytokines TNFα, IL-1β and IL-6 were 
selected as a readout. Furthermore, to test whether titanium can promote or inhibit the 
secretion cytokines with anti-inflammatory properties, CCL18 secretion was also 
analyzed.  
TNFα is secreted during the acute phase of inflammation and has a protective role 
against bacterial, viral and parasitic infections. However, it is widely recognized that it 
also plays a role in the pathophysiology of several chronic inflammatory diseases124. 
IL-1β is also a potent pro-inflammatory cytokine released in the acute phase of 
inflammation and involved in the innate immune response to infections and lesions. IL-
1β promotes differentiation of CD4+ T cells into TH17 cells and takes part in neutrophil 
recruitment125. Additionally, higher levels of IL-1β were linked to several chronic 
inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease and 
psoriasis126. IL-6 is involved in a variety of biological activities. It promotes B cell 
differentiation, T cell differentiation and activation, proliferation of thymocytes and 
regulates bone homeostasis. Macrophages produce high amounts of IL-6 when 
stimulated with LPS, IFNγ, IL-1α, TNFα, and GM-CSF125, 127. IL-6 was also shown to 
play an important role in the pathophysiology of rheumatoid arthritis, Crohn’s disease, 
juvenile idiopathic arthritis, Castleman’s disease and systemic lupus erythematosus128. 
Thus all three selected pro-inflammatory cytokines (TNFα, IL-1β and IL-6) are involved 
in both acute phase of inflammation as well as chronic inflammation.  
In contrast to TNFα, IL-1β or IL-6, CCL18 expression is induced in macrophages 
stimulated with IL-4/IL-13 and is suppressed in those stimulated with IFNγ129. Moreover, 
CCL18 is involved in activation of macrophages towards an anti-inflammatory 
phenotype, increasing the secretion of IL-10130. However, elevated levels of CCL18 
were associated with various chronic inflammatory diseases129, suggesting that higher 
levels of CCL18 are not necessarily beneficial in the long term.  
In macrophages cultured on polished titanium discs higher levels of TNFα and IL-
1β were observed in M(IFNγ) with no significant difference in other activation states. 
IL-6 secretion, on the other hand, was significantly elevated by titanium in all activation 
states. As a sensitive marker of inflammation TNFα was further selected as readout 
for macrophage reactions on porous titanium, µTi beads and nTi particles. It was found 
that porous titanium induced higher levels of TNFα in all activation states. This 
phenomenon was not observed on µTi beads and nTi particles. It can be explained by 
difference in sample size (11 monocyte donors in porous experiment, and 4 in µTi and 
nTi experiment) as well as high variation among the tested samples (in these 
experiments, macrophages from different donors were used). Although nTi particles 
did not increase the secretion of TNFα in macrophages, the results obtained on the 
titanium discs generally correlate with findings of other studies that showed elevated 
levels of TNFα, IL-1β and IL-6 in macrophages stimulated with titanium66-68. CCL18 
secretion was slightly up-regulated by polished titanium in M(Control) and down-
regulated in M(IFNγ). However, the amount of CCL18 in these activation states was 
negligible when compared to M(IL-4) in which polished titanium induced a slight 
inhibition of CCL18 secretion, although not statistically significant. In porous titanium 
this effect was even stronger, with titanium significantly inhibiting the secretion of 
CCL18 in M(IL-4). Additionally, both µTi and nTi inhibited the secretion of CCL18 in 
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M(IL-4), with nTi exerting the highest effect. Since CCL18 is known to promote an anti-
inflammatory phenotype in macrophages130, inhibition of CCL18 secretion upon 
stimulation with titanium can be regarded as a pro-inflammatory effect of titanium.  
Collectively these results suggest that titanium promotes a pro-inflammatory 
cytokine profile secreted by macrophages that can have detrimental effects on different 
stages for implant integration in the tissues. 
4.1.2 The analysis of gene expression in response to titanium using Affymetrix 
microarrays 
Analysis of cytokine release in macrophages cultured on titanium offered limited 
insight into the extent of macrophage reactions towards titanium. In order to study 
these reactions in more detail, the effect of titanium on gene expression (whole 
transcriptome) in macrophages was analyzed.  To accomplish this task microarray 
experiments were performed with polished and with porous titanium discs. Peripheral 
blood monocytes were cultured on polished or porous titanium discs and RNA from 6 
(polished) or 8 (porous) donors was chosen (based on RNA integrity number and 
concentration) for microarray analysis. For each donor 6 different groups of 
macrophages were analyzed: M(Control), M(IFNγ), M(IL-4), M(Control) Ti, M(IFNγ) Ti 
and M(IL-4) Ti. The analysis of microarray data from both experiments displayed 
similar trends: the highest number of differences between titanium and control settings 
were found in M(IL-4) activation state, with 1452 genes up-or down-regulated in 
macrophages cultured on polished titanium discs and 3560 genes on porous titanium 
discs. In M(Control) there were 214 genes affected by polished titanium and 1244 
genes by porous titanium. The lowest number of differences between titanium and 
control settings were found in M(IFNγ) activation state, where 150 genes were 
differentially regulated on polished titanium discs and 861 genes on porous titanium 
discs. Plotting the results on a 3D scatterplot confirmed these findings and showed that 
in both polished and porous titanium M(Control) and M(IFNγ) activation states have 
more homogeneous populations, when compared to M(IL-4). Consequently, these 
results demonstrate that macrophages in the M(IFNγ) activation state do not react as 
strongly to titanium as in M(IL-4) activation state. Furthermore, it can be hypothesized 
that IFNγ induces a pro-inflammatory gene expression profile similar to titanium and 
therefore can mask its effects.  
Although the results from both microarray experiments (on polished and porous 
titanium) show a lot of similarities they contradict data presented by Pajarinen et al., 
where more genes were differentially regulated by titanium in macrophages from 
M(IFNγ) activation state (192 genes), followed by 63 genes in M(Control) and 59 genes 
in M(IL-4)131. When the results from both studies were compared only 40 genes from 
either polished titanium experiment or porous titanium experiment were also found in 
the results of Pajarinen et al., however the direction of change (up- or down-regulation) 
did not always match. The difference in number of genes up- or down-regulated by 
titanium in both studies can be explained by a different sample size (6 for polished 
titanium, 8 for porous titanium and 4 tested by Pajarinen et al.) as well as high variation 
among the tested samples. Additionally, the differences in culture conditions used by 
Pajarinen et al. (RPMI medium + 100ng/ml M-CSF + 10%FBS) compared to the culture 
conditions used in this study (Macrophage SFM medium + 1ng/ml M-CSF + 10-8M 
Dexamethasone) as well as the titanium model employed (Ti microbeads vs Ti discs) 
introduce further variations in the study design and consequently lead to contrasting 
results. Moreover, the use of M-CSF at a concentration of 100ng/ml was shown to 
induce a macrophage phenotype very similar to the one obtained after IL-4 stimulation 
and, consequently, may interfere with the effects of IFNγ132.  
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The surface of the material is known to influence cell behavior. Higher surface 
roughness promotes cell attachment and cell proliferation89. Macrophages cultured on 
materials with different topography acquire distinct activation states90. Additionally, 
materials designed to induce a specific shape to macrophages are also able to change 
macrophage polarization133. Different activation states of macrophages are 
characterized by distinct expression and secretion patterns of inflammatory cytokines46, 
49. Surprisingly, when microarray data from the experiment with porous titanium is 
compared to data from polished titanium experiment, only small differences in the 
expression pattern of genes from cytokine-cytokine receptor family was noted. 
Although there were more gene members of this family affected by porous titanium (65 
compared to 44; Tables 18, 19), the direction of change (up- or down-regulation) for 
the common genes was similar. For example, both types of titanium surfaces 
stimulated CSF1, IL1RN, TNFSF14 and suppressed CCL8 and CCL23 expression. 
However, the spectrum of inflammatory responses also displayed some stimulation 
specific differences: 1) in M(IFNγ) a significant down-regulation of INHBA, CXCL9 and 
CXCL10 was observed on porous titanium, while no effects were noted on polished 
titanium; 2) in M(IL-4) CCL13 was strongly down-regulated on porous titanium, but not 
on polished titanium. Down-regulation of CXCL9, CXCL10 and CCL13 in porous 
titanium is indicative for the suppression of specific inflammatory reactions, since all 3 
genes are associated with adverse local tissue reaction100. Additionally, porous 
materials have been shown to promote osseointegration and capillary formation87, 
however no significant differences in the expression of genes associated with wound 
healing and angiogenesis was noted between both types of titanium.   
In order to identify which genes are regulated by titanium independently on the 
structure of the surface (polished vs porous) a comparison of the results obtained from 
microarray experiments was performed. A total of 1102 common genes were found 
differentially regulated by both types of titanium, with 135 genes in M(Control), 68 
genes in M(IFNγ) and 899 genes in M(IL-4). Comparing the data according to the 
algorithm described in section 3.2.2 and filtering the gene list by genes involved in 
inflammation and in extracellular matrix degradation a list of 14 genes with potential 
implication in implant related complications can be identified (Table 19). Interestingly, 
all of the selected genes followed the same direction of change in both experiments. 
 
Table 19. Comparison of microarray data from polished and porous titanium 
experiments. (↑ - up-regulation > 2 fold; ↓ - down-regulation > 2 fold; ▲- up-regulation < 2 
fold; ▼ - down-regulation < 2 fold; * - p > 0.05. M(IFNγ) was omitted due to the absence of any 
significant changes in the regulation of these genes) 
Gene Symbol Polished Titanium (6 donors) Porous titanium (8 donors) 
M(Control) M(IL-4) M(Control) M(IL-4) 
CCL8   ▼* ↓ not changed ↓ 
CCL23 not changed ↓ not changed ↓ 
CHI3L1 ↑ ↑ ↑ ↑ 
CHIT1 not changed   ▲* ↑ ↑ 
CSF1   ▲* ↑ ↑ ↑ 
IL17RB not changed   ▼* not changed ↓ 
IL1R2   ▲*   ↑*   ▲* ↑ 
IL1RN ↑   ↑* ↑   ▲* 
MMP7   ▲*   ↑* ↑ ↑ 
MMP8   ▲*   not changed   ↑* ↑ 
MMP9 not changed ↑ not changed ↑ 
SPP1 ↑ ↑ ↑   ↑* 
TNFRSF21 ↑ ↑   ▲* ↑ 
TNFSF14   ↑* ↑ ↑ ↑ 
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The comparison of gene expression on polished and porous titanium discs 
revealed that titanium surface can induce some changes in gene expression. However, 
the differences are mainly in magnitude of change and not in the direction of change 
(up- or down-regulation) of gene expression. Thus, the reactions of macrophages to 
titanium as a material are stronger than those induced by the surface of titanium.  
4.1.3 Validation of microarray results 
Evaluation of microarray data from polished and porous titanium experiments 
revealed several gene families affected by titanium. For polished titanium these were: 
metallothioneins, matrix metalloproteinases, cytokine-cytokine receptors, zinc fingers 
C2-H2 type, immunoglobulin-like domain containing and endogenous ligands (Table 
17). For porous titanium the most affected gene families were: metallothioneins, matrix 
metalloproteinases, cytokine-cytokine receptors, solute carrier family, chitinase-like 
proteins, integrins and purinergic receptors (Table 18). Thus three gene families were 
differentially regulated by both types of titanium (metallothioneins, matrix 
metalloproteinases, cytokine-cytokine receptors). Since genes from matrix 
metalloproteinases and cytokine-cytokine receptors families are more likely to be 
involved in implant related complications, several prominent members of these gene 
families were selected (based on microarray data) for RT-qPCR validation. The 
selected genes were: CSF1, CCL8, CCL13, CCL18, CCL23, IL17RB, TNFRSF21, 
TNFSF14, MMP8 and MMP9. Additionally, 2 members of the chitinase-like proteins 
(CHIT1 and CHI3L1) were also selected for RT-qPCR validation. 
RT-qPCR analysis of gene expression generally validated the results from 
microarrays. As previously shown (sections 3.2.3 and 3.3.2), most of the genes were 
significantly differentially regulated in M(IL-4). Although there was a difference in 
magnitude of fold change between samples from polished and porous titanium, no 
difference was observed in the direction of change (up- or down-regulation) of gene 
expression, which also correlated with microarray data. RT-qPCR results revealed that 
titanium up-regulates CSF1, CHI3L1, CHIT1, MMP8, MMP9, TNFRSF21 and 
TNFSF14, and down-regulates CCL8, CCL13, CCL18, CCL23 and IL17RB. 
CSF1 codes for macrophage colony-stimulating factor (M-CSF) which is an 
essential factor for the differentiation, migration and survival of macrophages and 
osteoclasts134. In macrophages cultured on polished titanium discs up-regulation of 
CSF1 was observed in M(Control) and M(IL-4) activation states. Similarly, on porous 
titanium CSF1 gene was up-regulated in M(Control), with the same tendency in M(IL-
4). These results correlate with data from other studies in which an increase in M-CSF 
was noted in periprosthetic tissue in cases with aseptic loosening135. Thus, in the 
periprosthetic tissue macrophages in contact with titanium constitute a source of M-
CSF, which can potentially lead to osteoclast activation and ultimately to aseptic 
loosening. 
CCL8, CCL13, CCL18 and CCL23 are members of the chemokine family. CCL8 
acts via CCR1, CCR2 and CCR5 and is chemotactic for lymphocytes, monocytes, 
basophils and eosinophils136, 137. CCL13 binds to CCR2 and CCR3 and along with 
CCL2, CCL3, CCL4, CCL5, CCL7 and CCL8 is chemotactic for monocytes and 
macrophages57, 137. Both polished and porous titanium discs down-regulated CCL8 and 
CCL13 in M(Control) and M(IL-4) macrophages, suggesting a decrease of the 
inflammatory reaction. In contrast, other studies have found that biomaterial adherent 
macrophages display an increased expression of CCL13 in vitro138. Moreover, in 
patients with adverse local tissue reaction, expression of CCL8 and CCL13 in the 
periprosthetic tissue is up-regulated when compared to patients with osteolysis100. This 
discrepancy between results may be explained by the use of different biomaterial for 
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assessing macrophage reactions (synthetic polymers) and by the presence of other 
cells, besides macrophages, in the periprosthetic tissue which alter the mRNA level of 
CCL8 and CCL13 in the tissue. 
CCL18 operates through PITPNM3 and CCR8 and is chemotactic factor for T 
cells137, 139. As previously described, it is also involved in activation of macrophages 
towards an anti-inflammatory phenotype130. Macrophages in M(IL-4) activation state 
on both polished and porous titanium discs induced down-regulation of CCL18. 
However, in the periprosthetic tissue of patients with aseptic loosening, expression of 
CCL18 was up-regulated in comparison to patients with osteoarthritis, suggesting that 
other cellular components of the periprosthetic tissue may alter the mRNA level of 
CCL18 in vivo101. Elevated levels of CCL18 were also associated with various chronic 
inflammatory diseases129. Thus, the role of CCL18 in inflammatory processes and in 
implant related complications is still controversial.  
CCL23 acts via CCR1 and FPR2 and is chemotactic for T cells, monocytes and 
neutrophils137, 140. Moreover, CCL23 was found to be involved in chemotaxis and 
differentiation of osteoclast precursors, suggesting a role in osteolysis141. Thus, the 
decrease in CCL23 expression in M(Control) and M(IL-4) macrophages observed on 
both polished and porous titanium discs represents an anti-inflammatory reaction, 
which may potentially inhibit osteolysis. Additionally, it is worth mentioning that all of 
the down-regulated chemokines are localized in close proximity on the chromosome, 
with CCL8, CCL13, CCL18 and CCL23 located in the 17q11.2 and 17q12 loci, 
suggesting that these genes are co-regulated. 
IL17RB and TNFRSF21 code for cytokine receptors, which upon interaction with 
their binding partners (IL-25 and TRADD respectively) are able to induce the activation 
of NF-κB102, 142, and consequently can lead to an increase in inflammatory response 
and apoptosis. IL17RB was down-regulated by polished and porous titanium in M(IL-
4) macrophages, an effect which can be considered favorable in light of published 
studies102. On the other hand, TNFRSF21 was up-regulated in M(Control) by polished 
titanium, suggesting potential exacerbation of an inflammatory reaction. 
TNFSF14, also known as LIGHT, is a member of tumor necrosis factor superfamily 
and has been shown to be involved in bone resorption by promoting RANKL-mediated 
osteoclastogenesis143. Polished titanium induced up-regulation of TNFSF14 in M(IL-4), 
with a similar tendency also observed on the protein level. Comparable results, 
although not statistically significant, were obtained on porous titanium, suggesting that 
titanium through up-regulation of TNFSF14 and M-CSF may promote 
osteoclastogenesis. 
MMPs are a family of proteolytic enzymes that have an essential role in maintaining 
the physiological human tissue homeostasis144. Additionally, they have been found to 
be involved in the activation of various cytokines, chemokines and growth factors145. 
Thus deregulated expression of MMPs can lead to several pathological processes146. 
In implantation, MMP8 has been linked to peri-implantitis and periodontitis105, while 
MMP9 to an early implant failure147. In the present study up-regulation of MMP8 was 
observed in M(IL-4) macrophages cultured on porous titanium, with similar tendency 
on polished titanium. MMP9 expression was up-regulated in M(IL-4) macrophages by 
both polished and porous titanium. Moreover, on protein level, up-regulation of MMP-
9 secretion by macrophages cultured on polished titanium was also noted. It can be 
hypothesized that in the periprosthetic tissue macrophages in contact with titanium 
constitute a major source of MMP8 and MMP9, which can lead to peri-implantitis and 
implant failure. 
CHIT1 and CHI3L1 are members of the chitinase-like proteins family and their up-
regulation has been linked to various chronic inflammatory diseases103. In this study, 
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CHIT1 (chitotriosidase) was up-regulated by porous titanium in all activation states, 
while polished titanium induced up-regulation only in M(IL-4), although this effect was 
not statistically significant. On the other hand, CHI3L1 was up-regulated by polished 
titanium in all activation states and by porous titanium in M(Control) and M(IL-4). 
Furthermore, similar patterns of CHIT1 and CHI3L1 expression were also detected on 
protein level in macrophages cultured on polished titanium discs. Up-regulation of 
CHIT1 was associated with aseptic loosening in total knee arthroplasty106, while 
elevated levels of CHI3L1 were noted in the periprosthetic tissue of patients with 
titanium implants148. Thus, titanium-induced up-regulation of CHIT1 and CHI3L1 may 
lead to chronic inflammation and aseptic loosening. Moreover, it is worth taking into 
consideration that both CHIT1 and CHI3L1 share a locus on the chromosome (1q32.1), 
suggesting that these genes are co-regulated. 
 A summary of microarray results validation by RT-qPCR in both polished and 
porous experiments is presented in Table 20. 
 
Table 20. Summary of microarray validation results. RT-qPCR data; in bold – p < 0.05; in 
italic – p > 0.05; positive values denote up-regulation, while negative values denote down-
regulation by titanium; N/A – not available; * 9 donors analyzed; ** 10 donors analyzed. 
 Fold change in Polished Ti vs control  Fold change in Porous Ti vs control  
Gene 
Symbol 
M(Control) 
(8 donors) 
M(IFNγ)  
(8 donors)  
M(IL-4)  
(8 donors) 
M(Control) 
(11 donors) 
M(IFNγ)  
(11 donors)  
M(IL-4)  
(11 donors) 
CSF1   3.5   2.8   8.0    4.2 no change   1.9 
CCL8  -3.3   1.1  -4.8   -2.6   -1.3  -9.7 
CCL13  -1.7   1.6  -3.5   -1.2  18.2  -8.7 
CCL18   1.5   1.8  -3.6   -1.1 *    1.9 *  -5.8 * 
CCL23   N/A   N/A  -3.1    N/A    N/A     -38.9 
CHI3L1   1.9   1.8   3.3    3.5    1.8   2.5 
CHIT1  -1.1   1.2   3.9    4.0    1.4   4.4 
IL17RB   N/A   N/A  -2.5    N/A    N/A     -32.6 ** 
MMP8   1.4   N/A   3.1    2.3    N/A   4.7 
MMP9   1.1   2.1   5.1    1.3    1.8   3.0 
TNFRSF21   2.5  -1.9   1.6    1.1    1.2   1.1 
TNFSF14   N/A   N/A   2.3    N/A    N/A   2.4 
 
These results share many similarities with data published by other authors, in 
which gene expression in the periprosthetic tissue of titanium implants was analyzed. 
It was shown that titanium implants induced up-regulation of MMP8, MMP9, CHIT1 
and CHI3L1 in the periprosthetic tissue148 that correlates with data from the present 
study. Thus, the model used in this study for analyzing the inflammatory reactions of 
macrophages to titanium reflects several findings made in vivo. However, CCL18 was 
found to be up-regulated in the periprosthetic tissue148, while in this study it was down-
regulated by titanium, indicating that the overall reaction to titanium in vivo is more 
complex. 
In summary these results suggest that titanium induces a specific activation state 
in macrophages with rather pro-inflammatory properties. Additionally, the activation 
state of macrophages plays a role in the extent of reaction towards titanium. The pro-
inflammatory effects of titanium are most strongly pronounced in M(IL-4) that model 
functional subtype of healing macrophages. Thus, microenvironmental cues in the 
periprosthetic tissue are expected to significantly influence the development of the 
foreign body reaction towards titanium. 
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4.1.4 Comparison of macrophages reactions to Ti discs, Ti microbeads and Ti 
nanoparticles 
Studies on THP-1 cells have demonstrated that cells react differently to titanium 
particles in comparison to titanium discs. THP-1 cells cultured on discs secreted 
significantly higher levels of TNFα, CCL2, CCL3 and IL-1Ra82. In the present study, 
when human monocyte-derived macrophages were cultured with polished Ti discs, Ti 
microbeads (µTi) and Ti nanoparticles (nTi) no difference was observed in the 
secretion of TNFα, while a slight inhibition of CCL18 secretion was observed in nTi 
when compared to µTi, but not with Ti discs. In order to investigate whether 
macrophages cultured with µTi and nTi can induce different cytokine expression 
patterns compared to Ti discs on the mRNA level, expression of several genes was 
analyzed by RT-qPCR. The genes analyzed by RT-qPCR were: CSF1, CCL8, CCL13, 
CCL23, IL17RB, TNFSF14, MMP7, MMP9, CHIT1 and CHI3L1. MMP7 was added to 
the gene list as a substitute for MMP8, since previous results from the polished titanium 
experiment did not show significant changes in MMP8 expression.  
The comparison of macrophage reactions to Ti discs, Ti microbeads and Ti 
nanoparticles revealed that all 3 types of titanium induce similar reactions in 
macrophages in terms of cytokine expression and production as well as in expression 
and secretion of matrix remodeling proteases. Apart from CSF1 and CHI3L1 
expression there was virtually no difference between macrophage reactions to Ti discs 
and µTi. However, macrophages cultured with nTi generally displayed stronger 
reactions to the material inducing significantly stronger up-regulation of CSF1, CHIT1 
and CHI3L1 and stronger down-regulation of CCL8, CCL13, CCL18 and CCL23 in 
comparison to Ti discs and µTi. In this study Ti discs were used as a model of bulk 
titanium implants, while µTi with a diameter of 125-200µm as a model of non-
phagocytosable implant debris and nTi with a diameter of 15nm as a model of 
phagocytosable implant debris. The stronger macrophage reactions to nTi suggest that 
nanoparticle phagocytosis enhances these reactions. Indeed, other authors also report 
that phagocytosable particles, in comparison to bigger particles, induce stronger 
inflammatory reaction in macrophages, which consequently secrete higher levels of 
TNFα, IL-1β, IL-6 and PGE2149. Furthermore, the size of the particles also influences 
macrophage response, with smaller phagocytosable particles causing more severe 
inflammatory reactions150. In a bone resorption model, only macrophages challenged 
with phagocytosable particles were able to increase their bone-resorbing activity151. 
Thus enhanced inflammatory response of macrophages to nTi could result in 
osteolysis and aseptic loosening.  
Collectively these results indicate that macrophages do not respond equally to 
titanium of different sizes. The difference in response can be explained by 
phagocytosis of the material which takes place when the particles are smaller than 
10µm57. However, these reactions differ only in their magnitude and are influenced by 
the initial activation state of macrophages. Therefore, in vivo, in the periprosthetic 
tissue both the size of wear particles and the microenvironmental signals will modulate 
the foreign body response. 
 
 
Discussion 
83 
4.2 Bacterial influence on cytokine secretion of macrophage in 
contact with titanium 
Titanium implants are used in many medical applications with great success. 
Nevertheless, due to the development of various complications (Table 8) a part of 
titanium implants fail. Studies report a failure rate of 3,4% to 6,5% in total knee 
arthroplasty and up to 9% in total hip arthroplasty152, 153. It is well established that 
biofilm formation is one of the reasons for implant failures. A biofilm can be defined as 
a “structured consortium of bacteria encased in a self-produced matrix”, which consists 
of exopolysaccharides, proteins, teichoic acids and extracellular DNA108. The formation 
of biofilm on the surface of implants presents additional difficulties in the treatment of 
infection, particularly because it provides resistance to antibiotics and host defense 
mechanisms154. One of the most common pathogens involved in metallic implant 
failures both in orthopedics and dentistry is Staphylococcus aureus108, 154, 155. To model 
a bacterial infection of titanium implants and to analyze its effects on macrophage 
cytokine secretion an experiment with Staphylococcus aureus and polished titanium 
was designed. Additionally, it is widely accepted that monocytes are constantly 
recruited into the tissue during infection and inflammation109. To model differentiation 
of naive monocytes in the proximity of an infected implant, an experiment with SA and 
naive monocytes cultured on titanium was also designed. 
The experiments in this study have shown that SA stimulation induces a minor 
response in mature macrophages with TNFα and IL-6 expressions only marginally 
elevated in M(IFNγ), while the expression of IL-1β and CCL18 were unchanged in all 
activation states. The only cytokine significantly up-regulated in response to SA 
stimulation on day 6 was IL-8 in M(IFNγ). Moreover, when titanium was taken into 
consideration (together with SA) no increase in the secretion of TNFα, IL-1β and 
CCL18 was determined, with only slightly elevated levels of IL-8 observed in M(Control) 
and of IL-6 in M(IL-4).  
In contrast, when SA was added to naive monocytes a stronger reaction was 
observed. The reaction was up to 100 times higher than when SA was added to already 
maturated macrophages, with up-regulation of CCL18 secretion in M(IL-4) and of TNFα, 
IL-1β, IL-6 and IL-8 secretion in all activation states. Titanium did not enhance cytokine 
secretion when SA was added to naive monocytes and, on the contrary, inhibited the 
secretion of IL-1β and CCL18. Furthermore, SA induced significantly higher levels of 
matrix remodeling proteinases MMP-7 and MMP-9 when added to naive monocytes, 
but not to the mature macrophages. Additionally, titanium synergistically up-regulated 
the secretion of MMP-7 in naive monocytes stimulated with IL-4. However, this 
phenomenon was not observed in MMP-9 secretion.  
An important role in the recognition of Staphylococcus aureus by immune cells is 
attributed to Toll-like receptor 2 (TLR2)156. Since monocytes and macrophages display 
different amounts of TLR2 on their surface, it is reasonable to assume that they present 
distinct reactions to Staphylococcus aureus157. Moreover, TNFα, IL-1β, IL-6, IL-8 and 
MMP-9 expression is dependent on the activation of TLR2156, 158. Thus, higher 
expression of TLR2 on naive monocytes in comparison to mature macrophages may 
explain the strong up-regulation of these cytokines when naive monocytes are 
challenged by SA. Furthermore, it was reported that immune cells recognize 
Staphylococcus aureus through the interaction of TLR2 with TLR1, TLR6, CD14 and 
CD36156. However, in order to fully elucidate the mechanisms of interaction of the 
receptors involved in titanium and SA recognition more research is needed. 
In summary, it can be hypothesized that in vivo, an infection with Staphylococcus 
aureus induces not only an up-regulation of pro-inflammatory cytokines and 
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chemokines, but also of matrix remodeling proteins, which constitutes a possible 
mechanism for implant failures. Moreover, the immune reaction against 
Staphylococcus aureus infection is not dependent on titanium. Thus, implants made of 
different materials are also subjected to failure when an infection with Staphylococcus 
aureus occurs. 
 
4.3 Macrophages, PBMC and fibroblasts in implant settings. 
The results of this study have shown that macrophage response to titanium 
implants is very complex and is determined not only by titanium surface and size but 
also by macrophage activation state. Previous data also indicated that two members 
of the matrix metalloproteinases family, namely MMP7 and MMP9, are up-regulated in 
macrophages in response to titanium on gene and protein level. MMPs are generally 
considered major factors involved in extracellular matrix remodeling, osteolysis and 
periprosthetic loosening107. Both MMP-7 and MMP-9 have been shown to be involved 
in osteoclastogenesis and consequently in osteolysis159, 160. Moreover, elevated levels 
of MMP-7 and MMP-9 were detected in periprosthetic tissue of patients with loose 
artificial hip joints161. The results from the current study generally correlate with data 
obtained from the analysis of periprosthetic tissue of patients with titanium implants. 
However, some discrepancies were still observed (for example: down-regulation of 
CCL18 on titanium vs up-regulation of CCL18 in periprosthetic tissue), suggesting that 
other cellular components of the periprosthetic tissue influence the overall reaction to 
titanium. In order to study whether other cells in the periprosthetic tissue can modulate 
macrophage secretion of MMP-7 and MMP-9 in response to titanium, co-culture 
systems with peripheral blood mononuclear cells (PBMC) and fibroblasts were 
employed. 
In order to distinguish which cells from the PMBC fraction are able to alter the 
secretion of MMP-7 and MMP-9 upon recognition of titanium or if the interaction of 
PBMC cells can enhance this effect, monocytes (CD14+ cells), PBMC depleted of 
CD14+ cells (PBMC-CD14) and whole PBMC were cultured on polished titanium discs. 
The experiments have shown that titanium does not induce increased levels of MMP-
7 and MMP-9 in PBMC-CD14 fraction. However, the whole fraction of PBMC secreted 
significantly higher levels of MMP-7 and MMP-9 in response to titanium than 
macrophages alone. PBMC are comprised mainly of 2 types of cells: lymphocytes (B 
cells, T cells and NK cells) and monocytes. Studies have shown that lymphocytes also 
have the ability to react to metals and have been used as a diagnostic tool for type IV 
hypersensitivity to metals in the form of a lymphocytes transformation test (LTT)162. 
Moreover, the results presented in the current study correlate with data published by 
other authors which show that lymphocytes in both paracrine and juxtacrine manner 
are able to enhance macrophage reactions to foreign bodies163. Still, the lack of 
reaction towards titanium by the PBMC-CD14 fraction reinforces the widely accepted 
concept that macrophages are the key immune cells involved in foreign body 
recognition. 
Fibroblasts represent one of the main cell types involved in the deposition of 
extracellular matrix. When stimulated with titanium wear particles fibroblasts were 
shown to increase the expression of pro-inflammatory factors such as IL-1β, IL-6, IL-
8, CCL2 and MMP-165. To determine if fibroblasts influence macrophage secretion of 
MMP-7 and MMP-9 in reaction to polished titanium a macrophage-fibroblast co-culture 
system was employed. In order to discriminate whether direct cell-cell interaction 
(juxtacrine macrophage-fibroblast interaction, JMFI) or secretion of soluble factors 
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(paracrine macrophage-fibroblast interaction, PMFI) influence macrophage response 
to titanium a transwell system was also used. The analysis of MMP-7 and MMP-9 
secretion from macrophage-fibroblast co-culture experiments revealed that fibroblasts 
are able to significantly alter the secretion of these matrix metalloproteinases in 
response to titanium. In IL-4 stimulated cultures MMP-7 secretion was up-regulated in 
macrophage-fibroblast co-cultures on titanium in both paracrine and juxtacrine 
interaction models. In contrast, the secretion of MMP-9 was significantly inhibited in 
the juxtacrine interaction model, while no significant change was observed in the 
paracrine interaction model. Thus direct cell-cell contact is needed for the inhibition of 
MMP-9. This comes in contradiction to data presented by other authors which show 
that in a macrophage-fibroblast co-culture model the levels of MMP-9 were up-
regulated in comparison to macrophage or fibroblast monoculture164. The discrepancy 
in the results can be explained by the use of different experimental settings (in this 
study MMP-9 levels were measured after 6 days of culture, while Zhu et al. after 24h). 
It is worth mentioning that fibroblasts alone did not present any changes in the 
secretion of MMP-7 and MMP-9 in response to titanium (data not shown), indicating 
that the primary source of these proteinases are macrophages, while fibroblasts can 
modulate their secretion.  
MMPs are secreted in a proenzyme form requiring additional activation to exert 
their proteolytic activity110. Furthermore, it was shown that MMPs can also be activated 
by cells not directly involved in their secretion165. To analyze whether PBMC or 
fibroblasts are able to activate MMP-7 and/or MMP-9 the concentration of their active 
forms was also measured. Although the total concentration (pro- and active form) of 
both MMP-7 and MMP-9 was significantly changed by PBMC and fibroblast when co-
cultured with macrophages on titanium, the concentration of their active form did not 
change substantially. These data suggest that MMP-7 and MMP-9 can be activated by 
other cells in the periprosthetic tissue. 
Collectively these results indicate that in the periprosthetic tissue macrophages 
represent major producers of MMP-7 and MMP-9. Moreover, both PBMC and 
fibroblasts are able to significantly alter macrophage response to titanium. The 
activation of MMP-7 and MMP-9 is however performed by other cellular components 
of the periprosthetic tissue. Although both MMP-7 and MMP-9 were linked to implant 
complications161, it is worth mentioning, that elevated levels of MMP-7 and MMP-9 in 
the periprosthetic tissue of titanium implants also correlated with osseointegration166. 
Thus the biological role of the metalloproteinases in the context of implants is 
ambiguous and probably dependent on the overall microenvironmental state. 
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4.4 Individual response to titanium 
Previous experiments revealed that titanium induces specific changes in the 
regulation of several genes involved in modulation of inflammation and matrix 
remodeling (up-regulation of CSF1, CHI3L1, CHIT1, MMP8, MMP9, TNFRSF21 and 
TNFSF14; and down-regulation of CCL8, CCL13, CCL18, CCL23 and IL17RB). On the 
other hand, a high variation in expression of some genes between individual donors 
was observed, suggesting that not all donors react to titanium in the same way. Studies 
have shown that implant failure does not happen in all patients. The failure rate of 
orthopedic implants lies between 3.4% and 9%, while a 5.4% failure rate was reported 
for dental implants 152, 153, 167. Aseptic loosening, characterized by a subtle, progressive 
destruction of the periprosthetic tissue as a result of foreign body response, constitutes 
a major factor in implant failure60. It is therefore reasonable to assume that in patients 
with higher reaction towards titanium there is a higher chance of implant failure. In this 
study a donor-specific gene expression profile (based on RT-qPCR data) was used to 
assess individual responses to titanium. By analyzing the differences induced by 
titanium in the expression of 11 genes it was possible to distinguish between donors 
with a high and low reaction to titanium. The results suggest that a macrophage-based 
approach for the identification of foreign body reaction towards titanium can be used 
to predict patients which react strongly to titanium and consequently have a higher 
chance of implant failure. However, in order for this method to be more sensitive and 
applicable in clinical settings, larger studies have to be conducted with samples from 
patients with both successful and failed implants. Additionally, to account for intrinsic 
interindividual variation multiple samples from the same individual at certain time 
intervals have to be taken for analysis168. 
 
4.5 Macrophage reactions to biodegradable implant coatings 
The widespread use of titanium in biomedical applications is due to its superior 
biocompatibility and excellent mechanical properties. Still, due to various complications 
up to 9% of implants fail153. Two main causes of implant failure are aseptic loosening 
and infection60, 108. In order to enhance implant biocompatibility and minimize the 
chance of biofilm formation on the surface of implants, implant coatings can be applied. 
The use of coatings gives the advantage of increasing certain surface characteristics 
of the implant, such as biocompatibility and antimicrobial properties, without altering 
the bulk mechanical properties of the implant material42.  
In this study two types of coatings have been used: polyarginine/hyaluronic acid-
based coatings (PAR/HA) and polylactic acid-based coatings (PLA). The coating made 
of polyarginine and hyaluronic acid was produced in the form of a polyelectrolyte 
multilayer film with polyarginine as polycation and hyaluronic acid as polyanion. Both 
components were chosen for their antimicrobial properties. Arginine is a common 
amino acid in the structure of antimicrobial peptides112, while hyaluronic acid has been 
shown to inhibit bacterial adhesion169. Additionally, polyelectrolyte multilayer films can 
be used as delivery systems for biologically active molecules113. Therefore, to enhance 
the bactericidal properties of PAR/HA coatings, these were loaded with catestatin 
(PAR/HA+CAT). Catestatin is an antimicrobial peptide which demonstrates activity 
against bacteria, yeast and fungi114. Thus both PAR/HA and PAR/HA+CAT coatings 
are able to provide protection against a variety of infectious agents. 
Polylactic acid is a synthetic biodegradable polymer commonly used in medical 
applications for the production of resorbable sutures, clips, screws and in drug delivery 
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devices116. The use of polylactic acid in biomedical applications is determined by its 
good mechanical properties, processability as well as high biocompatibility115. 
Moreover, through entrapment of biologically active molecules into its surface layer 
PLA can acquire additional properties117. In the present study two types of PLA 
coatings were used: unmodified PLA films and PLA films embedded with Brilliant 
Green dye (BGD), which possesses antiseptic properties.  
To determine how macrophages react to both PAR/HA-based coatings and to 
PLA-based coatings the secretion of TNFα and CCL18 was analyzed by ELISA. 
Elevated levels of TNFα and CCL18 were associated with various chronic inflammatory 
diseases124, 129. The analysis revealed that PAR/HA and PAR/HA+CAT coatings 
significantly inhibited the secretion of TNFα and CCL18, suggesting that these types 
of coatings are able to inhibit the development of chronic inflammation. Unmodified 
PLA films were generally able to decrease the secretion of TNFα and CCL18. However, 
the PLA films modified with BGD induced TNFα and CCL18 secretion in a donor-
specific way. These results demonstrated that surface modification of PLA films can 
be used to change inflammatory reactions of macrophages to the material. Thus 
embedding PLA-based coatings with antiseptic or immunomodulatory molecules can 
be used in implantation for the reduction of implant failure rate.  
In vivo, the coating of the implant rather than the main implant material will interact 
with immune cells. Thus, analyzing macrophage reactions to implant surface coatings, 
as well as to the main implant material, is important for the determination of the overall 
foreign body reaction towards the implant. Moreover, evaluation of individual 
responses to implant coatings represents a promising approach for the selection of an 
optimal implant coating in a personalized way. 
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5 SUMMARY 
Nowadays implants and medical devices are seen as efficient and practical 
solutions for a multitude of health associated problems. Titanium and titanium alloys 
have been successfully used in orthopedics, dentistry, cardiology and 
otorhinolaryngology.  Superior mechanical properties, excellent corrosion resistance, 
low magnetic susceptibility and high biocompatibility have been the reason for 
choosing titanium for implantation. Still, up to 9% of implants fail due to the 
development of various complications. A major cause of implant failure is aseptic 
loosening, characterized by a progressive destruction of the periprosthetic tissue as a 
result of foreign body response. Macrophages are essential cells involved in the 
recognition of the foreign body and in the initiation and coordination of the foreign body 
response. In order to investigate the extent of macrophage reaction to titanium, human 
peripheral blood monocyte-derived macrophages were cultured with polished and 
porous titanium discs. To simulate different macrophage activation states and to 
discriminate among their reactions to titanium, macrophages were brought to 3 distinct 
activation states: M(Control), M(IFNγ) and M(IL-4). ELISA analysis revealed that both 
polished and porous titanium discs induce similar inflammatory cytokine profiles in 
macrophages. Affymetrix microarray analysis revealed a total of 1690 genes were 
differentially regulated by polished titanium and 4648 genes were differentially 
regulated by porous titanium. In both experiments, the highest number of differences 
between titanium and control settings were found in M(IL-4). Microarray analysis 
showed that both polished and porous titanium affected several genes involved in 
inflammation and matrix remodeling. RT-qPCR analysis confirmed that polished 
titanium up-regulates CSF1, TNFSF14, CHI3L1 and MMP9 and down-regulates CCL8, 
CCL13, CCL18, CCL23 and IL17RB in M(IL-4) macrophages. Likewise, porous 
titanium up-regulates the expression of CHIT1, CHI3L1, MMP8 and MMP9 and 
suppresses CCL8, CCL13, CCL18, CCL23 and IL17RB in M(IL-4) macrophages. 
Additionally, in order to model wear debris, titanium microbeads and nanoparticles 
were used. RT-qPCR analysis demonstrated that nanoparticles induce stronger up-
regulation of CSF1, CHIT1 and CHI3L1 and stronger down-regulation of CCL8, CCL13, 
CCL18, and CCL23 when compared to polished titanium discs or to titanium 
microbeads. In summary, it was demonstrated that titanium induces pro-inflammatory 
and tissue-remodeling responses first of all in M(IL-4) macrophages, that model 
healing macrophages. This can explain failure of implants on later stages of implant 
integration. 
In order to simulate a bacterial infection of titanium implants, heat killed 
Staphylococcus Aureus were added to mature macrophages and naive monocytes 
cultured with polished titanium discs. Cytokine release analysis revealed that when 
Staphylococcus Aureus is added to naive monocytes higher levels of TNFα, IL-1β, IL-
6, IL-8, CCL18, MMP-7 and MMP-9 are secreted. However, the reaction to 
Staphylococcus Aureus is not affected by titanium. 
In order to examine the effect of peripheral blood mononuclear cells and fibroblasts 
on the secretion of MMP-7 and MMP-9 by macrophages in response to titanium, co-
culture models were established. MMP-7 and MMP-9 secretion levels were increased 
when the whole fraction of peripheral blood mononuclear cells was exposed to titanium. 
However, depletion of CD14+ monocytes abrogated this effect. Similarly, fibroblasts 
stimulated the secretion of MMP-7 in both juxtacrine and paracrine macrophage-
fibroblast interaction models. In contrast, MMP-9 secretion was inhibited by fibroblasts 
in the juxtacrine interaction model. Still, neither peripheral blood mononuclear cells nor 
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fibroblasts were able to substantially increase the concentration of active MMP-7 and 
MMP-9 in response to titanium. 
To increase implant biocompatibility implant coatings can be applied. In this study 
two types of coatings have been used: polyarginine/hyaluronic acid-based coatings 
and polylactic acid-based coatings. To test macrophage reaction to these coatings the 
secretion of TNFα and CCL18 was analyzed. Polyarginine/hyaluronic acid-based 
coatings inhibited the secretion of TNFα and CCL18 in all donors analyzed. In contrast, 
the reaction of macrophages to polylactic acid-based coatings was donor-dependent. 
Collectively the results of this study indicate that macrophage reaction to titanium 
implants is determined by several factors: 1) macrophage activation state; 2) titanium 
surface; 3) titanium size; 4) other cellular components of the periprosthetic tissue; 5) 
donor-specific factors. However, macrophage reaction to Staphylococcus Aureus is 
independent of titanium. Furthermore, analysis of macrophage responses to the main 
implant material as well as to coating materials in a donor-specific way represents a 
promising approach for the selection of optimal personalized implant materials.  
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